syndrome	score	normalized_score
HYDRANENCEPHALY	4.052016953000001	100.0
MENINGIOMA	3.56605334	88.00687117954413
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	3.5	86.37673634135952
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	2.868925004000001	70.80239390104055
PITUITARY CARCINOMA	2.6783736	66.09976293453083
BILATERAL POLYMICROGYRIA	2.4060298039999997	59.37857200273168
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	2.1021626600000003	51.879414236991714
TUBEROUS SCLEROSIS COMPLEX	1.7505798339999998	43.20267793311968
FAMILIAL CEREBRAL SACCULAR ANEURYSM	1.715422019	42.33501584266446
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	1.7046004899999998	42.06795059773778
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	1.5737737189999998	38.8392678820068
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	1.568001319	38.69681043261913
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	1.5344688240000002	37.86925972419543
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	1.5257836769999997	37.65491839490829
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	1.5188177	37.483004578140026
LEIGH SYNDROME WITH CARDIOMYOPATHY	1.4523980469999995	35.8438294766927
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	1.421417719	35.07926386999989
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	1.376542209	33.9717781284416
HOLOPROSENCEPHALY 1; HPE1	1.3501511669999997	33.32047182083938
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	1.345961888	33.2170843215127
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	1.342409264	33.129408873921854
CARIBBEAN PARKINSONISM	1.34025718	33.07629744756401
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	1.3351122530000001	32.94932544671414
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.333333	32.90541514178112
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	1.3081049900000001	32.282811379441924
FOCAL CORTICAL DYSPLASIA OF TAYLOR	1.279096234	31.566902331269688
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	1.266729183	31.261695044541927
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	1.2588121829999999	31.06631086693777
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	1.251473747	30.885205109357788
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	1.24555242	30.739072280480656
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	1.2407665	30.620960237626132
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	1.234793784	30.473559176147898
POLYMICROGYRIA DUE TO TUBB2B MUTATION	1.2075935879999997	29.80228370234066
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	1.2047783	29.73280501968324
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	1.201086973	29.64170651138931
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	1.1881851889999997	29.323302512846112
HYDROLETHALUS SYNDROME 1	1.1846612699999999	29.236335477888602
RHOMBENCEPHALOSYNAPSIS	1.180797644	29.140984790939
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	1.172218954	28.929270721143496
SLC35A2-CDG	1.154222124	28.485125738317702
PITUICYTOMA	1.1359054	28.033086069864716
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	1.1325577969999998	27.950470349377127
JOUBERT SYNDROME 2	1.1277055079999998	27.830720381489964
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.126150159	27.792335818492315
MYOPATHIC EHLERS-DANLOS SYNDROME	1.12114248	27.66875097030227
DUPLICATION OF THE PITUITARY GLAND	1.116349794	27.550471948876858
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	1.105755964	27.289026102946806
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	1.10434465	27.254196189440272
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	1.1031024839999999	27.223540690847642
MOWAT-WILSON SYNDROME; MOWS	1.099865389	27.143652204754236
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	1.088159473	26.854761113335346
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	1.087406319	26.83617397491179
DOORS SYNDROME	1.0684950139999998	26.36946060181006
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0627091000000002	26.226669639503854
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	1.060890523	26.18178885491943
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	1.0526316	25.977966336509546
HEMANGIOBLASTOMA	1.04992949	25.911280781356588
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.048163833	25.867706013025654
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	1.03866415	25.63326269479208
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	1.032146403	25.47241077646103
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	1.0315059739999999	25.45660558592435
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	1.030303	25.42691730934621
CRANIOPHARYNGIOMA	1.0273590970000002	25.35426452841892
OTOMANDIBULAR SYNDROME	1.0268410940000001	25.341480697403192
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	1.02301868	25.24714708418447
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	1.0183042889999998	25.130800310351013
TRANSSEXUALITY	1.0172414	25.104569200947267
PONTINE TEGMENTAL CAP DYSPLASIA	1.0098354969999999	24.921798420718495
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	1.007257034	24.858164358227942
RABSON-MENDENHALL SYNDROME	1.0072054579999998	24.856891510641212
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	1.002367937	24.737506003223274
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	1.00075643	24.69773551315149
OCULOSKELETODENTAL SYNDROME; OCSKD	1.000545554	24.69253129010785
LIPOID PROTEINOSIS OF URBACH AND WIETHE	1.000541419	24.69242924216363
PTEN HAMARTOMA TUMOR SYNDROME	1.000524934	24.692022407735465
AGENESIS OF CEREBRAL WHITE MATTER	1.000524934	24.692022407735465
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.0	24.67906752610272
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	1.0	24.67906752610272
259660 OSTEOMALACIA, SCLEROSING, WITH CEREBRAL CALCIFICATION	1.0	24.67906752610272
SPINOCEREBELLAR ATAXIA TYPE 2	0.99576839	24.574635337168584
PANHYPOPITUITARISM	0.97270717	24.005505931554275
HOLOPROSENCEPHALY 7	0.930000403	22.95154274493974
AICARDI-GOUTIÈRES SYNDROME	0.913252003	22.53820785038556
FUNCTIONING GONADOTROPIC ADENOMA	0.8939638200000001	22.062193479672736
JOUBERT SYNDROME 1	0.872070688	21.521891396686854
LISSENCEPHALY 2; LIS2	0.8670525339999999	21.398048035264473
NELSON SYNDROME	0.8665681000000001	21.386092655866534
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.850731629	20.995263318682365
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.8507299239999999	20.99522124087223
PANHYPOPHYSITIS	0.8464362	20.88925613633778
PURE MITOCHONDRIAL MYOPATHY	0.8446623500000001	20.845479172406613
TYPICAL NEMALINE MYOPATHY	0.8419169999999999	20.77772649437382
SEVERE HEMOPHILIA A	0.833333	20.565881378729756
MYOCLONUS AND ATAXIA	0.809523	19.978272780933253
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.809242208	19.97134309620446
ADENOHYPOPHYSITIS	0.7908806	19.518195732484635
INHERITED CREUTZFELDT-JAKOB DISEASE	0.780518569	19.262470469728065
PALLISTER-HALL SYNDROME	0.773051638	19.078193575366313
POSTENCEPHALITIC PARKINSONISM	0.771275819	19.034368018351177
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.76792911	18.951774360949962
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.761246334	18.786849680784144
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.761246334	18.786849680784144
SPINOCEREBELLAR ATAXIA TYPE 17	0.74877193	18.478993022120257
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.738854037	18.234228671056595
MEDULLOBLASTOMA	0.738602344	18.228017122513748
ACROMELIC FRONTONASAL DYSPLASIA	0.7094561069999998	17.50871517145895
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.7005414190000001	17.28870898433282
TUBEROUS SCLEROSIS-1	0.6950376529999999	17.152881171570947
TUBEROUS SCLEROSIS 2; TSC2	0.6950376529999999	17.152881171570947
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.6928570000000001	17.099064688932952
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.6928570000000001	17.099064688932952
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.6897973479999999	17.023555330618574
SHEEHAN SYNDROME	0.68808069	16.981189811917353
CONGENITAL MYASTHENIC SYNDROME	0.6839910730000001	16.880261877818455
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.6839910730000001	16.880261877818455
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.68181095	16.826458475086245
HYPOKALEMIC PERIODIC PARALYSIS	0.676191	16.687763349542923
ADULT-ONSET DYSTONIA-PARKINSONISM	0.675329073	16.66649179490735
JOUBERT SYNDROME 6	0.662700488	16.354830092933227
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.6568522800000002	16.210501772794533
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.6568522800000001	16.21050177279453
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.652098184	16.093175116584955
FAMILIAL CERVICAL ARTERY DISSECTION	0.65164725	16.08204648594914
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.6506447989999999	16.057306930028528
DANDY-WALKER SYNDROME	0.6485878200000001	16.006542606387757
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.645964487	15.9418011941373
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.632269657	15.603825559808804
GANGLIOCYTOMA	0.6313121100000001	15.580194192736387
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.6238385	15.395752466882628
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.6231104089999999	15.377783859928481
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.61752531	15.239948824567515
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.610905554	15.076579419237191
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.6072616	14.986650032409177
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.606468989	14.967089132018247
HISTIOCYTOID CARDIOMYOPATHY	0.6049806190000001	14.930357548284423
MYOPATHY, SCAPULOHUMEROPERONEAL	0.59898975	14.782508487693386
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.595715537	14.701703963971543
OCULOPHARYNGODISTAL MYOPATHY	0.5916516	14.601409788326716
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.5909091	14.583085580688582
SPINOCEREBELLAR ATAXIA TYPE 25	0.58734936	14.495234516853214
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.585634919	14.452923711644694
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.584419973	14.422939977270127
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.583333	14.396114497204076
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.579678243	14.30591850240958
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.57752018	14.252659519906995
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.5693456	14.050918508089469
ZOLLINGER-ELLISON SYNDROME	0.5693456	14.050918508089469
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.5693456	14.050918508089469
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.5656474	13.959650380564433
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.56409721	13.921393136876144
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.5637328930000001	13.91240213303224
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.5590278200000001	13.796285318749996
GIANT AXONAL NEUROPATHY	0.5583361739999999	13.779216140411835
AICARDI-GOUTIERES SYNDROME 5	0.5569707540000001	13.745518848030347
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.5555556	13.71059416690451
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.5555556	13.71059416690451
THYROTOXIC PERIODIC PARALYSIS	0.5514549	13.609392714700222
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.5505414190000001	13.586848855417411
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.5484036290000001	13.534090191650783
DISTAL 17P13.1 MICRODELETION SYNDROME	0.54477607	13.44456541813486
ISOLATED COMPLEX I DEFICIENCY	0.544729014	13.443404119933353
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.54427462	13.432190099723899
OROFACIODIGITAL SYNDROME TYPE 14	0.543750518	13.41925575107533
HEREDITARY METHEMOGLOBINEMIA	0.542395679	13.385819587907333
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.541667	13.367836469661482
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.5357143	13.22092938439885
DESMINOPATHY	0.5343063	13.186181257322097
ARNOLD-CHIARI MALFORMATION TYPE I	0.5333333	13.1621685246192
APROSENCEPHALY SYNDROME	0.5333333	13.1621685246192
PITUITARY APOPLEXY	0.52977848	13.07443888179606
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.528242524	13.036532919954938
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.525636359	12.972215197935771
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.523503559	12.919579682716098
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.520591154	12.84770424305774
CENTRAL NEUROCYTOMA	0.51952809	12.82146881481717
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.517952967	12.782596247938255
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.514677844	12.70176926626496
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.51392827	12.68327047890315
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.511199474	12.61592633815419
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.51111303	12.613792980840962
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.510269429	12.592973694796877
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.509609754	12.576693530926594
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.507834513	12.53288223841249
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.507779547	12.53152572878685
BRANCHIOOTORENAL SYNDROME 1	0.50581395	12.483016627694743
NEUTRAL LIPID STORAGE MYOPATHY	0.5050410399999999	12.463941929613142
KAPOSIFORM LYMPHANGIOMATOSIS	0.50373134	12.431619754874205
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.502898494	12.411065892201362
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.501822783	12.384518347793792
48,XXXY SYNDROME	0.501086973	12.36635924311741
AURICULOCONDYLAR SYNDROME	0.500545554	12.352997527056495
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.500541419	12.352895479112275
SUDANOPHILIC CEREBRAL SCLEROSIS	0.5	12.33953376305136
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	12.33953376305136
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.5	12.33953376305136
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2; CMAVM2	0.5	12.33953376305136
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.499506463	12.327353730101729
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.495513413	12.228808979516623
PHACE SYNDROME	0.494081023	12.19345892998291
MACHADO-JOSEPH DISEASE TYPE 3	0.48739383000000003	12.028425242375828
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.4868283	12.01446848931779
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.482732607	11.913390605204604
MACHADO-JOSEPH DISEASE TYPE 1	0.48110452000000004	11.873210936193237
MACHADO-JOSEPH DISEASE TYPE 2	0.48110452000000004	11.873210936193237
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.48013024	11.849166614283904
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.47968749	11.838239957136722
RFT1-CDG	0.47847059299999994	11.80820807390141
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.47801462299999997	11.796955159481533
FUMARASE DEFICIENCY; FMRD	0.477009184	11.772141862507155
MIYOSHI MYOPATHY	0.4761689	11.751404436930052
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.469569	11.588525059164526
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.46878667399999996	11.5692179829831
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.46464513899999993	11.46700876105638
NEMALINE MYOPATHY 3; NEM3	0.46252287000000003	11.414633141096829
NEMALINE MYOPATHY 2; NEM2	0.46252287000000003	11.414633141096829
SPINOCEREBELLAR ATAXIA TYPE 42	0.46099581999999995	11.376946971031092
TSH-SECRETING PITUITARY ADENOMA	0.455198879	11.23388387264726
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.45	11.105580386746224
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.45	11.105580386746224
GLUTAMINE DEFICIENCY, CONGENITAL	0.449952559	11.104409587103717
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.44883018	11.076710319972838
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.44609505699999996	11.00921003476364
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.445494794	10.99439610365322
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.44485048	10.978495034939206
ARIMA SYNDROME	0.44268955400000004	10.925165396266296
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.43943631899999996	10.844878590023013
SPINOCEREBELLAR ATAXIA 1	0.4388158	10.829564759720785
AMYOTROPHIC LATERAL SCLEROSIS	0.43578897000000005	10.754865417760753
INSULINOMA	0.43416361900000006	10.714753270678134
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.4320820569999999	10.663382261520361
LISSENCEPHALY 1; LIS1	0.4263143469999999	10.521040556959385
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.426293	10.520513732904906
GNE MYOPATHY	0.42538325000000005	10.498061951223034
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.42456393699999995	10.477842070371018
JOUBERT SYNDROME 4	0.4238251	10.459608262157237
DILATED CARDIOMYOPATHY WITH ATAXIA	0.423502169	10.451638626201964
JOUBERT SYNDROME 3; JBTS3	0.422154934	10.418390122663435
AICARDI SYNDROME; AIC	0.42114025999999993	10.393348914500454
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.4166663	10.282935753551373
JOUBERT SYNDROME 5	0.41524353399999997	10.247823215363528
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.41391424299999996	10.215017553012688
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.412704	10.185149884292697
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.409275554	10.100539033949099
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.40598329	10.019289028379342
PITUITARY ADENOMA, PROLACTIN-SECRETING	0.4047616	9.989138858373378
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.40457877999999997	9.984627031248255
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.40021149	9.876846386432183
COG1-CDG	0.3998745	9.868529787466562
PYRUVATE CARBOXYLASE DEFICIENCY	0.3971671769999999	9.801715580334589
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.39716640699999994	9.801696577452594
CADASIL	0.39629671899999996	9.780233488573952
TIBIAL MUSCULAR DYSTROPHY	0.3937756	9.718014622531614
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.3935898	9.713429251785263
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.39237749	9.683510571432693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.38827567300000004	9.58228155270998
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.3872746939999999	9.557578324376765
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.38680097299999994	9.545887331829233
MYOPATHY AND DIABETES MELLITUS	0.3859649	9.525253829805482
NON-FUNCTIONING PITUITARY ADENOMA	0.385860979	9.522689156429102
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.38263221999999997	9.44300639504259
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.3825144730000001	9.440100508878595
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.3824328	9.438084895396536
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.382380293	9.436789071597943
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.3813369869999999	9.411041252373552
RIDDLE SYNDROME	0.37376868399999996	9.224262591578547
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.37111052899999997	9.1586618048387
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.3708848	9.153091023605102
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.36773265299999996	9.075298974939898
LAING EARLY-ONSET DISTAL MYOPATHY	0.36726341	9.063718495256747
ENCEPHALITIS LETHARGICA	0.367017559	9.057651121826387
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.36428498899999995	8.990213842276585
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.363822793	8.978807275982291
WILLIAMS SYNDROME	0.363435724	8.969254773994031
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.3629484	8.957228072090938
MELAS	0.36286007000000003	8.95504817005636
O'SULLIVAN-MCLEOD SYNDROME	0.3627448	8.952203413942625
AMYOTROPHY, MONOMELIC	0.3627448	8.952203413942625
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.36260065699999994	8.948646099112208
DRAVET SYNDROME	0.36036	8.893348773706377
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.36029961899999996	8.89185862693008
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.35975820000000003	8.878496910869167
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.35903658	8.86068800216098
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.358930084	8.85805978018572
PROGRESSIVE NON-FLUENT APHASIA	0.35876620000000004	8.854015275883272
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.35811654400000004	8.837982371590536
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.35680150899999996	8.805528534026346
WRINKLY SKIN SYNDROME	0.355841614	8.781839220503377
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.35374138999999993	8.730007650587435
CANAVAN DISEASE	0.3537412	8.730002961564606
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.3525638	8.700945827459373
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.350836793	8.65832490508832
CARNEY COMPLEX	0.3455356	8.527496405072418
MELANOSIS, NEUROCUTANEOUS; NCMS	0.345439253	8.52511865095348
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.34514366899999993	8.517823913457843
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.34509766	8.516688454240036
WOLCOTT-RALLISON SYNDROME	0.344175393	8.493927764669941
PRADER-WILLI SYNDROME	0.34329030899999996	8.472084716867666
MECKEL SYNDROME, TYPE 1; MKS1	0.34318867000000003	8.469576361123382
PINEOBLASTOMA	0.34264634899999996	8.456192384543558
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34249279	8.452402691613317
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.34201742	8.440671003283434
PAPILLOMA OF CHOROID PLEXUS	0.340645299	8.406808336470451
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.3397889	8.385673207720163
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.33946797	8.37775295457901
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.33863579	8.357215528165138
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.337354547	8.325595645650793
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.33734906	8.325460231607277
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.33727001	8.32350935131934
PAPILLOMA OF CHOROID PLEXUS	0.33662923899999997	8.307695720541568
307010 HYDROCEPHALUS WITH CEREBELLAR AGENESIS	0.33608782	8.294334004480655
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION	0.33602842	8.292868067869605
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.334868513	8.264242644692606
ENCEPHALOMALACIA, MULTILOCULAR	0.33461436399999994	8.257970484359912
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.334482654	8.25472000437605
EPIDERMAL NEVUS SYNDROME	0.333878554	8.239811379683532
CHILDHOOD DISINTEGRATIVE DISORDER	0.333874419	8.239709331739311
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.33385793399999997	8.239302497311144
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.333333	8.226347615678396
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.333333	8.226347615678396
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	8.226347615678396
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.333333	8.226347615678396
PLACENTAL INSUFFICIENCY	0.333333	8.226347615678396
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.333333	8.226347615678396
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.333333	8.226347615678396
HEMOPHILIA A	0.333333	8.226347615678396
NEUROMYELITIS OPTICA	0.333333	8.226347615678396
BRAIN-LUNG-THYROID SYNDROME	0.33308213400000003	8.220156476724394
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.332612454	8.208565212288734
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.33188174000000004	8.190531872140467
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.33081437700000005	8.164190348588603
47,XYY SYNDROME	0.32943441300000004	8.130134123849011
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.327307824	8.077651890317744
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.32595256699999997	8.044205411299519
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.32428531899999996	8.00305928532476
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.323675963	7.988020947453325
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.323675963	7.988020947453325
CLASSIC MULTIMINICORE MYOPATHY	0.3233276	7.979423673452729
FRONTORHINY	0.32315920000000004	7.975267718481334
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.322919533	7.969352960404555
HARTSFIELD SYNDROME; HRTFDS	0.321905694	7.944332359262959
LISSENCEPHALY 5; LIS5	0.321400133	7.931855585205394
ETHYLMALONIC ENCEPHALOPATHY	0.3208464529999999	7.91819127909754
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.31891751	7.870586764546539
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.31548719299999994	7.7859297396675995
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.31432169299999996	7.757166286465927
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.314085614	7.751340076883434
ACUTE BILIRUBIN ENCEPHALOPATHY	0.313796759	7.74421140483318
KALLMANN SYNDROME	0.312314769	7.707637273550172
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.31193364	7.698231365223015
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.31091443999999996	7.6730784596004105
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.31009659399999995	7.652894782940457
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.310069554	7.652227460954554
POST-TRAUMATIC PITUITARY DEFICIENCY	0.30973467	7.643962836105141
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.30903572799999995	7.62671359929031
COSTELLO SYNDROME; CSTLO	0.30821974799999996	7.6065759737703615
MECKEL SYNDROME	0.30715721	7.580353526719313
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.304649227	7.518458844907997
THYMIC NEUROENDOCRINE TUMOR	0.3026786	7.469825608106234
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.297619	7.344959398051165
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.2951279	7.2834813729368895
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.29418220000000006	7.260142378777457
BETA-THALASSEMIA	0.29385895	7.252164870199643
SOMATOMAMMOTROPINOMA	0.2927521	7.224848844308377
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.291594879	7.196289709106751
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.29141743899999994	7.191910655364918
ALG13-CDG	0.29054050000000003	7.170268618567648
DISTAL MONOSOMY 10Q	0.28869244699999996	7.124660393788829
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.28587503999999997	7.055129416187314
CULLER-JONES SYNDROME; CJS	0.285267554	7.040137228172153
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.28493249000000004	7.031868161090589
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.28481974	7.029085596227019
JOUBERT SYNDROME 7	0.28328368800000003	6.991177265195415
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.2814797	6.946656523527135
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.28098167999999996	6.934365854317784
PITT-HOPKINS-LIKE SYNDROME	0.28040661899999997	6.920173885067156
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	6.8553020192657605
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.27772341	6.85395478896951
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.27770311000000003	6.853453803898732
16P13.2 MICRODELETION SYNDROME	0.27737399700000004	6.845331601948014
HOLOPROSENCEPHALY 2; HPE2	0.27710069699999995	6.838586812793128
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.27635862	6.820273044400562
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	0.2763158	6.819216286729094
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.2763158	6.819216286729094
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.27627788999999997	6.818280703279179
SECKEL SYNDROME 1; SCKL1	0.27551288299999993	6.799401043868237
SMITH-KINGSMORE SYNDROME; SKS	0.274400023	6.771936696781139
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.27400749299999994	6.762249422405116
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.27280747	6.732633973755241
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.27146036	6.699388555100154
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.270617043	6.678576277911243
LAFORA DISEASE	0.2704082	6.673422227411889
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.269670428	6.655214702405021
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.268559779	6.627804920736223
LHERMITTE-DUCLOS DISEASE	0.268359779	6.622869107231002
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.268275634	6.620792487094018
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.268207403	6.619108609637644
MANGANESE POISONING	0.267857	6.610460990339295
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.267766543	6.608228595928088
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.26757865000000003	6.603591571893405
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.267475264	6.601040101818151
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.267191988	6.594049114285627
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.26541327	6.550152012653731
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.264473553	6.526960673355306
OROFACIODIGITAL SYNDROME I; OFD1	0.26420051299999997	6.520222300757979
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.26391205	6.513103302902197
ANEURYSM, INTRACRANIAL BERRY, 2	0.2625	6.478255225601963
HARTSFIELD SYNDROME	0.2620482	6.467105222893671
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.261649804	6.457273181107541
ACROMEGALY	0.2615021	6.453627984117666
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.261236	6.4470608842489705
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.259836089	6.4125123861494355
MARINESCO-SJÖGREN SYNDROME	0.259641068	6.407699449721427
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.25825102	6.373394361264903
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.257764029	6.361375877491299
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.257279149	6.349409491229243
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.2569918	6.3423179858546845
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.256232213	6.323572086989734
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.256232213	6.323572086989734
FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1	0.25581395	6.313249746169064
AL KAISSI SYNDROME; ALKAS	0.254777977	6.287682898546845
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.2546537	6.284615858071903
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.254513554	6.28115718547439
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.25450941899999996	6.281055137530169
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.25440529	6.278485330907745
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.25419454299999994	6.27328429146382
ENTERIC ANENDOCRINOSIS	0.25401606	6.2688794974545585
GM2 GANGLIOSIDOSIS, AB VARIANT	0.254013639	6.26881974943208
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.253964847	6.267615608369345
LOWE OCULOCEREBRORENAL SYNDROME	0.25358524299999996	6.258247335620165
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.25349126899999996	6.255928144928467
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.25349126899999996	6.255928144928467
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.25287141799999996	6.240630800243345
BOUCHER-NEUHAUSER SYNDROME	0.25269542	6.236287333716888
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25235294	6.227835246670548
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.252254089	6.225395696166525
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.25144093399999995	6.205327789012335
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.25114939999999997	6.198133001740181
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.251086973	6.19659236159173
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.251086973	6.19659236159173
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.251070488	6.1961855271635615
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.25106635299999996	6.19608347921934
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.250545554	6.183230645530815
17Q24.2 MICRODELETION SYNDROME	0.250541419	6.183128597586594
EARLY-ONSET LAFORA BODY DISEASE	0.250541419	6.183128597586594
RESTRICTIVE DERMOPATHY	0.25	6.16976688152568
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.25	6.16976688152568
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25	6.16976688152568
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.25	6.16976688152568
DYSTONIA 6, TORSION	0.25	6.16976688152568
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.25	6.16976688152568
SPINOCEREBELLAR ATROPHY WITH PUPILLARY PARALYSIS	0.25	6.16976688152568
POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS	0.25	6.16976688152568
HYPERPARATHYROIDISM 2	0.25	6.16976688152568
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.25	6.16976688152568
MYOCLONIC EPILEPSY OF LAFORA	0.25	6.16976688152568
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.24961642899999997	6.160300706915624
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.24947623900000002	6.15684094843914
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.247442889	6.106659766484939
COCKAYNE SYNDROME A; CSA	0.24468282300000002	6.03854391129444
PITUITARY STALK INTERRUPTION SYNDROME	0.24438957699999997	6.031306873458679
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.24361343	6.012152289235497
SPINOCEREBELLAR ATAXIA TYPE 1	0.24269542	5.9894966584558595
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.24155421	5.9613326598043965
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.24114465300000001	5.951225174945608
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.2411408	5.95113008649843
UNILATERAL POLYMICROGYRIA	0.24011018000000003	5.925695345924678
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.239933104	5.921325275363426
NORRIE DISEASE	0.239686689	5.915243982938981
HSD10 DISEASE	0.238128393	5.876786690729325
ADNP SYNDROME	0.23790386899999993	5.871245647772094
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.23674240000000002	5.842581675891621
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.23674240000000002	5.842581675891621
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.23622604400000002	5.829838491300112
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.23571430000000002	5.817209126568034
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.23571430000000002	5.817209126568034
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.233942123	5.7734734507168275
PITUITARY GIGANTISM	0.23392860000000001	5.773139715686672
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.23281979399999997	5.745775417539323
INFANTILE MYOFIBROMATOSIS	0.23225810000000002	5.731913333384318
YUNIS-VARON SYNDROME	0.23143593399999998	5.711623043152652
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.23072035300000002	5.693963171333256
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.230432594	5.686861547541012
CONGENITAL HYDROCEPHALUS	0.22969410299999998	5.668636278284592
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.22953616999999998	5.664738639112992
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.2277778	5.621343707147119
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.227629574	5.617685627683996
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.22621010000000003	5.582654332986449
MONOSOMY 9Q22.3	0.22575351700000001	5.571386290298178
CRANIOTELENCEPHALIC DYSPLASIA	0.225301464	5.5602300437858005
FAMILIAL HYPERALDOSTERONISM TYPE I	0.22422645000000002	5.533699700688295
KAGAMI-OGATA SYNDROME	0.22352876700000002	5.516481534819481
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.2223946	5.4884913508406035
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.22209040000000002	5.480983978499164
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.22197110700000006	5.4780399384967735
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.22182215400000002	5.474363917351557
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.221689564	5.47109171978827
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.22107420300000002	5.45590518411634
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.21899524	5.404598315855071
RHEUMATIC FEVER	0.21863824	5.395787888748252
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.21818755999999997	5.384665526595588
CAP MYOPATHY	0.21751919000000003	5.368170778233168
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.21720841899999999	5.360501239739012
DISTAL MYOPATHY WITH ANTERIOR TIBIAL ONSET	0.2166667	5.347132119957839
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.21613308700000003	5.333963048698035
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.21611291800000001	5.3334652965851
OROFACIODIGITAL SYNDROME TYPE 4	0.216112518	5.333455424958089
PMM2-CDG	0.21539151699999998	5.315661792592701
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.21538133	5.315410386931814
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.21538133	5.315410386931814
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.21380700700000002	5.276557563306917
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.212885924	5.253826093752771
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.212810219	5.251957764945708
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.212296457	5.239278597855361
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.21212150000000002	5.234960822238198
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.211963064	5.231050769495632
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.211236	5.213107507943834
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.21104824	5.208473766225132
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.210477494	5.194388287150879
MALARIA	0.20986631	5.179304835944007
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.20961685000000002	5.173148395758945
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.209338413	5.166276830234179
20Q11.2 MICRODELETION SYNDROME	0.20931748400000003	5.165760322029926
ADENYLOSUCCINATE LYASE DEFICIENCY	0.209230193	5.1636060615465045
PALLISTER-HALL SYNDROME	0.209230073	5.163603100058401
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.209081573	5.159938258530775
MALIGNANT ATROPHIC PAPULOSIS	0.20869648899999999	5.150434744491553
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	5.143200594106694
TETRASOMY 5P	0.207687943	5.125544769654373
19P13.13 MICRODELETION SYNDROME	0.20743956700000002	5.119415081578509
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.20636900000000002	5.092994486294292
MYOPATHY, DISTAL 3	0.20628931	5.091027811403136
BENIGN SCHWANNOMA	0.20581395000000002	5.079296369863929
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.205640233	5.075009196290496
BASAL CELL NEVUS SYNDROME	0.205632694	5.074823140800417
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.20523090000000002	5.064907239542834
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.20508241300000002	5.061242718843086
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.20508241300000002	5.061242718843086
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.204461944	5.045930122494233
FRONTONASAL DYSPLASIA 1; FND1	0.204461944	5.045930122494233
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.20401606	5.034926121149423
POLYARTERITIS NODOSA	0.20373134	5.027899497043392
AREGENERATIVE ANEMIA	0.20373134	5.027899497043392
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.20356589400000002	5.023816444037468
PROLACTINOMA	0.20343567899999998	5.020602859259556
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.203348964	5.01846281391903
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.203253613	5.016109640151349
ROIFMAN SYNDROME	0.20316607	5.013949160542912
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.20304096000000002	5.010861562404721
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20304096000000002	5.010861562404721
SARCOSINEMIA	0.202898494	5.007345634370548
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.20289435900000002	5.007243586426327
6P22 MICRODELETION SYNDROME	0.20275482	5.003799894022802
SPINOCEREBELLAR ATAXIA 42	0.20269542000000002	5.002333957411752
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.20251889	4.997977361621368
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.20236811	4.994256251819782
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.20235294	4.993881870365412
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.20201120399999994	4.98544814454531
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.201297849	4.967843208330228
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.20127375300000003	4.967248541519121
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.201270517	4.967168680056605
FLOATING-HARBOR SYNDROME	0.20107048800000002	4.962232150858427
GLYCOGEN STORAGE DISEASE WITH SEVERE CARDIOMYOPATHY DUE TO GLYCOGENIN DEFICIENCY	0.2007927	4.955376602048485
LAMBOTTE SYNDROME	0.20075643	4.954481492269314
OCULOAURICULOFRONTONASAL SYNDROME	0.20075643	4.954481492269314
HYDROCEPHALUS, NORMAL-PRESSURE	0.20054555400000001	4.9492772692256795
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.20054555400000001	4.9492772692256795
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.200541419	4.949175221281458
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.20052493400000002	4.948768386853291
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.200285337	4.942855356311239
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.2	4.935813505220544
JUVENILE HYALINE FIBROMATOSIS	0.2	4.935813505220544
WAARDENBURG-SHAH SYNDROME	0.2	4.935813505220544
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	4.935813505220544
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.2	4.935813505220544
ANEURYSM, INTRACRANIAL BERRY, 3	0.2	4.935813505220544
HOLOPROSENCEPHALY 4	0.2	4.935813505220544
HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS	0.2	4.935813505220544
SYDENHAM CHOREA	0.2	4.935813505220544
SPINOCEREBELLAR ATAXIA TYPE 36	0.2	4.935813505220544
POLYCYSTIC KIDNEYS	0.2	4.935813505220544
WALKER-WARBURG SYNDROME	0.19922179699999998	4.916608180834527
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.198946819	4.9098219802043355
3P25.3 MICRODELETION SYNDROME	0.19878154	4.905743048602688
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.19872538	4.904357072170423
NEU-LAXOVA SYNDROME	0.19860650999999999	4.901423471413594
5Q14.3 MICRODELETION SYNDROME	0.19832694899999997	4.89452416661693
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.197917	4.884407007563672
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.197764363	4.8806400687336895
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.19763056399999998	4.877338034177765
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.19739812299999995	4.871601607042929
DRACUNCULIASIS	0.19661147	4.852187744536319
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.1960788	4.83904194563719
JUVENILE HUNTINGTON DISEASE	0.19588162899999995	4.834175949213999
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1953606	4.821317439339942
MICROPHTHALMIA, SYNDROMIC 3	0.195148634	4.816086316112704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.19411611299999998	4.790604660631585
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.194055014	4.789096794284808
HUNTINGTON DISEASE-LIKE 1	0.193694	4.78018730540094
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.19355287399999999	4.776704447317251
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.19179208300000003	4.733249767328898
PARKINSON DISEASE, LATE-ONSET; PD	0.1916667	4.730155431805272
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.1916667	4.730155431805272
PARKINSONIAN-PYRAMIDAL SYNDROME	0.1916667	4.730155431805272
MICROHYDRANENCEPHALY; MHAC	0.19125468	4.719987162403167
ANE SYNDROME	0.18980426400000003	4.684192247998228
SCHINZEL-GIEDION SYNDROME	0.18949242	4.676496228864617
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.18889477400000002	4.661746882873912
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.188238413	4.645548505433411
VICI SYNDROME; VICIS	0.187620853	4.630307700491992
COG5-CDG	0.18718660900000003	4.619590963493187
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.18657832	4.604578958186801
DESMOSTEROLOSIS	0.18559325399999999	4.580268447855133
MARDEN-WALKER SYNDROME	0.185524898	4.578581485515318
TRICHOTHIODYSTROPHY	0.18450003400000003	4.553288797654248
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.18412091299999997	4.543932444894683
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.18390357	4.538568622321358
OCULO-PALATO-CEREBRAL SYNDROME	0.183759118	4.535003681659077
MARINESCO-SJOGREN SYNDROME; MSS	0.183145418	4.519858137918308
PROPIONIC ACIDEMIA	0.18190892300000003	4.489342594317621
JOUBERT SYNDROME 26	0.18169660399999998	4.484102759379545
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.18118508299999997	4.471478898079525
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.180970709	4.466188347657685
BAND HETEROTOPIA; BH	0.18095116299999997	4.4657059706038185
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.180653027	4.458348252127857
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.180544813	4.455677631514588
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.18036560000000001	4.451254821786033
COG2-CDG	0.180003394	4.442315915453673
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.17988352999999999	4.4393577837037235
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.17933143900000004	4.425732692634171
JUVENILE POLYPOSIS SYNDROME	0.1785713	4.406973170923946
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.1782949	4.400151876659732
VAN MALDERGEM SYNDROME 1; VMLDS1	0.17706937399999997	4.369907037750736
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.17690040999999998	4.365737163785257
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.17630867800000002	4.351133769799901
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.17623959000000003	4.349428742382658
BOTULISM	0.17606947	4.345230339415116
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.17570200700000002	4.3361616952247735
OROFACIODIGITAL SYNDROME TYPE 6	0.17529010700000003	4.325996387310772
SCHIZENCEPHALY	0.1750093	4.319066332395968
300270 ADRENOMYODYSTROPHY	0.17461996400000002	4.309457882961626
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.174484778	4.306121618539041
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.174478959	4.305978011045107
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.17443351999999995	4.304856618895788
LATHOSTEROLOSIS	0.174206603	4.299256518929968
MUCOLIPIDOSIS TYPE II	0.17407441	4.29599411895649
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.17402174000000004	4.294694272469892
VISCERAL STEATOSIS, CONGENITAL	0.173875089	4.291075062538121
ULNAR-MAMMARY SYNDROME; UMS	0.173611	4.2845575922742185
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.17356387	4.283394467821714
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.17292200999999996	4.2675539615394085
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.17226879999999997	4.251433347840683
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.17172799300000002	4.238086735369095
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.171541853	4.233492973739786
DISTAL NEBULIN MYOPATHY	0.171381	4.2295232716910105
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.1713221	4.228069674613723
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.1713221	4.228069674613723
HEREDITARY FRUCTOSE INTOLERANCE	0.17122447899999998	4.225660479362756
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.17107229000000002	4.221904596755027
FG SYNDROME TYPE 1	0.171043043	4.22118280806709
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.170996299	4.22002920973465
CRYPTOSPORIDIOSIS	0.17068306	4.212298763301842
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.16973104400000003	4.188803896151913
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.16849459399999997	4.158289463109261
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.16838119299999998	4.155490832172734
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.16837513400000004	4.155341301702594
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.16829085300000002	4.153261325212427
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.168278907	4.152966509071759
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.168278907	4.152966509071759
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.167753973	4.140011627439012
CRIGLER-NAJJAR SYNDROME TYPE 1	0.167733353	4.139502745066624
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.167212554	4.126649911378098
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.167212554	4.126649911378098
CEREBROOCULONASAL SYNDROME	0.16719193400000001	4.1261410290057094
DERMATOLEUKODYSTROPHY	0.16719193400000001	4.1261410290057094
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.16706807899999995	4.123084403097263
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.166763044	4.115556423734438
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.166667	4.113186147372962
AORTIC ANEURYSM, FAMILIAL THORACIC 6	0.166667	4.113186147372962
HYPERKALEMIC PERIODIC PARALYSIS; HYPP	0.166667	4.113186147372962
TUBULAR AGGREGATE MYOPATHY	0.166667	4.113186147372962
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	4.113186147372962
HYPERKALEMIC PERIODIC PARALYSIS	0.166667	4.113186147372962
PAPILLON-LEFEVRE SYNDROME	0.166667	4.113186147372962
KIKUCHI-FUJIMOTO DISEASE	0.166667	4.113186147372962
INSULIN-RESISTANCE SYNDROME TYPE B	0.166667	4.113186147372962
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	4.113186147372962
PRIMARY MYELOFIBROSIS	0.166667	4.113186147372962
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.166667	4.113186147372962
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	0.166667	4.113186147372962
PANHYPOPITUITARISM, X-LINKED	0.1666666	4.113176275745952
MONOSOMY 18Q	0.166020173	4.097223060162255
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.165868949	4.093490992854687
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.16534970000000002	4.080676411720827
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.16454210000000002	4.060745596786747
CHARGE SYNDROME	0.164182828	4.0518790988385085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.16285402899999998	4.01908557858889
OROFACIODIGITAL SYNDROME VI	0.16270048800000003	4.015296329881866
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.162685913	4.014936632472672
SPINOCEREBELLAR ATAXIA 2; SCA2	0.1625	4.010348472991692
X-LINKED ACROGIGANTISM	0.1625	4.010348472991692
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.16238487899999998	4.007507394059019
DISTAL ANOCTAMINOPATHY	0.1621744	4.002312968605192
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.161060619	3.9748258920969017
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.16059839400000003	3.9634186101096502
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.15925859	3.930353496721907
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.15904409	3.925059836737558
VIPOMA	0.15902767	3.9246546064487795
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.15795606700000003	3.898208443650606
SRD5A3-CDG	0.15780262699999997	3.8944216875293995
INTERNAL CAROTID AGENESIS	0.157738	3.89282675343239
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.15769408299999998	3.891742922823846
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.1575658	3.888577018004396
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.1565556	3.8636462239895266
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.15649910900000003	3.8622520787859105
CEREBROCOSTOMANDIBULAR SYNDROME	0.15546036400000002	3.8366168207885085
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.15501160400000003	3.825541842445495
MONOSOMY 22Q13.3	0.154540887	3.813924985816809
8Q24.3 MICRODELETION SYNDROME	0.15368281299999997	3.792748519628416
CENTRAL PRECOCIOUS PUBERTY	0.15339582	3.7856658000018975
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.15184172999999998	3.747312307950256
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.15139743	3.7363473982484097
CHARGE SYNDROME	0.151349514	3.7351648760488283
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.15093827999999998	3.7250160043937988
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.150784753	3.721227101193719
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.15066799699999997	3.7183456719856407
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.15048379	3.713799614993861
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.15004365000000003	3.702937370212923
HEREDITARY COPROPORPHYRIA	0.14953338899999996	3.6903446045379846
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.14946724300000003	3.6887121829374045
CURRY-JONES SYNDROME	0.149263324	3.6836796521665485
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.14843174299999998	3.6631570085141236
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.148313944	3.660249839038617
XQ12-Q13.3 DUPLICATION SYNDROME	0.147876594	3.649456448856076
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.14694037000000001	3.6263513135405185
PORPHYRIA, ACUTE HEPATIC	0.14687305999999997	3.624690165505335
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.14633712799999998	3.6114638634879364
20Q13.33 MICRODELETION SYNDROME	0.14633299299999997	3.6113618155437157
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.14581219399999998	3.598508981855189
VAN MALDERGEM SYNDROME 2; VMLDS2	0.14579157399999998	3.598000099482801
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.144995664	3.578357782848101
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.14492812300000002	3.576690933948321
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.14479817	3.573483815086101
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.14452797400000003	3.5668156297568183
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.1442308	3.5594816525438158
EAST SYNDROME	0.14394397299999998	3.5524030296425058
SIALURIA	0.14394397299999998	3.5524030296425058
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.14392335299999998	3.5518941472701173
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.14391975299999998	3.5518053026270238
MARDEN-WALKER SYNDROME	0.14390680299999997	3.5514857087025606
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.14388468000000001	3.5509397336916813
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.14378738	3.548538460421391
COHEN SYNDROME	0.14366017299999997	3.545399110278598
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.143627484	3.5445923762402374
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.143422899	3.5395434092104097
JOUBERT SYNDROME 21	0.143405528	3.539114709128414
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.143381934	3.538532431209203
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.14310229300000002	3.531631152087137
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.14306351	3.5306740238112715
SPINOCEREBELLAR ATAXIA 40; SCA40	0.14285699999999998	3.5255775495764556
ARTERIOVENOUS MALFORMATIONS OF THE BRAIN	0.14285699999999998	3.5255775495764556
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.14285699999999998	3.5255775495764556
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.14285699999999998	3.5255775495764556
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.14285699999999998	3.5255775495764556
AUTOIMMUNE HYPOPARATHYROIDISM	0.14285699999999998	3.5255775495764556
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	3.5255775495764556
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	3.5255775495764556
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	3.5255775495764556
SPINOCEREBELLAR ATAXIA TYPE 40	0.14285699999999998	3.5255775495764556
MUSCULAR ATROPHY, MALIGNANT NEUROGENIC	0.14285699999999998	3.5255775495764556
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.142361	3.5133367320835087
ALEXANDER DISEASE	0.141652203	3.49584428305821
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.14081949300000002	3.4752937767385492
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.14051500300000003	3.467779247467526
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.13928578	3.4374431700458876
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.13909166900000003	3.432652691569329
PITT-HOPKINS SYNDROME	0.139087103	3.4325400069470033
BECKWITH-WIEDEMANN SYNDROME	0.13867716000000002	3.422422995968151
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.13867158300000001	3.4222853608085577
SPINOCEREBELLAR ATAXIA TYPE 43	0.1383922	3.4153904488859124
MOHR-TRANEBJAERG SYNDROME	0.13813799999999998	3.4091170299207767
NON-DISTAL MONOSOMY 20Q	0.13795124900000003	3.4045081893812106
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.13772003400000002	3.3988020187831625
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.1372223	3.386518407787125
LISSENCEPHALY 3; LIS3	0.13698349900000004	3.380625021782825
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.136476794	3.3681200148720105
DPM3-CDG	0.1359649	3.355486948279803
SPINOCEREBELLAR ATAXIA TYPE 29	0.135756974	3.3503555284853705
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.13563855000000002	3.3474329345926606
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.1356383	3.3474267648257783
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.135540477	3.345012584403172
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.13552904400000002	3.3447304286241466
MARSHALL-SMITH SYNDROME; MRSHSS	0.135287104	3.3387595750268813
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.13506879299999996	3.3333718631161893
GRFOMA	0.13427597	3.313805730762943
PPOMA	0.13427597	3.313805730762943
GLUCAGONOMA	0.13427597	3.313805730762943
SOMATOSTATINOMA	0.13427597	3.313805730762943
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.13384003700000002	3.303047310819087
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.13310740000000001	3.2849665128239653
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.132145748	3.2612338381793533
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.13169182999999998	3.250031565206039
CENTRAL CONGENITAL HYPOTHYROIDISM	0.13113497	3.2362887796634534
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.1309091	3.2307145186813333
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.129825987	3.203984299815934
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.129501654	3.1959800638079896
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.12925304299999998	3.189844576151258
GLYCOGEN STORAGE DISEASE II	0.12918492	3.1881633640341778
ALG11-CDG	0.128858627	3.1801107570538827
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.1287878	3.178362812738212
RETICULAR DYSGENESIS	0.12873134	3.176969432585688
COACH SYNDROME	0.128626073	3.1743715411844176
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.128436333	3.1696889349120148
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.128099703	3.1613812204107026
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.12768535	3.15115537474406
3Q27.3 MICRODELETION SYNDROME	0.12735294	3.142951805907708
PULMONARY ARTERIOVENOUS MALFORMATION	0.127164819	3.13830915504563
CRANIOTELENCEPHALIC DYSPLASIA	0.127093214	3.136542010415423
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.126533519	3.122729259716402
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3	0.1263158	3.1173561578136857
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.12628820400000002	3.116675114266236
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.126244233	3.1155899509880456
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.126070488	3.1113020864007224
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.125545554	3.098347204767975
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.125069474	3.0865979943001483
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.12501116300000004	3.0851589331936347
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.125	3.08488344076284
DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	0.125	3.08488344076284
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.125	3.08488344076284
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.125	3.08488344076284
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.12491986900000002	3.082905882402906
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.12484299700000001	3.0810087531240393
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.124722994	3.078047190983704
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.12463528400000001	3.07588258997099
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.12453802300000001	3.0734822791843337
PIERPONT SYNDROME	0.12446883700000001	3.071774833218473
MULTIFOCAL MOTOR NEUROPATHY	0.124359	3.069064158478608
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.124343267	3.0686758827092193
HOLOPROSENCEPHALY	0.12398140300000002	3.0597454166179547
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.12361576800000003	3.0507218857630485
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.123375759	3.044798687445175
RAVINE SYNDROME	0.1233333	3.0437508389170844
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.12227423399999998	3.017614077588484
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.12180162	3.0059504047687033
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.12174929999999999	3.004659195955737
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.121334533	2.9944231331551387
MECKEL SYNDROME, TYPE 4; MKS4	0.12132815000000001	2.9942656066671196
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.12124833800000002	2.9922959209297266
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12107199	2.9879438167296333
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.12104733300000002	2.9873353049616425
ADAMS-OLIVER SYNDROME	0.12041173299999999	2.971649289642051
AICARDI SYNDROME	0.12034679999999999	2.970046803750378
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.120253144	2.967735461002154
PETTIGREW SYNDROME	0.12016235300000001	2.9654948237823917
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.11951540000000002	2.949528627009177
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.11843029999999999	2.9227493708366024
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.118365613	2.9211529559955416
ADAMS-OLIVER SYNDROME 1; AOS1	0.118364937	2.921136272945894
CHOREOACANTHOCYTOSIS	0.11834446900000002	2.92063114179177
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.1179361	2.910552975665203
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.11777766999999999	2.906643070997042
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.11777766999999999	2.906643070997042
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.116891413	2.8847710746485613
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.11679678400000001	2.882435719167634
DISTAL MYOTILINOPATHY	0.1166667	2.879225367347568
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.1166667	2.879225367347568
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.11642662299999999	2.8733004908531035
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.116419134	2.873115669316401
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.11630438700000001	2.870283820354983
HUNTINGTON DISEASE-LIKE 3	0.11605770899999998	2.8641960373357787
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.11604770300000002	2.8639490985861134
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.115816228	2.858236511430508
HUNTINGTON DISEASE-LIKE 2	0.11551629	2.850834321274864
NARP SYNDROME	0.11525753300000001	2.8444484397990126
PITUITARY DWARFISM IV	0.11489887999999998	2.835597218193573
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.11458321999999999	2.8278070237382833
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.11420298000000001	2.8184230551021585
16P12.1P12.3 TRIPLICATION SYNDROME	0.11374250000000001	2.8070588380877384
MULTIMINICORE MYOPATHY	0.11360961	2.8037792368041945
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.11301282000000001	2.789051016095292
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.112987	2.7884138025717675
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.112954403	2.787609339007619
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.112937918	2.7872025045794517
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.112933783	2.787100456635231
SPINOCEREBELLAR ATAXIA TYPE 37	0.11274510000000001	2.782443936137204
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.11240884899999999	2.7741455750024837
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.11219797299999999	2.7689413519588495
CHROMOSOME 1P36 DELETION SYNDROME	0.11209366700000001	2.766367177141472
PAINE SYNDROME	0.11186742999999999	2.7607838589415685
19P13.12 MICRODELETION SYNDROME	0.111765533	2.7582691359978617
ISOLATED BILIARY ATRESIA	0.11165241899999999	2.7554775879537137
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.11163593399999999	2.7550707535255463
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.1114551	2.750607939028531
RENAL AGENESIS, BILATERAL	0.11111099999999999	2.742115871892799
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.11111099999999999	2.742115871892799
HYPERLIPOPROTEINEMIA, TYPE IV	0.11111099999999999	2.742115871892799
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.11111099999999999	2.742115871892799
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.11111099999999999	2.742115871892799
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.11111099999999999	2.742115871892799
INCLUSION BODY MYOSITIS	0.11111099999999999	2.742115871892799
CHILDHOOD APRAXIA OF SPEECH	0.11111099999999999	2.742115871892799
RHYNS SYNDROME	0.11111099999999999	2.742115871892799
CRANIOSYNOSTOSIS 4; CRS4	0.11111099999999999	2.742115871892799
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.11064495300000002	2.730614266509462
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.11054859	2.728236117525444
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.11004104900000002	2.7157104789141786
WAISMAN SYNDROME; WSMN	0.10994530699999999	2.7133476556310936
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.109764323	2.7088811392739496
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.10970975000000001	2.707534328521848
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.10968065000000002	2.7068161676568385
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.109678669	2.7067672784240693
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.10966304400000002	2.706381667993974
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.10952595400000001	2.7029984146268204
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.1093837	2.6994877185549617
VACTERL WITH HYDROCEPHALUS	0.10883535400000001	2.685955050593294
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.10876620000000001	2.6842483943575934
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.10862641900000002	2.6807987296197275
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.10854836400000001	2.6788724050039776
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.10795194900000002	2.664153438945397
SEPTOOPTIC DYSPLASIA	0.107923864	2.663460327333926
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.107717164	2.658359164076281
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.10746559900000001	2.652150774454077
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.10733117	2.6488331920856103
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.10732030000000001	2.648564930621602
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.10732030000000001	2.648564930621602
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.10732030000000001	2.648564930621602
XIA-GIBBS SYNDROME	0.10722162800000001	2.646129797670666
HYPOALPHALIPOPROTEINEMIA	0.10714290000000001	2.644186864042471
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.10647775000000001	2.6277715822774836
PEHO SYNDROME	0.10630800400000001	2.623582409281198
RADICULONEUROPATHY, FATAL NEONATAL	0.10628931000000001	2.623121058792865
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.10628931000000001	2.623121058792865
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.106252147	2.6222039106063924
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.10621982300000002	2.6214061844276793
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.10612889	2.6191620427803275
PFAPA SYNDROME	0.10581600000000001	2.6114402093420854
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.10572301800000002	2.6091455002853734
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.1055556	2.605013780158288
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.1055556	2.605013780158288
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.10473394	2.5847359775347902
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.10472127700000002	2.5844234665027077
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.104469024	2.5781980976820456
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.10431932300000002	2.574503616594321
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.10423390700000001	2.5723956293625108
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.10413083	2.5698517851191225
DE SANCTIS-CACCHIONE SYNDROME	0.10397678400000002	2.566050073482997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.10284946000000002	2.5382287683632008
MOSAIC TRISOMY 1	0.10242233	2.5276875982507763
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.10174469	2.510964074932388
LINEAR NEVUS SEBACEUS SYNDROME	0.10159811300000002	2.5073466912516147
NEMALINE MYOPATHY 1; NEM1	0.10142872	2.5031662299661654
ADAMS-OLIVER SYNDROME 2; AOS2	0.10142364300000002	2.5030409343403357
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.10106635300000001	2.4942233503039346
JOUBERT SYNDROME 23; JBTS23	0.100796154	2.4875550909374486
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.10006889000000001	2.469606893572145
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.1	2.467906752610272
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.1	2.467906752610272
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.1	2.467906752610272
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.09979695400000001	2.462895766665367
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.09979695400000001	2.462895766665367
INIENCEPHALY	0.09976328000000002	2.462064723745493
PHELAN-MCDERMID SYNDROME	0.09923503300000001	2.449028080362032
ZEBRA BODY MYOPATHY	0.09908831400000001	2.4454071922536693
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.09902522999999999	2.4438503379578527
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.09890862000000002	2.440972511893634
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.09870886800000002	2.43604281879716
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.09805489	2.419903251574574
WYBURN-MASON SYNDROME	0.098024677	2.419157622907408
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.09774440000000001	2.4122406478983947
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.09769098	2.4109222921111497
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.09749436000000002	2.406069893854168
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.09735484700000002	2.402626843106399
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.097059223	2.395331118448062
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.09696671300000001	2.3930480579112223
ADULT-ONSET NEMALINE MYOPATHY	0.09628270000000001	2.37616725489549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.09618497300000002	2.373755443663367
TEMPLE SYNDROME	0.09557802000000001	2.3587764095911963
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.09556422	2.3584358384593362
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.0955556	2.358223104897261
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.0955556	2.358223104897261
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.09555108400000001	2.358111654228313
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.095518138	2.357298577669598
HYDROLETHALUS	0.09539819000000001	2.354338372877977
LISSENCEPHALY, X-LINKED, 1; LISX1	0.09514900300000001	2.3481886700783505
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.094932124	2.3428362985923568
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.09463776	2.3355716695591027
COG4-CDG	0.094620724	2.335151236964728
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.09453993400000002	2.333157415099295
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.09433691	2.3281469720938746
SILVER-RUSSELL SYNDROME	0.09423310000000001	2.3255850380939904
USHER SYNDROME TYPE 1	0.09385357800000002	2.316218789028349
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.093835554	2.3157739735152583
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.09380925	2.3151248153230513
PELVIS-SHOULDER DYSPLASIA	0.09366392000000001	2.311538206439483
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.09366392000000001	2.311538206439483
HUNTINGTON DISEASE-LIKE 1	0.09349431900000002	2.307352611907989
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.09342035300000001	2.3055271999993527
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.09321128000000001	2.3003674733144677
TRISOMY 8P	0.09317723900000001	2.299527373176812
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.09307536400000001	2.29701319317259
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.092938073	2.293624979312864
CEDNIK SYNDROME	0.09285690700000002	2.29162187811804
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.09281354	2.2905516209966357
USHER SYNDROME TYPE 2	0.09278309000000001	2.289800143390466
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.09274697000000001	2.2889087354714235
LEBER CONGENITAL AMAUROSIS	0.09252100700000002	2.2833321793360226
GLIOBLASTOMA	0.09242406900000001	2.2809398398881773
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.09230769999999999	2.2780679614792314
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.09206415300000001	2.2720574486204526
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.09184337300000002	2.26660880409204
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.09166553000000001	2.2622198046859947
NEMALINE MYOPATHY 4	0.09165424	2.2619411780136245
CONGENITAL ENTEROVIRUS INFECTION	0.09157669000000002	2.2600273163269757
MYOCLONIC EPILEPSY OF INFANCY	0.09145465400000001	2.2570155816423605
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.09145465400000001	2.2570155816423605
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.09145051900000001	2.25691353369814
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.09145051900000001	2.25691353369814
ARTERIAL TORTUOSITY SYNDROME	0.09143403400000001	2.256506699269972
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.09132765000000001	2.253881241350275
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.09095658000000002	2.2447235797633645
ULNAR-MAMMARY SYNDROME	0.0909091	2.2435518176372247
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0909091	2.2435518176372247
SPINOCEREBELLAR ATAXIA TYPE 3	0.0909091	2.2435518176372247
DYSTROPHIA MYOTONICA 2	0.09072468	2.2390005040040606
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.09057968000000001	2.2354220392127764
STORMORKEN SYNDROME; STRMK	0.09057968000000001	2.2354220392127764
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.09051255	2.2337653334097487
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.090434	2.231826792655573
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.090247029	2.2272125227211506
THYMIC EPITHELIAL NEOPLASM	0.0900735	2.222929988812413
THYMIC CARCINOMA	0.0900735	2.222929988812413
THYMIC TUMOR	0.0900735	2.222929988812413
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.09006148900000002	2.2226335685323577
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	2.222063753542247
CEREBROFACIOARTICULAR SYNDROME	0.08970412400000001	2.213814133565892
SEVERE CONGENITAL NEMALINE MYOPATHY	0.08962529999999999	2.2118688307472136
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.08960834000000001	2.2114502737619715
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.08943493	2.2071706766622694
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.08929225	2.2036494673076454
CRYPTOCOCCOSIS	0.088906159	2.1941211014474247
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.08856130000000001	2.185610302899441
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.08840992300000002	2.181874459694542
SECKEL SYNDROME 10; SCKL10	0.08837543	2.1810232046183637
49,XYYYY SYNDROME	0.08820862400000001	2.176906588080605
49,XXXYY SYNDROME	0.08820862400000001	2.176906588080605
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.088201373	2.176727640161973
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.088164554	2.1758189815747295
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.08815161300000002	2.1754996097618746
DISTAL MYOPATHY, TATEYAMA TYPE	0.0879433	2.170358639168309
SALT-AND-PEPPER SYNDROME	0.087900644	2.169305928863916
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0878137	2.167160232016926
6Q TERMINAL DELETION SYNDROME	0.08769993300000002	2.1643525685416845
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.087619	2.162355217569594
OVARIAN DYSGENESIS 8; ODG8	0.087619	2.162355217569594
46,XY PARTIAL GONADAL DYSGENESIS	0.087619	2.162355217569594
ANDROGEN INSENSITIVITY SYNDROME	0.087619	2.162355217569594
SPERMATOGENIC FAILURE 28; SPGF28	0.087619	2.162355217569594
PREMATURE OVARIAN FAILURE 14; POF14	0.087619	2.162355217569594
46,XX SEX REVERSAL 1; SRXX1	0.087619	2.162355217569594
PRECOCIOUS PUBERTY, CENTRAL	0.087619	2.162355217569594
PREMATURE OVARIAN FAILURE 7	0.087619	2.162355217569594
46,XY SEX REVERSAL 3	0.087619	2.162355217569594
46,XY SEX REVERSAL 1; SRXY1	0.087619	2.162355217569594
COG8-CDG	0.087566843	2.161068031444635
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.08734693900000001	2.1556410057793753
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0871212	2.1500699777551002
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.08697942300000001	2.146571053598452
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.08682456900000002	2.1427494012757653
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.08679153	2.14193402956377
MICROFORM HOLOPROSENCEPHALY	0.08666795300000002	2.138884264436097
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.086612657	2.137519610718173
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.08649380300000002	2.1345864048264263
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0864143	2.132624344920898
WHITE-SUTTON SYNDROME; WHSUS	0.08612080800000001	2.125381236034527
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.08608239899999999	2.1244333377299167
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.08596490000000001	2.1215335719746675
OROFACIODIGITAL SYNDROME XIV; OFD14	0.08591770400000001	2.1203688187037057
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.08568624000000001	2.114656503017844
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.08568624000000001	2.114656503017844
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.08538296800000002	2.107172032851068
YUNIS-VARON SYNDROME	0.08521996000000001	2.1031491474117727
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0846836	2.089912282753472
VON HIPPEL-LINDAU DISEASE	0.08466249	2.089391307637996
MICROTRIPLICATION 11Q24.1	0.08461466400000002	2.088211006554493
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.084470813	2.0846608980117955
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.083878854	2.070051901878111
LENNOX-GASTAUT SYNDROME	0.08385823400000002	2.069543019505723
DDOST-CDG	0.08359948900000001	2.063157434178682
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08345316	2.0595461709066543
PERIPARTUM CARDIOMYOPATHY	0.08333330000000001	2.0565881378729762
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.08333330000000001	2.0565881378729762
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.08333330000000001	2.0565881378729762
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08333330000000001	2.0565881378729762
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.08333330000000001	2.0565881378729762
SPEECH-LANGUAGE DISORDER 1	0.08333330000000001	2.0565881378729762
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.083296019	2.055668077556535
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.08305807000000001	2.0497957181177666
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.082954784	2.047246715949265
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.08279115000000001	2.043208381413699
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.082666474	2.0401314939908146
DISTAL MYOPATHY, WELANDER TYPE	0.0826646	2.040085245418271
TRISOMY 18	0.08250058400000002	2.03603748347891
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.08248249900000001	2.0355911625427003
PETERS PLUS SYNDROME	0.08237761800000001	2.0330027972614952
RIGID SPINE MUSCULAR DYSTROPHY 1	0.08228639	2.0307513752892232
DISTAL MONOSOMY 12Q	0.08179981800000001	2.018743232044913
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.08164669000000001	2.014964175792776
JOUBERT SYNDROME 10	0.08117878800000002	2.0034167907391773
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.08054839999999999	1.9878594027195318
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.080407403	1.9843797282355542
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.08027590400000001	1.9811344555349393
MECKEL SYNDROME 12; MKS12	0.07996819000000002	1.9735403609502127
LISSENCEPHALY 8; LIS8	0.079612337	1.9647582407338458
XQ21 MICRODELETION SYNDROME	0.079598573	1.9644185580484166
GRISCELLI SYNDROME	0.07952666700000002	1.9626439850188853
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07944199	1.960554235617977
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.07943141000000001	1.9602931310835507
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.07913737800000001	1.9530366955007157
PFEIFFER SYNDROME TYPE 2	0.07879022700000002	1.944469332529962
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07867498	1.941625144034781
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.07831286300000001	1.9326884341394315
SHPRINTZEN-GOLDBERG SYNDROME	0.078223754	1.9304893071112477
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.07820932400000002	1.9301331881668466
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0781276	1.928116316052343
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.07809527000000001	1.927318441799224
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.07801592	1.9253601577910278
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.07776651999999999	1.9192051983500171
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.077744164	1.918653473116404
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.077612834	1.915412371178201
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.07732841900000001	1.9083932741877647
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.07723238300000002	1.906023195258828
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.07711356000000001	1.9030907544181737
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.077001499	1.900325193432131
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	1.8983903792171524
LARYNGEAL NEUROENDOCRINE TUMOR	0.07692310000000001	1.8983903792171524
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.07692310000000001	1.8983903792171524
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	1.8983903792171524
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.07692310000000001	1.8983903792171524
PROLACTIN DEFICIENCY, ISOLATED	0.07692310000000001	1.8983903792171524
16Q24.3 MICRODELETION SYNDROME	0.07689854900000001	1.897784483430319
HOLOPROSENCEPHALY 3; HPE3	0.07685060800000001	1.8966013442540501
MERCURY POISONING	0.07684001900000001	1.8963400176080158
FOODBORNE BOTULISM	0.07672317000000001	1.8934562932466585
DUODENAL NEUROENDOCRINE TUMOR	0.07670450000000001	1.8929955350559462
GALLOWAY-MOWAT SYNDROME	0.07667196300000001	1.8921925522358491
GENITOPATELLAR SYNDROME; GTPTS	0.076667594	1.8920847293898277
OPTIC ATROPHY 11; OPA11	0.07656206799999998	1.8894804461100676
17Q12 MICRODELETION SYNDROME	0.07651272700000002	1.888262756239263
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.076492328	1.8877593279407978
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.07639878000000001	1.8854506505318662
TENORIO SYNDROME; TNORS	0.07623552300000001	1.881421620004757
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.07619698400000001	1.8804705134213686
TURNPENNY-FRY SYNDROME; TPFS	0.07588055800000001	1.8726614148003542
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.07583389000000001	1.871509692077046
MYXEDEMA	0.07575152	1.8694768772849206
PFEIFFER SYNDROME TYPE 3	0.07548985300000001	1.8630191797225681
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.07539577300000001	1.8606973730497123
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.075359013	1.8597901705274527
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.07523250000000001	1.856667947657523
NEUROCUTANEOUS MELANOCYTOSIS	0.075196443	1.855778094519734
ADULT-ONSET STILL DISEASE	0.07515994000000001	1.854877234517829
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07515994000000001	1.854877234517829
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.074995288	1.8508137766915205
RAMOS-ARROYO SYNDROME	0.074980634	1.8504521296359933
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.074955657	1.8498357205663938
ALLAN-HERNDON-DUDLEY SYNDROME	0.07483054	1.8467479496747305
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.07478270999999999	1.8455675498749566
STIFF SKIN SYNDROME	0.07437845000000001	1.8355907900368549
WOUND BOTULISM	0.07431954	1.834136946168892
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.07427350999999999	1.8330009686906652
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.07396845	1.8254723723511526
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.07394749	1.8249550990958054
MYOTILINOPATHY	0.07391307999999999	1.8241058923822322
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.073453079	1.8127534966411576
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.073435654	1.8123234638895152
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.07332228300000002	1.809525573325014
BANGSTAD SYNDROME	0.073251383	1.8077758274374127
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.073221334	1.8070342461373206
VASCULAR HYALINOSIS	0.0731383	1.8049850444443585
NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	0.07295601	1.8004862972250253
KAPUR-TORIELLO SYNDROME	0.07295470400000001	1.8004540663628363
CYSTINOSIS, NEPHROPATHIC; CTNS	0.07293402	1.7999436045301263
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.07280167	1.7966773299430465
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.07270996400000002	1.794414111376498
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.07263715	1.7926171297536522
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.07261204000000002	1.7919974383680721
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.072226714	1.7824879519945085
GITELMAN SYNDROME	0.072073929	1.7787173606625326
WEBB-DATTANI SYNDROME; WEDAS	0.072052023	1.7781767410093063
CHROMOSOME 4Q21 DELETION SYNDROME	0.07197415400000001	1.7762550067001164
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.07197415400000001	1.7762550067001164
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07197001900000001	1.7761529587558957
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.07195353400000001	1.7757461243277282
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.07195353400000001	1.7757461243277282
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.07171066300000001	1.7697522945185957
ICHTHYOSIS AND MALE HYPOGONADISM	0.071520933	1.7650699350368682
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.07151645400000001	1.764959397493419
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	1.7627912426949808
KENNEDY DISEASE	0.07142860000000001	1.7627912426949808
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	1.7627912426949808
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.071341299	1.760636735420884
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.07125000000000001	1.7583835612348189
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.07125000000000001	1.7583835612348189
PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	0.07125000000000001	1.7583835612348189
CARNEY COMPLEX, TYPE 1; CNC1	0.07125000000000001	1.7583835612348189
PRIMARY PROGRESSIVE FREEZING GAIT	0.07107199	1.7539904404244973
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.07107199	1.7539904404244973
49,XXXXY SYNDROME	0.07097074700000001	1.7514918575909522
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.070722264	1.7453595288548636
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.07065273	1.7436434945735033
ADULT INTESTINAL BOTULISM	0.0705882	1.742050954346044
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.0705882	1.742050954346044
WITTEVEEN-KOLK SYNDROME	0.070566767	1.7415220078917568
DE BARSY SYNDROME	0.070542954	1.740934325256758
OCULODENTODIGITAL DYSPLASIA	0.07052847300000001	1.7405769476799127
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.07031220800000001	1.7352397291413801
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.0701755	1.7318659031780215
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.070118074	1.730448683046267
WEAVER SYNDROME	0.070098637	1.7299689960107625
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.070094423	1.7298649984202072
CLASSIC HOMOCYSTINURIA	0.06996195300000001	1.7265957623450248
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.069706943	1.7203023533351929
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.069565194	1.7168041201924353
14Q22Q23 MICRODELETION SYNDROME	0.069501454	1.715231076428322
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.069497873	1.7151427006875108
PSEUDOXANTHOMA ELASTICUM	0.0694618	1.7142524526846419
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0694618	1.7142524526846419
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.06942721300000002	1.7133988777761167
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0693305	1.7110120911184645
BETHLEM MYOPATHY 1	0.06932002999999999	1.7107537012814658
BARAITSER-WINTER SYNDROME 2; BRWS2	0.068901553	1.7004260791403454
ANEURYSM, INTRACRANIAL BERRY, 1	0.0688956	1.7002791646513624
CAUDAL REGRESSION SEQUENCE	0.06886790000000001	1.6995955544808896
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.068855774	1.6992962961080678
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.06876962	1.6971700957244242
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.06872549	1.696081008474497
KRABBE DISEASE	0.06858889900000001	1.6927100699620394
LISSENCEPHALY 4	0.068496263	1.6904238998626913
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.06848891400000001	1.6902425333954423
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.068275634	1.6849789818734746
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.06826214900000001	1.6846461846478853
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.06821398899999999	1.6834576407558275
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.06814387999999999	1.6817274160106401
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.06814387999999999	1.6817274160106401
WIEDEMANN-STEINER SYNDROME	0.06813448300000001	1.681495506813098
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.06745169399999999	1.6646449109760173
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.06728864300000001	1.6606209643368193
BRONCHOPULMONARY DYSPLASIA	0.06722686	1.6590962175078536
WOODHOUSE-SAKATI SYNDROME	0.067191634	1.6582268726751792
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.06717706300000001	1.6578672739822566
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.067043429	1.6545693114724733
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.066814813	1.6489272817709257
CENTRAL CORE DISEASE	0.06674924	1.6473090012760365
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.066718834	1.6465586095488378
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.0666667	1.645271991042432
THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	0.0666667	1.645271991042432
ISOLATED FOLLICLE STIMULATING HORMONE DEFICIENCY	0.0666667	1.645271991042432
GENETIC TRANSIENT CONGENITAL HYPOTHYROIDISM	0.0666667	1.645271991042432
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.0666667	1.645271991042432
DEMENTIA, LEWY BODY; DLB	0.0666667	1.645271991042432
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.0666667	1.645271991042432
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0666667	1.645271991042432
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.0666667	1.645271991042432
PARKINSON DISEASE 21; PARK21	0.0666667	1.645271991042432
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0666667	1.645271991042432
19P13.3 MICRODUPLICATION SYNDROME	0.06666614400000001	1.6452582694808877
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.06652820000000001	1.6418539401900671
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.066489669	1.6409030310392185
SCHIZENCEPHALY	0.066291707	1.6360175134736163
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.0661939	1.6336037279160907
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.06609885300000001	1.6312580565849375
L1 SYNDROME	0.066057297	1.6302324932548227
ENDOCARDIAL FIBROELASTOSIS	0.066031589	1.6295980437868613
SPASTIC PARAPLEGIA TYPE 7	0.06599751	1.6287570058446392
AMISH LETHAL MICROCEPHALY	0.06590174000000001	1.626393491547665
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.065799753	1.6238765474878798
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.065744787	1.62252003786224
NEMALINE MYOPATHY 7; NEM7	0.06573015000000001	1.622158810350861
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.06571568700000001	1.6218018769972309
ACUTE INTERMITTENT PORPHYRIA	0.065499889	1.6164761835832326
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.06549017	1.6162363277259464
ADRENOCORTICAL CARCINOMA	0.06544985	1.6152412677232941
NEMALINE MYOPATHY 10	0.06528481	1.611168234418786
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.06520450800000001	1.6091864559383051
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.065198269	1.6090324832360097
MACHADO-JOSEPH DISEASE; MJD	0.06519542	1.6089621725726275
9Q33.3Q34.11 MICRODELETION SYNDROME	0.06509031900000001	1.606368377896567
SMITH-LEMLI-OPITZ SYNDROME	0.064918327	1.6021237757146172
CITRULLINEMIA, CLASSIC	0.064781067	1.5987363269059844
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.064734394	1.5975844807873385
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.064716404	1.5971405043625442
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.06463745	1.5951919932650882
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.064515939	1.5921932150909237
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.064281557	1.586408885886021
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0642595	1.5858645396935975
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.06412783	1.5826150468724356
HEC SYNDROME	0.06395896000000001	1.578447492739303
MYASTHENIA GRAVIS; MG	0.06354113	1.568135837954871
FRYNS SYNDROME; FRNS	0.063267823	1.5613908760465147
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.063228459	1.560419409232417
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.063213627	1.5600533693028698
DISTAL MONOSOMY 13Q	0.06308713000000002	1.556931541298021
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.063045554	1.5559054843865554
ACTH DEFICIENCY, ISOLATED; IAD	0.063041419	1.555803436442335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.062817299	1.5502723638283846
AMYLOIDOSIS VI	0.062753	1.548685524465524
NEMALINE MYOPATHY 6	0.0627091	1.547602113401128
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.062669894	1.5466345458796997
CONGENITAL FACTOR X DEFICIENCY	0.0625	1.54244172038142
LOEYS-DIETZ SYNDROME 3; LDS3	0.0625	1.54244172038142
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.0625	1.54244172038142
MOYAMOYA DISEASE	0.062408742999999996	1.5401895827161902
SSR4-CDG	0.062352836999999994	1.5388098747670758
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.062290938	1.5372822651662776
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.062206093000000004	1.5351883696820257
COFFIN-LOWRY SYNDROME	0.062186122999999996	1.534695528703529
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.061860947000000006	1.5266704882416615
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.061678053999999996	1.5221568595446096
MEVALONIC ACIDURIA; MEVA	0.061485684	1.5174093473246135
ABETA AMYLOIDOSIS, DUTCH TYPE	0.061428049	1.5159869692677466
HEPARIN-INDUCED THROMBOCYTOPENIA	0.0613176	1.513261190938556
FAMILIAL AORTIC DISSECTION	0.0613176	1.513261190938556
COFFIN-SIRIS SYNDROME	0.061241636999999995	1.5113864949320706
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.061136052999999996	1.5087807802663946
LISSENCEPHALY, X-LINKED, 2	0.060988629	1.5051424934154265
MYOPATHY, SPHEROID BODY	0.06080187	1.5005334554433192
TARP SYNDROME; TARPS	0.060690504	1.497785046409207
SPINOCEREBELLAR ATAXIA TYPE 8	0.060678619999999996	1.4974917603707267
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.060393720000000005	1.4904606940325404
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.06028108799999999	1.48768104129894
TRIPLE A SYNDROME	0.060121349000000004	1.4837388317313882
SECKEL SYNDROME 5; SCKL5	0.060104864	1.4833319973032202
MEGALENCEPHALY WITH DYSMYELINATION	0.060065218999999996	1.4823535956711478
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.060004494	1.4808549592956253
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0598141	1.4761562129130605
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.05953675399999999	1.4693115722509658
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.05951945	1.4688845256664944
THAKKER-DONNAI SYNDROME	0.05949261	1.4682221394940937
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.059418039	1.4663817967496047
SLC39A8-CDG	0.059388819	1.4656606743964922
CONGENITAL HYPOTHYROIDISM	0.059369054	1.4651728926268386
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.059343480000000004	1.4645417501539262
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.059210599999999995	1.4612623956610573
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.058981943999999994	1.4556193787968088
COFFIN-SIRIS SYNDROME 6; CSS6	0.058979028	1.4555474146359029
APERT SYNDROME	0.05890655399999999	1.453758823896016
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.05887739399999999	1.4530391822869548
NEUROFIBROMATOSIS, TYPE I	0.058851839	1.4524085087163254
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.0588235	1.4517091286217032
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	1.4517091286217032
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	1.4517091286217032
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.0588235	1.4517091286217032
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	1.4517091286217032
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0588235	1.4517091286217032
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0588235	1.4517091286217032
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	1.4517091286217032
ATYPICAL WERNER SYNDROME	0.0588235	1.4517091286217032
WERNER SYNDROME	0.0588235	1.4517091286217032
3M SYNDROME	0.0588235	1.4517091286217032
KEARNS-SAYRE SYNDROME	0.0588235	1.4517091286217032
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0588235	1.4517091286217032
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0588235	1.4517091286217032
CARNITINE DEFICIENCY, MYOPATHIC	0.0588235	1.4517091286217032
GAPO SYNDROME	0.0588235	1.4517091286217032
IATROGENIC BOTULISM	0.0588235	1.4517091286217032
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0588235	1.4517091286217032
AMISH INFANTILE EPILEPSY SYNDROME	0.05873312	1.449478634498694
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.058669729	1.4479142037291468
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.058581333000000006	1.4457326728761095
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.05847043899999999	1.4429959123618696
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.05831042	1.4390467926554105
COLE-CARPENTER SYNDROME 1; CLCRP1	0.05831042	1.4390467926554105
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.058144556999999986	1.434953448478328
SECONDARY SYRINGOMYELIA	0.058107219	1.4340319814550389
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.05808054	1.43337356861251
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.058074490000000006	1.433224260253977
SPINAL MUSCULAR ATROPHY-DANDY-WALKER MALFORMATION-CATARACTS SYNDROME	0.058032070000000005	1.4321773742095198
BEHÇET DISEASE	0.058026729	1.4320455633098628
GRANULOMATOSIS WITH POLYANGIITIS	0.058026729	1.4320455633098628
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.05787409	1.4282785751217462
WARBURG MICRO SYNDROME 2; WARBM2	0.05782082	1.4269639211946306
MECKEL SYNDROME, TYPE 10; MKS10	0.05768421900000001	1.4235927358914977
MADRAS MOTOR NEURON DISEASE	0.057649860000000004	1.422744787810368
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.057399003000000004	1.4165538709679726
MAPLE SYRUP URINE DISEASE; MSUD	0.057203583	1.4117310875920215
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.057167507	1.4108407655519497
MUCOLIPIDOSIS IV; ML4	0.057153937999999994	1.410505895284688
EVEN-PLUS SYNDROME	0.057114163999999995	1.4095243100529047
BRANCHIOOCULOFACIAL SYNDROME	0.057111799000000005	1.4094659440582058
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.05705327699999999	1.4080216756684427
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.056915123	1.404612163773442
CROME SYNDROME	0.056849193	1.402985072851446
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.056832192999999996	1.4025655287035022
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.056802199	1.401825304752124
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.05667638900000001	1.3987204312666655
MUCOPOLYSACCHARIDOSIS TYPE 2	0.056642573	1.3978858839192028
ICF SYNDROME	0.056626088000000005	1.397479049491035
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.056579397	1.3963267591491735
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.05646683999999999	1.3935489573456377
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.056414533999999995	1.3922580940396174
ADRENOLEUKODYSTROPHY	0.056342219	1.3904734272714676
ANTERIOR SEGMENT DYSGENESIS 3	0.05629880000000001	1.3894018868385518
PORENCEPHALY	0.056216842999999996	1.3873792645013148
OROFACIODIGITAL SYNDROME IV; OFD4	0.05610382	1.3845899622523121
COLE-CARPENTER SYNDROME	0.056101154	1.3845241678582876
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.056101154	1.3845241678582876
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.056097019000000005	1.3844221199140674
PROTEUS-LIKE SYNDROME	0.056080534	1.3840152854858994
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.056080534	1.3840152854858994
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.056080534	1.3840152854858994
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.056080534	1.3840152854858994
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.056067599999999995	1.3836960864265164
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.05606688	1.383678317497898
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.05603732	1.3829488042618263
ISOLATED SPINA BIFIDA	0.056022373	1.3825799262395138
EBSTEIN MALFORMATION	0.05602236	1.382579605411636
CHROMOSOME 19P13.13 DELETION SYNDROME	0.05579615300000001	1.376997027583759
MYOPATHY, CENTRONUCLEAR, 5	0.05578589	1.3767437463137382
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.055696044	1.374526430812788
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.055571964	1.3714642521141494
PFEIFFER SYNDROME TYPE 1	0.055555600000000004	1.3710604038531522
WOLFRAM-LIKE SYNDROME	0.055555600000000004	1.3710604038531522
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.055555600000000004	1.3710604038531522
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.055555600000000004	1.3710604038531522
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.3710604038531522
BEEMER-ERTBRUGGEN SYNDROME	0.055555600000000004	1.3710604038531522
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.055555600000000004	1.3710604038531522
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.3710604038531522
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.055471643	1.3689884233808631
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.055454840000000005	1.3685737410092222
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.055442823	1.368277172654761
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.05538642	1.366885199209086
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05536529999999999	1.3663639773029346
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.05532081	1.3652660055886985
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.05511436	1.3601710120979347
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.055090207	1.3595749385799767
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.055084127000000004	1.359424889849418
HEART AND BRAIN MALFORMATION SYNDROME	0.055064922999999995	1.3589509530366466
PSEUDO-TORCH SYNDROME 2	0.055007559	1.3575352630070792
INTERMEDIATE NEMALINE MYOPATHY	0.0549933	1.3571833641832245
ALZHEIMER DISEASE 3; AD	0.054946709	1.356033541748116
TAKAYASU ARTERITIS	0.054841609	1.3534397717511226
22Q11.2 DELETION SYNDROME	0.054598223	1.3474332322222144
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.054557479000000006	1.346427708294931
ZELLWEGER SYNDROME	0.054344079	1.3411611952848608
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.054329474	1.3408007575036418
GIANT CELL ARTERITIS	0.05430019	1.3400780556902074
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.05420085699999999	1.3376266098756369
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.05418349	1.3371980085099113
INFANTILE REFSUM DISEASE	0.054134353	1.3359853531688812
COFFIN-SIRIS SYNDROME 4; CSS4	0.054111097	1.3354114167744942
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.05393701	1.3311151119460776
FETAL AKINESIA SYNDROME, X-LINKED	0.05393701	1.3311151119460776
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.053912964	1.330521679088345
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.05389150899999999	1.3299921896945721
JOUBERT SYNDROME WITH RENAL DEFECT	0.05386230699999999	1.329271511564675
JOUBERT SYNDROME WITH OCULAR DEFECT	0.05386230699999999	1.329271511564675
MENKES DISEASE	0.053757773	1.3266917099199016
GLYCEROL KINASE DEFICIENCY; GKD	0.053733077	1.3260822356682767
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.053713420000000005	1.3255971192379163
INCONTINENTIA PIGMENTI	0.053636197	1.3236913276063478
RING CHROMOSOME 7 SYNDROME	0.05362096	1.323315292654453
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.05350191	1.3203772496654702
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.053084982999999995	1.3100878800790148
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.053044927	1.3090993353501892
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.053037320000000006	1.3089116016835183
RIGID SPINE SYNDROME	0.052879554	1.3050180839161951
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.052836209999999995	1.3039483944133436
MICROPHTHALMIA WITH LIMB ANOMALIES	0.05275482	1.301939765107394
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.05274598	1.3017216021504634
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.052705548	1.3007237780922478
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.05261402	1.298464952399719
AMISH NEMALINE MYOPATHY	0.05257914	1.2976041465244086
SYRINGOMYELIA, ISOLATED	0.0525641	1.297232973348816
CHIARI MALFORMATION TYPE I	0.0525641	1.297232973348816
SUSAC SYNDROME	0.052563120000000005	1.2972087878626404
JOUBERT SYNDROME 32; JBTS32	0.052514424	1.2960070159903891
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.052297524	1.2906541262439775
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.052047818999999995	1.284491639687372
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.051785863999999994	1.2780268345535715
NIEMANN-PICK DISEASE, TYPE C2	0.051611907000000005	1.2737337380039337
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.051611907000000005	1.2737337380039337
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.051611907	1.2737337380039335
HYPOTONIA-CYSTINURIA SYNDROME	0.051480604	1.2704933024005538
STURGE-WEBER SYNDROME	0.05143126299999999	1.269275612529748
WILLIAMS-BEUREN SYNDROME; WBS	0.051402984	1.2685777131791776
FAMILIAL ATRIAL MYXOMA	0.05135034	1.2672785083483333
611961 STEVENSON-CAREY SYNDROME	0.051345997	1.2671713271580676
ABETAL34V AMYLOIDOSIS	0.051318817999999995	1.2665005747817755
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.051257846999999995	1.2649958673556414
DISTAL TRISOMY 17Q	0.051144053	1.2621875375455762
ARGININOSUCCINIC ACIDURIA	0.051082467	1.2606676524929137
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.050930277999999995	1.2569117698851835
NEONATAL LUPUS ERYTHEMATOSUS	0.050914919999999995	1.2565327487661175
17Q12 MICRODUPLICATION SYNDROME	0.050865153	1.2553045456125462
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.050771754	1.2529995453846758
IMMUNODEFICIENCY 9; IMD9	0.050585200000000004	1.2483955666214113
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.05057901000000001	1.2482428031934247
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.05057549399999999	1.2481560315920026
LIDDLE SYNDROME	0.05056885	1.2479920638673594
CITRULLINEMIA TYPE II	0.050557533	1.2477127708601665
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.050545554	1.2474171403102714
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.050541419000000004	1.247315092366051
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.05050765	1.2464817049347618
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.050479244	1.2457806713426156
HISTIDINEMIA	0.05043863	1.2447783556941103
RETT SYNDROME, CONGENITAL VARIANT	0.050280398999999996	1.2408733621603873
ABETA AMYLOIDOSIS, IOWA TYPE	0.050248329999999994	1.240081929143893
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.05024471900000001	1.2399928130310565
FABRY DISEASE	0.050138089000000004	1.237361284060748
MEESTER-LOEYS SYNDROME; MRLS	0.050137890000000004	1.2373563729263104
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.050137709	1.237351906015088
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.05012488799999999	1.2370354956903356
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.050045780000000005	1.235083184016481
GITELMAN SYNDROME	0.05002611999999999	1.2345979935489175
DEMENTIA, FAMILIAL DANISH	0.05	1.233953376305136
LAMBERT-EATON MYASTHENIC SYNDROME	0.05	1.233953376305136
EARLY-ONSET ALZHEIMER DISEASE WITH CEREBRAL AMYLOID ANGIOPATHY	0.05	1.233953376305136
BETHLEM MYOPATHY	0.05	1.233953376305136
ALZHEIMER DISEASE	0.05	1.233953376305136
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.05	1.233953376305136
ALZHEIMER DISEASE 2	0.05	1.233953376305136
ALZHEIMER DISEASE 4	0.05	1.233953376305136
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.05	1.233953376305136
ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL	0.05	1.233953376305136
OCULODENTODIGITAL DYSPLASIA; ODDD	0.049982883	1.2335309447062914
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.049819999999999996	1.2295111441504372
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.049727259	1.2272223827489992
COFFIN-SIRIS SYNDROME 3; CSS3	0.049692787	1.2263716459332394
ERYTHERMALGIA, PRIMARY	0.0494995	1.2216015030083216
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.049238164	1.21515197421732
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.049099827	1.2117379460529614
RHYNS SYNDROME; RHYNS	0.0490998	1.211737279718138
TARP SYNDROME	0.048936357	1.2077036588844694
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.048895913000000006	1.206705538677444
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.04877531	1.2037291690965932
DUCHENNE MUSCULAR DYSTROPHY	0.048606374	1.1995599861450035
MOEBIUS SYNDROME; MBS	0.04852834	1.1976341797896715
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.048477043	1.196368217662785
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.04844306699999999	1.195529721664518
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.048429144	1.1951861150073522
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.04838124	1.1940038889565818
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.048286079999999995	1.191655428890798
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.048164554	1.1886562805306207
CORNELIA DE LANGE SYNDROME 3	0.048142907	1.1881220527558831
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.04813784900000001	1.1879972260323364
EMANUEL SYNDROME	0.048068107	1.1862760585049308
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.047996189999999994	1.184501214005656
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.04795600999999999	1.183509609072457
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.047883590000000004	1.1817223510022168
3-HYDROXYISOBUTYRIC ACIDURIA	0.047857729	1.1810841256369242
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.04779929	1.1796419056097665
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.04769906699999999	1.1771684954250976
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.047619	1.1751925165254853
BODY SKIN HYPERLAXITY DUE TO VITAMIN K-DEPENDENT COAGULATION FACTOR DEFICIENCY	0.047619	1.1751925165254853
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.047619	1.1751925165254853
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.047619	1.1751925165254853
POLYCYSTIC KIDNEY DISEASE 3	0.047619	1.1751925165254853
INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	0.047619	1.1751925165254853
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0475924	1.174536053329291
MEIER-GORLIN SYNDROME 7	0.047577454	1.174167199986046
JOUBERT SYNDROME 13; JBTS13	0.0474996	1.1722458358628687
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.047462044	1.1713189888028583
MALAN OVERGROWTH SYNDROME	0.04728825899999999	1.1670301370528344
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.047252199999999994	1.1661402345569107
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.046937110000000004	1.1583641071701112
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.046937110000000004	1.1583641071701112
CHRISTIANSON SYNDROME	0.046780840000000004	1.1545075092878072
DUBOWITZ SYNDROME	0.046735864	1.153397543546753
FAMILIAL COLORECTAL CANCER TYPE X	0.046676389	1.151929756005638
LYNCH SYNDROME	0.046676389	1.151929756005638
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.046618653	1.1505048853629511
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.046522499	1.1481318943040462
7Q11.23 MICRODUPLICATION SYNDROME	0.046506918999999994	1.1477473944319894
AYMÉ-GRIPP SYNDROME	0.046492427999999995	1.1473897700644686
PHENYLKETONURIA	0.046373853	1.1444634496325612
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.046267749	1.1418449018517713
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.046180454	1.1396905426520805
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.046167639999999996	1.1393743050808007
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.046167639999999996	1.1393743050808007
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.04582342	1.1308792764569657
MILLER-DIEKER SYNDROME	0.045817849	1.130741789371778
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.04558061000000001	1.124886952070953
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.0455466	1.12404761698439
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0455466	1.12404761698439
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.0455466	1.12404761698439
ILEAL NEUROENDOCRINE TUMOR	0.0454545	1.121774674865236
JEJUNAL NEUROENDOCRINE TUMOR	0.0454545	1.121774674865236
ADENOCARCINOMA OF OVARY	0.0454545	1.121774674865236
SANDIFER SYNDROME	0.0454545	1.121774674865236
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.045317488999999996	1.118393371144417
METACHROMATIC LEUKODYSTROPHY	0.045239253	1.116462579617445
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.045114139000000004	1.1133748827629841
COFFIN-SIRIS SYNDROME 2; CSS2	0.045090207	1.1127842633189495
MEGALENCEPHALY	0.04494645399999999	1.1092365733248695
FAMILIAL PAROXYSMAL ATAXIA	0.04484363399999999	1.1066990716018357
CHIARI MALFORMATION TYPE II	0.04479053	1.1053885143999296
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.04474230699999999	1.104198415726618
VASCULAR EHLERS-DANLOS SYNDROME	0.04466321400000001	1.1022464742387765
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.044658413	1.1021279900355836
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.04463445	1.1015366055404554
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.04463445	1.1015366055404554
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.044576212999999996	1.1000993706849376
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.044527593	1.0988994744218186
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.044460044000000004	1.097232428089498
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.04430232	1.093339946843011
COFFIN-SIRIS SYNDROME 1; CSS1	0.044292437000000004	1.0930960436186505
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.044131694	1.0891290562673022
TURCOT SYNDROME WITH POLYPOSIS	0.04401606	1.0862753169729888
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.044003234	1.085958783252899
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.043879267999999985	1.0828994179679579
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.043868	1.082621334235074
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.043810747	1.0812083835820019
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.043727079	1.0791435353602281
ADENYLOSUCCINASE DEFICIENCY	0.043721186999999995	1.0789981262943642
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.04372020399999999	1.078973866770986
TANGIER DISEASE	0.043674279999999996	1.0778405052739173
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.043494099999999994	1.073393830887064
ATELOSTEOGENESIS TYPE I	0.043478300000000004	1.073003901620152
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.043478300000000004	1.073003901620152
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.043399014	1.0710471970722772
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.043236839	1.0670448692962315
POEMS SYNDROME	0.0430147	1.0615626859150507
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.043011167	1.0614754947694809
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.043000739999999996	1.061218166132386
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.04296868399999999	1.0604270539437692
XP22.13P22.2 DUPLICATION SYNDROME	0.042964549	1.060325005999549
ACTH-DEPENDENT CUSHING SYNDROME	0.04294985	1.0599622483859827
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.042861604	1.0577844193930743
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.04283237	1.0570629515330163
BECKWITH-WIEDEMANN SYNDROME	0.04274726	1.0549625160958698
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.04269542	1.0536831532353166
SCHISIS ASSOCIATION	0.042493090000000004	1.0486898375027602
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.042458904	1.0478461589003127
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.042442179999999996	1.047433426175006
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.042431629	1.0471730373335384
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.042423129999999996	1.0469632899386339
VICI SYNDROME	0.042371756999999996	1.0456954522026154
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.04235034	1.045166900613409
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.04228426	1.043536107831284
PGM3-CDG	0.042208118999999995	1.041657018950779
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.042143314	1.04005769197975
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.042084103000000005	1.0385964197124622
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.042017819	1.0369605924005618
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.042017819	1.0369605924005618
MICRO SYNDROME	0.041986993	1.0361998354650022
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.04192968899999999	1.034785626179486
VACTERL/VATER ASSOCIATION	0.04173666	1.0300218504539902
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.028295302889864
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.041666699999999994	1.028295302889864
HAMAMY SYNDROME; HMMS	0.041666699999999994	1.028295302889864
PEHO-LIKE SYNDROME; PEHOL	0.041666274	1.0282847896070981
RETT SYNDROME	0.041605389	1.0267822045807713
CAMOS SYNDROME	0.041533123	1.02499874708693
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.04152921	1.0249021778957002
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.04151909	1.024652425732336
ACYS AMYLOIDOSIS	0.0414764	1.0235988763396466
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.04143844000000001	1.022662058936356
PEROXISOME BIOGENESIS DISORDER 11B	0.04141135	1.0219935029970737
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.041389973	1.0214659385705682
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.041301984	1.019294452098014
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.04100649299999999	1.0120020097556581
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.040964507	1.0109658344265073
DERMATOMYOSITIS	0.04092219	1.0099214903260052
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.040920363999999994	1.0098764263487026
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.04075643	1.0058306880928787
COFS SYNDROME	0.040698049	1.0043898994516371
CONGENITAL ANALBUMINEMIA	0.040661459999999996	1.0034869170499245
MYOPATHY, DISTAL, 1; MPD1	0.040626239999999994	1.002617720291655
WILSON DISEASE	0.040524934	1.000117582676856
KLEEFSTRA SYNDROME	0.040482393	0.999067710465228
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.040460938999999994	0.9985382457505227
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.04036259	0.9961110841383982
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.040360189	0.996051829697268
LEPTOSPIROSIS	0.04016931	0.9913411139669531
CIRCUMVALLATE PLACENTA SYNDROME	0.0401445	0.9907288263016305
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.040073407	0.9889743173539973
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.04	0.9871627010441086
PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5	0.04	0.9871627010441086
CUSHING DISEASE	0.04	0.9871627010441086
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.04	0.9871627010441086
HYPOGONADISM-CATARACT SYNDROME	0.04	0.9871627010441086
MAFFUCCI SYNDROME	0.04	0.9871627010441086
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z	0.04	0.9871627010441086
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.04	0.9871627010441086
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.04	0.9871627010441086
46,XY SEX REVERSAL 5	0.04	0.9871627010441086
PREMATURE OVARIAN FAILURE 11	0.04	0.9871627010441086
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.039957354	0.9861102375303906
DEND SYNDROME	0.039765429	0.9813737074954433
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.039763484	0.981325706709105
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.039763484	0.981325706709105
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.039761487	0.9812764226112554
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.039759349	0.9812236587648845
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.039742864	0.9808168243367168
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.039735847000000005	0.9806436513198862
PEHO SYNDROME; PEHO	0.039688803	0.9794826492671882
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.039531988	0.9756126012930821
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.039523542999999994	0.9754041865678242
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.03945153	0.9736269728780672
MILLER-DIEKER SYNDROME (MDS)	0.039217930000000005	0.9678619427039696
CONO-SPONDYLAR DYSPLASIA	0.039198829000000004	0.9673905478351535
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0391495	0.9661731541131582
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.03914725	0.9661176262112245
OPTIC PATHWAY GLIOMA	0.039107853	0.9651453449878987
CHROMOSOME 18Q DELETION SYNDROME	0.039036163	0.9633761026369524
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.039007154	0.9626601875670878
CENTRONUCLEAR MYOPATHY	0.039002919000000004	0.9625556717161149
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.03898962	0.9622274647970851
GOLDBERG-SHPRINTZEN SYNDROME	0.03896012799999999	0.9614996297376049
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.03882174799999999	0.9580845403733428
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.038800799999999996	0.9575675632668063
16P13.11 MICRODELETION SYNDROME	0.038791584	0.9573401209804856
SPINOCEREBELLAR ATAXIA TYPE 21	0.038708664	0.9552937327012212
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.03857192	0.9519190182914319
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.038485652999999995	0.9497900291731575
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.038471943	0.9494516791573747
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.0384615	0.9491939556551997
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0384615	0.9491939556551997
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0384615	0.9491939556551997
9P13 MICRODELETION SYNDROME	0.03839307	0.9475051670643884
SPINOCEREBELLAR ATAXIA TYPE 34	0.03839307	0.9475051670643884
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.038367087	0.9468639308528577
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.038363827999999996	0.94678350177179
15Q OVERGROWTH SYNDROME	0.038258849	0.9441927179419672
ATAXIA-PANCYTOPENIA SYNDROME	0.038258150000000005	0.9441754672737668
JOUBERT SYNDROME	0.038163997000000005	0.9418518590289816
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.03812394	0.9408632896210886
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.038072049999999996	0.939582692807159
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.03805405	0.9391384695916891
NEUROLEPTIC MALIGNANT SYNDROME	0.0380504	0.9390483909952188
RING CHROMOSOME 13 SYNDROME	0.03802674	0.9384644842575514
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.03796747	0.9370017559252793
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.03794777699999999	0.9365157510484874
CEREBROTENDINOUS XANTHOMATOSIS	0.037910303	0.9355909276720145
AYME-GRIPP SYNDROME; AYGRP	0.037871873	0.9346425111069864
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.037844527999999995	0.933967662005485
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.03783541	0.9337426382677819
MYOTONIC DYSTROPHY 1	0.03767207	0.9297115593780684
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.037652909	0.9292386837652007
DENGUE FEVER	0.03764411	0.9290215326500386
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.037482207999999996	0.9250259422594274
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.037399642999999996	0.9229883150491348
TANGIER DISEASE; TGD	0.037384970000000003	0.9226261990913244
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.037384970000000003	0.9226261990913244
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.03727031	0.9197964972087814
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.03727031	0.9197964972087814
ACROCALLOSAL SYNDROME	0.03726186	0.9195879590881858
MOWAT-WILSON SYNDROME	0.037219429000000005	0.9185408015739858
CAREY-FINEMAN-ZITER SYNDROME	0.037201703999999995	0.9181033651020856
MUSCLE-EYE-BRAIN DISEASE	0.037194639	0.9179290074900136
JOUBERT SYNDROME 17; JBTS17	0.037175554	0.9174580074862779
PSEUDOTRISOMY 13 SYNDROME	0.03717218	0.9173747403124448
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.03708507	0.915224946740246
YOU-HOOVER-FONG SYNDROME; YHFS	0.037016284	0.9135273724013957
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.037001690000000004	0.9131672060899197
GABRIELE-DE VRIES SYNDROME	0.03691125000000001	0.9109352312228591
OCULOCEREBROCUTANEOUS SYNDROME	0.036908553000000004	0.9108686717777412
SECKEL SYNDROME 2; SCKL2	0.03686068	0.9096872107780639
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.036858712999999994	0.90963866705224
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.036806293	0.9083449903325217
OCULOECTODERMAL SYNDROME; OES	0.036801273	0.9082211014135408
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.036798673999999996	0.9081569605170403
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.036756109999999995	0.9071065206868592
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.036756109999999995	0.9071065206868592
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.036756109999999995	0.9071065206868592
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.036756109999999995	0.9071065206868592
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.036669384	0.9049662038765905
ACALVARIA	0.03665322	0.9045672914290986
LEGIONELLOSIS	0.03662566	0.9038871363280792
GLUTARIC ACIDEMIA I; GA1	0.036619889	0.9037447134293861
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.036587196999999995	0.9029379053538227
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03655279	0.9020887726774522
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03647073000000001	0.9000636083962603
JOUBERT SYNDROME 30; JBTS30	0.036381287	0.8978562385595228
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.0363548	0.8972025640979591
CAFFEY DISEASE	0.03631277	0.896165302889837
FAMILIAL THROMBOCYTOSIS	0.036255719000000006	0.8947573374084054
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.03622618	0.8940283424327516
AICARDI-GOUTIERES SYNDROME 7	0.03614355699999999	0.8919892838365424
ACUTE ADRENAL INSUFFICIENCY	0.036126479	0.8915678147213317
THUMBS, CONGENITAL CLASPED	0.0361093	0.8911438530203007
THORACOABDOMINAL SYNDROME	0.03608812	0.890621150370098
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.03608812	0.890621150370098
MECKEL SYNDROME, TYPE 6; MKS6	0.03608812	0.890621150370098
PENTALOGY OF CANTRELL	0.03608812	0.890621150370098
RING CHROMOSOME 22 SYNDROME	0.036083412999999995	0.8905049859992525
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.03598944	0.8881858199866222
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.035967623	0.8876473967704052
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.03592011	0.8864748202350374
SNEDDON SYNDROME	0.035892739	0.8857993294777806
ISOTRETINOIN-LIKE SYNDROME	0.03576935	0.8827542040148023
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.035714300000000004	0.8813956213474904
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	0.8813956213474904
PARTIAL ATRIOVENTRICULAR CANAL	0.035714300000000004	0.8813956213474904
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I	0.03570111	0.8810701044468211
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.03570111	0.8810701044468211
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.03570111	0.8810701044468211
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	0.03570111	0.8810701044468211
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.03570111	0.8810701044468211
LATERAL MENINGOCELE SYNDROME	0.03568624	0.8807031267127079
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.03566544	0.8801898021081649
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.03560579	0.8787176957302328
JAWAD SYNDROME	0.035553287999999995	0.8774219953269774
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.035549153	0.877319947382757
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0354509	0.8748951549611148
MEIER-GORLIN SYNDROME 5; MGORS5	0.03536747	0.8728361803574121
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.035327707	0.8718548665953717
MENTAL RETARDATION, BUENOS AIRES TYPE	0.035286184	0.8708301176744853
PRIMARY CUTIS VERTICIS GYRATA	0.035225473	0.869331826805908
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.035207949999999995	0.868899375505648
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.03518521	0.8683381735101047
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.03512255	0.8667917831389191
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.035098673999999996	0.8662025457226656
PSEUDOAMINOPTERIN SYNDROME	0.035075308	0.8656258946308509
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.035065113999999994	0.8653743162164896
GLYCOGEN STORAGE DISEASE 0, LIVER	0.035024219	0.8643650657500099
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.035024219	0.8643650657500099
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.035005373	0.8638999640434128
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.034960347	0.8627887643489827
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.03487476	0.8606765569966259
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.034824723999999994	0.8594417151738898
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.034685509999999996	0.8560060434673109
MEIER-GORLIN SYNDROME 6; MGORS6	0.034680803999999996	0.8558899037755332
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.034618807	0.8543598756261175
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.034609552999999994	0.8541314955352307
KEARNS-SAYRE SYNDROME; KSS	0.034550699	0.8526790336950496
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.03453165	0.8522089221377448
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.034516859999999996	0.8518439187290336
MODY	0.0344828	0.8510033496890949
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.034403788	0.8490534072057222
PAPILLORENAL SYNDROME	0.034399653	0.848951359261502
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.034323337999999995	0.8470679762232474
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.03431906	0.8469623991723707
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.03429987799999999	0.8464890052990849
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.034283236999999994	0.8460783209363829
CEREBELLOFACIODENTAL SYNDROME	0.034244468	0.8451215381674636
TORIELLO-LACASSIE-DROSTE SYNDROME	0.034240009999999994	0.8450115188844322
1Q41Q42 MICRODELETION SYNDROME	0.034194893	0.8438980733948571
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.034153949999999995	0.8428876383331358
MIRAGE SYNDROME; MIRAGE	0.034138003	0.8424940812432972
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.034085017999999995	0.8411864608504264
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.03401462399999999	0.839449202570994
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.033894192999999996	0.836477077789758
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.033890229	0.8363792499660846
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.033877508	0.836065307548085
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.033849734	0.835379871126615
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.033801319999999996	0.8341850587514061
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.033794268999999995	0.8340110466462797
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.03360294	0.829289225335578
CORNELIA DE LANGE SYNDROME	0.03357458900000001	0.8285895490921458
SECKEL SYNDROME	0.033539464	0.827722696845291
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.033537593000000004	0.8276765223099499
POPOV-CHANG SYNDROME; POPCHAS	0.033519844	0.8272384935404289
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.033445436999999995	0.8254021981630142
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.033425624	0.8249132317981196
21Q22.11Q22.12 MICRODELETION SYNDROME	0.033386673	0.8239519574389103
CRANIORACHISCHISIS	0.0333333	0.8226347615678398
DIPROSOPUS	0.0333333	0.8226347615678398
DYSRAPHISM-CLEFT LIP/PALATE-LIMB REDUCTION DEFECTS SYNDROME	0.0333333	0.8226347615678398
MECKEL SYNDROME, TYPE 5	0.0333333	0.8226347615678398
301410 NEURAL TUBE DEFECTS, X-LINKEDSPINA BIFIDA, X-LINKED, INCLUDED	0.0333333	0.8226347615678398
MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	0.0333333	0.8226347615678398
ISOLATED ANENCEPHALY/EXENCEPHALY	0.0333333	0.8226347615678398
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0333333	0.8226347615678398
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.0333333	0.8226347615678398
ANENCEPHALY; ANPH	0.0333333	0.8226347615678398
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.033332153999999996	0.8226064793564547
HYDROXYKYNURENINURIA	0.03332858799999999	0.8225184738016564
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.033304654	0.8219278049994871
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.033252849999999994	0.8206493305853647
MCLEOD SYNDROME; MCLDS	0.033252849999999994	0.8206493305853647
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.033252849999999994	0.8206493305853647
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.033252849999999994	0.8206493305853647
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.033252849999999994	0.8206493305853647
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.03321283	0.8196616743029701
MAST SYNDROME	0.03321164	0.8196323062126141
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.033193383	0.81918174047679
FRIED SYNDROME	0.033169474	0.8185916886513083
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.033157997999999994	0.8183084716723786
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.03310471799999999	0.8169935709545878
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.032997819	0.8143554033151152
FAMILIAL MULTIPLE NEVI FLAMMEI	0.032981252999999995	0.8139465698824778
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.032890907	0.8117169148477645
SPINOCEREBELLAR ATAXIA 47; SCA47	0.032831093	0.8102407611027582
NETHERTON SYNDROME; NETH	0.032803653999999995	0.8095635921689094
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	0.8095635921689094
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	0.8094615442246891
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.032783033999999996	0.8090547097965213
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.03276615	0.8086380284204105
CLASSIC PHENYLKETONURIA	0.03270117299999999	0.8070344566497668
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.032652773999999996	0.805840014460571
NONAKA MYOPATHY	0.03260511	0.8046637113860069
MILROY DISEASE	0.03258143	0.8040793110669889
PRIMARY HYPEROXALURIA TYPE 1	0.0325665	0.803710852588824
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.032521003	0.802588029053589
DIABETIC EMBRYOPATHY	0.03250865	0.8022831685324391
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	0.03241755	0.8000349054808111
EPISODIC ATAXIA, TYPE 2	0.03236165	0.798655345606102
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.032345043999999996	0.7982455250107635
4Q21 MICRODELETION SYNDROME	0.032335379	0.7980070018231237
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.03229489	0.7970077710580593
FRONTONASAL DYSPLASIA	0.032277154	0.7965700631164165
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	0.796099828163774
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	0.796099828163774
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	0.796099828163774
DENT DISEASE	0.0322581	0.796099828163774
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	0.796099828163774
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	0.796099828163774
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	0.796099828163774
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	0.796099828163774
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	0.796099828163774
DESMOID TUMOR	0.0322581	0.796099828163774
ROWLEY-ROSENBERG SYNDROME	0.0322581	0.796099828163774
THROMBOCYTOPENIA 1	0.0322581	0.796099828163774
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	0.796099828163774
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	0.796099828163774
DYSTONIA, JUVENILE-ONSET	0.0322581	0.796099828163774
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	0.796099828163774
MILD CANAVAN DISEASE	0.0322581	0.796099828163774
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	0.796099828163774
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	0.796099828163774
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	0.796099828163774
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	0.796099828163774
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.032238353	0.7956124906173361
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.032229123	0.7953847028240701
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.032205704	0.7948067437416764
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.032138627	0.7931513459292281
NOCARDIOSIS	0.032098319	0.792156582075386
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.032090757	0.7919699589667534
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.032068013	0.7914086582549398
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.032027730000000004	0.7904145113777858
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.03200643	0.7898888472394798
MICROPHTHALMIA, SYNDROMIC 1	0.031953523	0.7885831518138762
NIEMANN-PICK DISEASE TYPE B	0.031950834	0.7885167898012986
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.031931073	0.7880291067479152
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.03193031	0.7880102766193929
FOLATE MALABSORPTION, HEREDITARY	0.03191490699999999	0.7876301449422881
SMITH-MAGENIS SYNDROME; SMS	0.031908597	0.7874744200261985
TETRASOMY 9P	0.031904423	0.7873714095983447
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.031861280000000006	0.7863066805880661
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.031795554	0.7846846241958453
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.031795554	0.7846846241958453
13Q12.3 MICRODELETION SYNDROME	0.03179386	0.7846428178554561
HELLP SYNDROME	0.03179386	0.7846428178554561
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.031771388	0.7840882298500095
TRIPLOIDY	0.031752220000000005	0.7836151814836694
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.031697332999999994	0.7822606215043638
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.031687517	0.7820183717775278
SOTOS SYNDROME	0.031617597	0.7802928113761026
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.031592053999999994	0.7796624339542834
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.031434364	0.7757707917960923
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.031383634	0.7745188227004931
BOHRING-OPITZ SYNDROME	0.031379913	0.7744269918902286
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.031330758	0.7732138923259829
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0312766	0.7718773233869043
PACHYDERMOPERIOSTOSIS	0.03125	0.77122086019071
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.03125	0.77122086019071
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.03125	0.77122086019071
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.03125	0.77122086019071
ACANTHOSIS NIGRICANS-INSULIN RESISTANCE-MUSCLE CRAMPS-ACRAL ENLARGEMENT SYNDROME	0.03125	0.77122086019071
HYPERPROLACTINEMIA; HPRL	0.03125	0.77122086019071
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.03125	0.77122086019071
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.03125	0.77122086019071
GOOD SYNDROME	0.03125	0.77122086019071
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.03125	0.77122086019071
THYMOMA	0.03125	0.77122086019071
BRONCHIAL NEUROENDOCRINE TUMOR	0.03125	0.77122086019071
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.03125	0.77122086019071
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.0312184	0.770441001656885
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.031183243000000003	0.76957335967987
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.031157778999999997	0.7689449319043852
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.03114291	0.7685779788493395
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.031059429999999996	0.7665177702922604
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.031037478	0.7659760154019275
SMITH-MAGENIS SYNDROME	0.031019927000000003	0.7655428730877769
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.030958358999999998	0.7640234322583298
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.030956073	0.7639670159099652
WARBURG MICRO SYNDROME 3; WARBM3	0.030852009000000003	0.7613988134269288
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.030844418999999998	0.7612114993044057
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.030844418999999998	0.7612114993044057
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.030844418999999998	0.7612114993044057
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.030844418999999998	0.7612114993044057
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.030827933999999998	0.7608046648762379
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.030827933999999998	0.7608046648762379
JACOBSEN SYNDROME	0.030812987000000003	0.7604357868539252
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.030811813000000004	0.7604068136286496
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.030807988	0.7603124161953623
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.030749667	0.7588731082981724
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.030749667	0.7588731082981724
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.030738623999999996	0.7586005773554816
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.03072109	0.7581678545854789
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.03072109	0.7581678545854789
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.030717713000000004	0.7580845133744434
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.030709649	0.7578855013739128
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.030302999999999997	0.7478497832434905
GLYCOGEN STORAGE DISEASE XI; GSD11	0.030302999999999997	0.7478497832434905
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.030302999999999997	0.7478497832434905
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.030302999999999997	0.7478497832434905
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.030302999999999997	0.7478497832434905
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.030302999999999997	0.7478497832434905
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.030302999999999997	0.7478497832434905
OROFACIODIGITAL SYNDROME XV; OFD15	0.0302654	0.7469218503045092
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.030231273000000003	0.746079627767046
46,XX GONADAL DYSGENESIS	0.030185310000000003	0.7449453037863437
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.030168229999999997	0.7445237853129977
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.030146137000000003	0.7439785506741436
LOEYS-DIETZ SYNDROME 5	0.030130740000000003	0.7435985670714442
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.030027733	0.7410564503627829
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.029957354	0.7393195622693632
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.029855603	0.7368084424695149
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.029739	0.7339307891587687
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.02972242	0.7335216102191859
N-ACETYLASPARTATE DEFICIENCY; NACED	0.029621203000000002	0.7310236690413964
HYPOPHOSPHATASIA, INFANTILE	0.029565419000000003	0.7296469719385204
PREMATURE OVARIAN FAILURE 1	0.029428880000000004	0.7262773167375738
SPINOCEREBELLAR ATAXIA TYPE 30	0.0294118	0.7258557982642279
SPINOCEREBELLAR ATAXIA TYPE 14	0.0294118	0.7258557982642279
SPINOCEREBELLAR ATAXIA TYPE 41	0.0294118	0.7258557982642279
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0294118	0.7258557982642279
JOUBERT SYNDROME 31; JBTS31	0.029283584	0.7226915469423011
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.02926565	0.722248952545288
11Q22.2Q22.3 MICRODELETION SYNDROME	0.029205213	0.720757423741213
CONGENITAL DISORDER OF GLYCOSYLATION	0.029108133	0.7183615798657789
ERDHEIM-CHESTER DISEASE	0.02909711	0.7180895425044387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.029075649000000002	0.717559905036261
CRI-DU-CHAT SYNDROME	0.029059164000000002	0.7171530706080932
3C SYNDROME	0.029038968	0.716654652160336
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.028944177	0.7143152986704692
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.028870072999999996	0.7124864810505147
MECKEL SYNDROME 13; MKS13	0.028726138000000002	0.7089342994661453
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.028721133	0.7088107807331772
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.028717903000000003	0.708731067345068
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.028669049000000002	0.7075253961801476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.02866874	0.7075177703482821
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.028668488000000002	0.7075115512232655
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.02865432	0.7071618981945557
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.028634	0.7066604195424252
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.02834393	0.6995017624251286
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.028323354000000002	0.6989939659317115
1P21.3 MICRODELETION SYNDROME	0.028323354000000002	0.6989939659317115
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.028323354000000002	0.6989939659317115
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.028319219000000003	0.6988919179874912
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.028319219000000003	0.6988919179874912
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.028302734000000003	0.6984850835593234
SMITH-MAGENIS SYNDROME	0.028302734000000003	0.6984850835593234
JOUBERT SYNDROME 25	0.028201204	0.695979417833398
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.028156903	0.6948861104629241
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.028070863999999997	0.6927627481720458
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.028035838000000004	0.6918983391528767
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.027965973999999998	0.6901741607792329
MICROPHTHALMIA, LENZ TYPE	0.027955483000000003	0.6899152526818166
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.02794327	0.6896138472301203
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.02787305	0.6878808831084373
IMMUNE THROMBOCYTOPENIC PURPURA	0.027777800000000002	0.6855302019265761
NON-FUNCTIONING PARAGANGLIOMA	0.027777800000000002	0.6855302019265761
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.027777800000000002	0.6855302019265761
FAMILIAL AFIBRINOGENEMIA	0.027777800000000002	0.6855302019265761
FIBRONECTIN GLOMERULOPATHY	0.027777800000000002	0.6855302019265761
CONGENITAL FACTOR XIII DEFICIENCY	0.027777800000000002	0.6855302019265761
PHEOCHROMOCYTOMA	0.027777800000000002	0.6855302019265761
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.027777800000000002	0.6855302019265761
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.027777800000000002	0.6855302019265761
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.027777800000000002	0.6855302019265761
ACROOSTEOLYSIS DOMINANT TYPE	0.02775769	0.6850339058786262
PRIMROSE SYNDROME; PRIMS	0.027657374000000002	0.6825582005406777
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027604494000000004	0.6812531714498974
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.027560017	0.6801555205635388
MONOSOMY 18P	0.027548048000000006	0.679860136804319
MELIOIDOSIS	0.02754084	0.6796822500855908
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02754084	0.6796822500855908
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.02754084	0.6796822500855908
WELLS SYNDROME	0.02754084	0.6796822500855908
AUTOSOMAL AGAMMAGLOBULINEMIA	0.02754084	0.6796822500855908
X-LINKED AGAMMAGLOBULINEMIA	0.02754084	0.6796822500855908
ISOLATED AGAMMAGLOBULINEMIA	0.02754084	0.6796822500855908
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.027529289	0.6793971821765967
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.027482239999999998	0.6782360567285611
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.027438098	0.6771466733298239
FAMILIAL HYPOALDOSTERONISM	0.02741157	0.6764919870264914
1P36 DELETION SYNDROME	0.027314027	0.6740847167427929
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.027292623000000002	0.6735564859814641
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.02725578	0.6726472350966
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.02717797	0.6707269568523939
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.027130437	0.6695538867356756
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.027090549999999998	0.6685695127692619
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.027090549999999998	0.6685695127692619
OROFACIODIGITAL SYNDROME XVI; OFD16	0.026873944	0.663223878668703
MYASTHENIA GRAVIS	0.026857219	0.662811121264329
FOCAL DERMAL HYPOPLASIA; FDH	0.026841094000000003	0.6624131713004706
TRISOMY 13	0.026816729	0.661811865820197
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.026707994000000002	0.6591283874127463
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.026638713999999997	0.6574186216145378
HEREDITARY FOLATE MALABSORPTION	0.026632173000000002	0.6572571958338497
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02659279	0.6562852601174691
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.026397430000000003	0.6514639574855697
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.026397430000000003	0.6514639574855697
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0263158	0.6494494052034139
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.0263158	0.6494494052034139
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.6494494052034139
RICHIERI COSTA-DA SILVA SYNDROME	0.0263158	0.6494494052034139
AMYLOIDOSIS, FINNISH TYPE	0.0263158	0.6494494052034139
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.026292354	0.6488707797861969
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.026270387	0.6483286547098509
L-2-HYDROXYGLUTARIC ACIDURIA	0.026262549000000003	0.6481352201785815
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.026188613	0.6463105486419715
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.026186554000000004	0.6462597344419353
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.026186150000000002	0.6462497640986548
CONGENITAL TOXOPLASMOSIS	0.026158773000000003	0.6455741252669926
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.026132700000000002	0.6449306679393845
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.026107254	0.6443026843871152
HEMIFACIAL MICROSOMIA	0.026084664	0.6437451842517006
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.026079877	0.6436270455554531
FRONTAL ENCEPHALOCELE	0.025982739	0.6412297702941027
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.025955673000000005	0.6405618066524412
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.0258988	0.639158234045029
ATYPICAL RETT SYNDROME	0.025696163000000005	0.6341573418387423
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.0256922	0.6340595386941362
COMBINED SAPOSIN DEFICIENCY	0.02566544	0.6333991268471377
OVARIAN HYPERSTIMULATION SYNDROME	0.025641000000000004	0.6327959704367999
MOSAIC MONOSOMY X	0.025641000000000004	0.6327959704367999
OVARIAN DYSGENESIS 1	0.025641000000000004	0.6327959704367999
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.025641000000000004	0.6327959704367999
LEYDIG CELL HYPOPLASIA	0.025641000000000004	0.6327959704367999
MONOSOMY X	0.025641000000000004	0.6327959704367999
PREMATURE OVARIAN FAILURE 8; POF8	0.025641000000000004	0.6327959704367999
45,X/46,XY MIXED GONADAL DYSGENESIS	0.025641000000000004	0.6327959704367999
MALE INFERTILITY WITH TERATOZOOSPERMIA DUE TO SINGLE GENE MUTATION	0.025641000000000004	0.6327959704367999
TURNER SYNDROME	0.025641000000000004	0.6327959704367999
TESTICULAR AGENESIS	0.025641000000000004	0.6327959704367999
FRASIER SYNDROME	0.025641000000000004	0.6327959704367999
HYPERGONADOTROPIC HYPOGONADISM	0.025641000000000004	0.6327959704367999
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.025641000000000004	0.6327959704367999
ESTROGEN RESISTANCE SYNDROME	0.025641000000000004	0.6327959704367999
MALE INFERTILITY WITH AZOOSPERMIA OR OLIGOZOOSPERMIA DUE TO SINGLE GENE MUTATION	0.025641000000000004	0.6327959704367999
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.025601514	0.631821492776464
FONTAINE PROGEROID SYNDROME; FPS	0.025537390000000004	0.6302389722504204
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.025528328	0.6300153305404987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.025511233	0.62959344188114
CROUZON DISEASE	0.025468869999999998	0.6285479625435316
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.025326724	0.6250399318109663
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.025300390000000002	0.624390033246734
CAROLI DISEASE, ISOLATED	0.02529266	0.6241992640547571
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.02529266	0.6241992640547571
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.02529266	0.6241992640547571
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.025182403999999995	0.621478248785599
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.025150853	0.6206995995260831
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.025107349	0.6196259613724275
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.025103893	0.6195406705150573
KLIPPEL-TRÉNAUNAY SYNDROME	0.025090864	0.6192191269442597
10Q22.3Q23.3 MICRODELETION SYNDROME	0.025082387	0.619009922488841
FRYNS SYNDROME	0.025080523	0.6189639207069724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.025016153000000003	0.6173753291303171
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.02500794	0.6171726399487252
WISKOTT-ALDRICH SYNDROME	0.02500794	0.6171726399487252
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.02500794	0.6171726399487252
HEMORRHAGIC FEVER-RENAL SYNDROME	0.02500794	0.6171726399487252
JOUBERT SYNDROME 27	0.024879988000000002	0.6140149039006253
JOUBERT SYNDROME 15	0.024879988000000002	0.6140149039006253
JOUBERT SYNDROME 8	0.024879988000000002	0.6140149039006253
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.024787849999999997	0.6117410239769052
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.024769087999999998	0.6112779953119805
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.024758023	0.6110049214298042
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.024746393000000002	0.6107179038744757
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.024711518000000002	0.6098572213945028
TONNE-KALSCHEUER SYNDROME; TOKAS	0.024683348	0.6091620120622925
CORNELIA DE LANGE SYNDROME 1	0.024679213000000002	0.6090599641180721
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.024663903	0.6086821275942473
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.024635704	0.6079862025690788
BAKER-GORDON SYNDROME; BAGOS	0.024630054000000002	0.6078467658375564
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.024626944	0.6077700139375501
MEHMO SYNDROME; MEHMO	0.024601837	0.6071503965891724
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.024554427000000004	0.6059803619977598
BONNEMANN-MEINECKE-REICH SYNDROME	0.024551919999999998	0.6059184915754718
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.02453359	0.6054661242677184
SCLERODERMA	0.024533139000000002	0.6054549940082641
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.02450218	0.6046909547567234
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02445878	0.6036198832260906
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.024398314	0.6021276387290573
LYMPHEDEMA, HEREDITARY, III	0.024355054	0.6010600222678781
JOUBERT SYNDROME 33; JBTS33	0.024355054	0.6010600222678781
WHIM SYNDROME	0.024350919000000002	0.6009579743236577
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.02434521	0.6008170815271511
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.024295923	0.5996007243259921
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.024295236999999997	0.5995837944856691
SECKEL SYNDROME 9; SCKL9	0.024229074	0.5979509533409396
NAKAJO-NISHIMURA SYNDROME	0.02422645	0.5978861954677511
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.02422645	0.5978861954677511
FAMILIAL HYPERALDOSTERONISM TYPE II	0.02422645	0.5978861954677511
FAMILIAL HYPERALDOSTERONISM TYPE III	0.02422645	0.5978861954677511
JOUBERT SYNDROME 24	0.024189874	0.5969835338939165
LATHOSTEROLOSIS	0.024162903	0.5963179147636699
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.024119392999999996	0.5952441285356092
STROMME SYNDROME; STROMS	0.024114910000000003	0.5951334922758897
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.024082437	0.5943320889161146
H SYNDROME	0.024031419999999998	0.5930730369281353
8P INVERTED DUPLICATION/DELETION SYNDROME	0.023996449	0.59220998525768
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02397913	0.5917825684871955
SPINOCEREBELLAR ATAXIA TYPE 35	0.02397202	0.5916071003170849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.023945803	0.5909600892037531
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.023904812999999997	0.589948494225858
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.023903604	0.589918657233219
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.02387338	0.5891727570963101
CALCIPHYLAXIS	0.0238095	0.5875962582627426
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0238095	0.5875962582627426
MEIGE DISEASE	0.0238095	0.5875962582627426
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.0238095	0.5875962582627426
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0238095	0.5875962582627426
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.0238095	0.5875962582627426
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0238095	0.5875962582627426
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.0238095	0.5875962582627426
RETINOBLASTOMA	0.0238095	0.5875962582627426
LYMPHATIC MALFORMATION 1	0.0238095	0.5875962582627426
EOSINOPHILIC FASCIITIS	0.0238095	0.5875962582627426
SLC35A1-CDG	0.0238095	0.5875962582627426
DISSECTING CELLULITIS OF THE SCALP	0.0238095	0.5875962582627426
FELTY SYNDROME	0.0238095	0.5875962582627426
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.0238095	0.5875962582627426
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.0238095	0.5875962582627426
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.023801354	0.587395222578675
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.02379549	0.5872505045267019
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.023789993	0.587114843692511
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.023769373	0.5866059613201228
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.02363609	0.5833166611630412
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.023541018	0.5809703728551996
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.023535689999999998	0.5808388827834204
LOWRY-MACLEAN SYNDROME	0.023508279	0.5801624048634625
BARAITSER-WINTER SYNDROME 1; BRWS1	0.023481717000000003	0.5795068794718342
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.02341221	0.5777915115252973
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.023410658	0.5777532096124969
PELIZAEUS-MERZBACHER DISEASE	0.023403363000000003	0.577573175814894
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.02337637	0.5769070137451618
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.023362852999999996	0.5765734267894114
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.02335785	0.5764499574145783
TOWNES-BROCKS SYNDROME	0.023329844000000002	0.5757587954494424
JUNG SYNDROME	0.023310684	0.5752859445156422
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0232558	0.5739314585735396
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.023244439	0.5736510796873755
HOYERAAL-HREIDARSSON SYNDROME	0.023235547999999998	0.5734316580980009
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.023177273	0.5719934854379174
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.023130834000000003	0.5708474142210727
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.023120003	0.5705801152406974
MENKES DISEASE	0.023099383	0.5700712328683092
KOOLEN-DE VRIES SYNDROME	0.023070397	0.5693558854169976
ATYPICAL TERATOID RHABDOID TUMOR	0.023019359	0.5680963151686003
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.02301868	0.56807955808175
LUSCAN-LUMISH SYNDROME; LLS	0.022998697000000002	0.567586396275376
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.022938289	0.5660955831642592
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.022927089999999997	0.5658192022870343
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.022926548999999997	0.5658058509115027
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.022888507000000002	0.5648670098246749
CARDIOFACIOCUTANEOUS SYNDROME	0.022768928	0.5619159116089709
THANATOPHORIC DYSPLASIA TYPE 2	0.022764329	0.5618024125774184
DUBOWITZ SYNDROME	0.022760773	0.5617146538132956
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.022748909999999997	0.5614218860352332
WOLF-HIRSCHHORN SYNDROME	0.022729613000000003	0.5609456540691823
BIOTINIDASE DEFICIENCY	0.022726204	0.5608615231279858
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.022722069	0.5607594751837652
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.022720034	0.5607092532813497
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.022709693000000003	0.5604540470440623
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.022705584	0.5603526407555974
CEREBROFACIOTHORACIC DYSPLASIA	0.022679254000000003	0.5597028409076352
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02265578	0.5591235244765274
NEPHROSIALIDOSIS	0.02265578	0.5591235244765274
SPINAL ARACHNOIDITIS	0.02265578	0.5591235244765274
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.022639303	0.5587168874808998
LETTERER-SIWE DISEASE	0.02259924	0.5577281699986016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.022497263	0.5552114727294921
ADDISON DISEASE	0.022427879	0.5534991403082611
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.022377413	0.5522536864864888
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.022363573	0.5519121281919276
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.022363573	0.5519121281919276
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.022321764000000004	0.5508803210577288
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.02230762	0.5505312603266396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.022281083	0.5498763519116994
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.022265177	0.5494838066636292
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.022251603	0.5491488130010298
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.022246787000000004	0.5490299586118242
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.022218758999999998	0.5483382537072025
RITSCHER-SCHINZEL SYNDROME 1	0.022203134	0.5479526432771071
HOLOPROSENCEPHALY 11	0.022188194	0.5475839380082672
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.022181858999999998	0.5474275961154893
CK SYNDROME	0.022166507000000002	0.5470487230708286
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.021986403	0.5426039242931074
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.021928209	0.5411677506374933
SPINOCEREBELLAR ATAXIA 18	0.02192622	0.5411186639721839
SIFRIM-HITZ-WEISS SYNDROME	0.021911724	0.5407609162093255
NEPHROPATHIC INFANTILE CYSTINOSIS	0.021873160000000003	0.539809192649249
FETAL GAUCHER DISEASE	0.021818019	0.5384483641867921
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.021755368000000008	0.5369021959272144
OROFACIODIGITAL SYNDROME IX; OFD9	0.021710183999999997	0.5357870969401147
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.021710183999999997	0.5357870969401147
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.021706048999999998	0.5356850489958943
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.021702580000000003	0.5355994373106463
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.021689563999999998	0.5352782145677265
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.02164498	0.5341779230211429
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.02164264	0.5341201740031318
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.021639832999999997	0.5340508998605858
BEEMER LETHAL MALFORMATION SYNDROME	0.021622719999999998	0.5336285669780118
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.021622719999999998	0.5336285669780118
POSTERIOR MENINGOCELE	0.021622719999999998	0.5336285669780118
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.021622719999999998	0.5336285669780118
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.021600503	0.5330802721347844
HOLOPROSENCEPHALY 5; HPE5	0.021530938000000003	0.531363472802331
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.021524542999999997	0.5312056501655015
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.021523182999999998	0.531172086633666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.021495173	0.5304808259522599
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.02149191	0.5304002981549223
ATYPICAL JUVENILE PARKINSONISM	0.021474553	0.5299719435798717
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.021452243	0.5294213535833643
GABRIELE-DE VRIES SYNDROME; GADEVS	0.021446478	0.5292790787590764
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.021445477	0.5292543750124828
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.021415154	0.5285060316478887
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.021380874	0.527660033213094
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.02137585	0.5275360455778427
USHER SYNDROME	0.02135449	0.5270089006954852
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.021295808	0.5255606836549185
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.0212766	0.525086648125877
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.0212766	0.525086648125877
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0212766	0.525086648125877
LEISHMANIASIS	0.0212766	0.525086648125877
CONGENITAL FACTOR II DEFICIENCY	0.0212766	0.525086648125877
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0212766	0.525086648125877
ACQUIRED VON WILLEBRAND SYNDROME	0.0212766	0.525086648125877
STUVE-WIEDEMANN SYNDROME	0.0212766	0.525086648125877
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.0212766	0.525086648125877
IMMUNODEFICIENCY 61; IMD61	0.0212766	0.525086648125877
CONGENITAL FACTOR V DEFICIENCY	0.0212766	0.525086648125877
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0212766	0.525086648125877
FAMILIAL MEDITERRANEAN FEVER; FMF	0.0212766	0.525086648125877
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.0212766	0.525086648125877
CONGENITAL FACTOR VII DEFICIENCY	0.0212766	0.525086648125877
MAJEED SYNDROME	0.0212766	0.525086648125877
ACQUIRED PURPURA FULMINANS	0.0212766	0.525086648125877
STÜVE-WIEDEMANN SYNDROME	0.0212766	0.525086648125877
ACQUIRED HEMOPHILIA	0.0212766	0.525086648125877
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0212766	0.525086648125877
GLANZMANN THROMBASTHENIA	0.0212766	0.525086648125877
MARSILI SYNDROME; MARSIS	0.0212766	0.525086648125877
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.0212766	0.525086648125877
FACTOR XIII, A SUBUNIT, DEFICIENCY OF	0.0212766	0.525086648125877
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.0212766	0.525086648125877
YAO SYNDROME	0.0212766	0.525086648125877
DOHLE BODIES AND LEUKEMIA	0.0212766	0.525086648125877
HEMOPHILIA B	0.0212766	0.525086648125877
CONGENITAL ALPHA2-ANTIPLASMIN DEFICIENCY	0.0212766	0.525086648125877
TEMPI SYNDROME	0.0212766	0.525086648125877
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.021192367	0.5230078562309509
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.021166899000000003	0.5223793297391962
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.021164629999999997	0.5223233329349793
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.021164629999999997	0.5223233329349793
SALIH MYOPATHY; SALMY	0.02115389	0.522058279749749
KUFOR-RAKEB SYNDROME	0.02112363	0.5213114911664092
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.021098074	0.5206807929167121
PEROXISOME BIOGENESIS DISORDER 6B	0.021098074	0.5206807929167121
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.021054867	0.5196144844461118
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.5189830211453214
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.5189830211453214
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.5189830211453214
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.5189830211453214
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.020990369000000005	0.5180227339488133
JACOBSEN SYNDROME	0.020985384000000003	0.5178997087971956
LESCH-NYHAN SYNDROME; LNS	0.020978434	0.5177281892778891
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.020953753999999998	0.5171191098913449
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.020949619	0.5170170619471244
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.020945616999999996	0.516918296318885
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.02094498	0.5169025757528709
AGNATHIA-OTOCEPHALY COMPLEX	0.020886210000000002	0.5154521869543619
NASU-HAKOLA DISEASE	0.020858718999999998	0.5147737347090017
LINEAR VERRUCOUS NEVUS SYNDROME	0.020854079	0.5146592238356806
COWDEN SYNDROME	0.020842707000000002	0.5143785734797739
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.020815783000000004	0.5137141142657011
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.020796239	0.5132317865699709
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.020756644	0.5122546188912749
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.020755488000000002	0.5122260898892147
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.020730114	0.5115998832298073
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020711303	0.5111356452905738
12Q14 MICRODELETION SYNDROME	0.020694818	0.510728810862406
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.020690483000000003	0.5106218271046804
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.020667433	0.5100529745982036
MONOSOMY 13Q14	0.020640204000000002	0.5093809882685355
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.02049375	0.5057666401130676
SIMPSON-GOLABI-BEHMEL SYNDROME	0.020480046999999998	0.5054284628507574
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.020438259000000004	0.5043971739769767
SEMANTIC DEMENTIA	0.020408199999999998	0.5036553458862094
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.020365269999999998	0.5025958735173138
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.020343724	0.5020641383283965
KAPUR-TORIELLO SYNDROME	0.020339589	0.501962090384176
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.020317773	0.5014236918470266
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.020317773	0.5014236918470266
ISOLATED DANDY-WALKER MALFORMATION	0.020312660000000003	0.5012975077747657
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.020301288	0.5010168574188588
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.020233380000000002	0.4993409513012963
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.020224520000000003	0.49912229476301495
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.02020518	0.49864500159706004
SNEDDON SYNDROME	0.020053968999999998	0.4949132551173705
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.020038733000000003	0.4945372448445429
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019934253000000002	0.4919587758694157
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.019914957	0.49148256858243206
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.019896840000000002	0.4910354579160617
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.019896840000000002	0.4910354579160617
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.019896840000000002	0.4910354579160617
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.019896840000000002	0.4910354579160617
ANGELMAN SYNDROME	0.019893403000000004	0.4909506359609745
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.01987825	0.49057667405075134
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.019776354	0.4880619757861116
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.019776354	0.4880619757861116
GRISCELLI SYNDROME, TYPE 2; GS2	0.019772219	0.48795992784189113
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.019772219	0.48795992784189113
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.019727987000000002	0.4868683233270766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.019705533	0.4863141795448455
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.019700503	0.48619004383518916
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.019693837000000002	0.48602553317106023
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.019684018	0.48578320940702135
RECOMBINANT CHROMOSOME 8 SYNDROME	0.019651217000000006	0.48497371131309785
TETRAPLOIDY	0.01962433	0.48431016522452336
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.019587214	0.4833941769542245
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01951233	0.4815461096615999
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.019497204000000004	0.4811728140862001
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.019490333000000002	0.4810032442132282
LATERAL MENINGOCELE SYNDROME	0.019413454	0.4791059421808889
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.47900389423666845
HHHH SYNDROME	0.019409319	0.47900389423666845
OROFACIODIGITAL SYNDROME TYPE 1	0.019402793000000005	0.47884283864199323
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.019400558000000002	0.4787876809260723
VAN DEN BOSCH SYNDROME	0.019392834	0.47859705980850076
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.019392834	0.47859705980850076
MICROPHTHALMIA, SYNDROMIC 4	0.019392834	0.47859705980850076
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.01938729	0.47846023905813595
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.019354057	0.477640079607041
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.01934964	0.47753107216577817
CINCA SYNDROME	0.019340158	0.47729706524749566
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.019317537000000003	0.4767388000609878
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.019302813000000002	0.47637542547073347
HYPERMANGANESEMIA WITH DYSTONIA 2	0.019286328000000005	0.4759685910425657
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.0192308	0.4745982117809761
ADENOSINE MONOPHOSPHATE DEAMINASE DEFICIENCY	0.0192308	0.4745982117809761
AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	0.0192308	0.4745982117809761
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.0192308	0.4745982117809761
REFSUM DISEASE	0.0192308	0.4745982117809761
CREUTZFELDT-JAKOB DISEASE; CJD	0.0192308	0.4745982117809761
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0192308	0.4745982117809761
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.0192308	0.4745982117809761
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.0192308	0.4745982117809761
602197 CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3;;CDR3	0.0192308	0.4745982117809761
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.0192308	0.4745982117809761
%109500 BASILAR IMPRESSION, PRIMARY	0.0192308	0.4745982117809761
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0192308	0.4745982117809761
SHORT RIB-POLYDACTYLY SYNDROME	0.019208310000000003	0.4740431795523142
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.019186568	0.47350660726616156
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.019168627	0.47306384011567576
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.019159084	0.4728283277742742
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.019138464	0.472319445401886
FRAGILE X SYNDROME	0.019031209	0.4696724920143737
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.019019590000000003	0.469385745928788
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.018967033	0.46808868817681865
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.4656421781757535
KNUCKLE PADS	0.0188679	0.4656421781757535
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.4656421781757535
CARPAL DISPLACEMENT	0.0188679	0.4656421781757535
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.4656421781757535
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.4656421781757535
TRACHEOBRONCHOMEGALY	0.0188679	0.4656421781757535
VESICOURETERAL REFLUX 1	0.0188679	0.4656421781757535
TOE, MISSHAPEN	0.0188679	0.4656421781757535
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.4656421781757535
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.4656421781757535
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.4656421781757535
THROMBOCYTOPENIA 3	0.0188679	0.4656421781757535
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.4656421781757535
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.4656421781757535
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.4656421781757535
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.4656421781757535
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.4656421781757535
ISOLATED OXYCEPHALY	0.0188679	0.4656421781757535
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.4656421781757535
MONOPHALANGY OF GREAT TOE	0.0188679	0.4656421781757535
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.4656421781757535
PUBIC BONE DYSPLASIA	0.0188679	0.4656421781757535
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.4656421781757535
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.4656421781757535
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.4656421781757535
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.4656421781757535
RAYNAUD DISEASE	0.0188679	0.4656421781757535
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.4656421781757535
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.4656421781757535
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.4656421781757535
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.4656421781757535
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.4656421781757535
REVESZ SYNDROME	0.018817884	0.46440782993436797
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.01880095	0.46398991460488087
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.018771503000000002	0.4632631901034398
OGDEN SYNDROME	0.018731764	0.46228246863902
SPONTANEOUS PERIODIC HYPOTHERMIA	0.018724589	0.46210539632952014
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.018707793	0.4616908867113518
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.01865331	0.46034629707532704
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.01865276	0.4603327235881877
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.018641848	0.4600634256033429
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.018619144000000004	0.4595031120542304
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.018616533	0.4594386750089196
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.018614388000000003	0.45938573840907615
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.01861353	0.4593645637691387
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.01857728	0.4584699475713176
ALSTRÖM SYNDROME	0.018561107000000004	0.45807081301221786
CEREBROOCULONASAL SYNDROME	0.018509894	0.4568069239270035
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.01848238	0.4561279040630904
MENTAL RETARDATION, X-LINKED 104; MRX104	0.018426836999999998	0.45475715461548794
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.018285883000000003	0.4512785413314138
LYSOSOMAL ACID LIPASE DEFICIENCY	0.018260214	0.45064505434708624
DISTAL MONOSOMY 7Q36	0.018247049	0.4503201544231051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.018241308	0.4501784718964378
KNOBLOCH SYNDROME 1; KNO1	0.018156519	0.44808595843996696
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.018090343000000002	0.44645279646735964
GM2-GANGLIOSIDOSIS, AB VARIANT	0.018072692999999997	0.4460172109255239
ALLAN-HERNDON-DUDLEY SYNDROME	0.01804571	0.445351295646467
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.017952967	0.4430624848868937
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.017942084	0.44279390259500717
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.017940980000000002	0.44276665690445843
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.01791721	0.44218003546936285
INTESTINAL BOTULISM	0.01789967	0.44174716462495506
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.017850524	0.44053428717231713
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.017828093	0.43998071100863917
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.017807583000000002	0.43947454333367886
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.017766543	0.4384617144024075
SPINOCEREBELLAR ATAXIA TYPE 38	0.01775666	0.4382178111780471
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.017751339	0.43808649385974074
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.01770563	0.43695843836219006
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.01770563	0.43695843836219006
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.01770563	0.43695843836219006
20P13 MICRODELETION SYNDROME	0.017689223	0.4365535289012893
OCULOCEREBRORENAL SYNDROME OF LOWE	0.017669743	0.43607278066588084
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.01766384	0.43592710013027425
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.017648564	0.4355501026947454
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.017620913000000002	0.4348677017985813
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.0175439	0.4329670927711935
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.0175439	0.4329670927711935
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0175439	0.4329670927711935
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0175439	0.4329670927711935
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.01752531	0.4325083089058832
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.01752531	0.4325083089058832
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.01752531	0.4325083089058832
MYOPATHY, DISTAL, INFANTILE-ONSET	0.01752531	0.4325083089058832
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.01752531	0.4325083089058832
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.01752531	0.4325083089058832
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.01752531	0.4325083089058832
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.01752531	0.4325083089058832
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.01752531	0.4325083089058832
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.01752531	0.4325083089058832
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.017522738000000003	0.4324448343442062
NAVAJO NEUROHEPATOPATHY	0.017517594	0.43231788522085185
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.017494754	0.4317542153185557
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.017478347	0.4313493058576549
LAMBERT SYNDROME	0.017474134000000002	0.4312453329461674
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.017473397	0.4312271444734007
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.017464547000000004	0.4310087347257947
OLIVER-MCFARLANE SYNDROME	0.017452544	0.43071251187827886
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.017429939999999998	0.43015466623591875
WALDENSTRÖM MACROGLOBULINEMIA	0.017429939999999998	0.43015466623591875
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.017389612999999998	0.42915943347979363
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.017351494	0.4282186921047661
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.017337994000000002	0.4278855246931638
BETA-KETOTHIOLASE DEFICIENCY	0.017308429	0.4271558880617545
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.017303064000000003	0.4270234848644771
EEC SYNDROME	0.017298204	0.4269035445963002
GALACTOSE EPIMERASE DEFICIENCY	0.017281648	0.426494957954338
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.42550167484454743
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.42550167484454743
MYOPATHY, CONGENITAL	0.0172414	0.42550167484454743
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.42550167484454743
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.42550167484454743
MOSAIC TRISOMY 15	0.0172414	0.42550167484454743
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.42550167484454743
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.42550167484454743
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.42550167484454743
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.42550167484454743
CERVICAL RIB	0.0172414	0.42550167484454743
PALMOMENTAL REFLEX	0.0172414	0.42550167484454743
DIASTEMATOMYELIA	0.0172414	0.42550167484454743
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.42550167484454743
ALCOHOL DEPENDENCE	0.0172414	0.42550167484454743
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.42550167484454743
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.42550167484454743
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.42550167484454743
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.42550167484454743
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.42550167484454743
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.42550167484454743
RHEUMATOID ARTHRITIS	0.0172414	0.42550167484454743
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.42550167484454743
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.42550167484454743
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.42550167484454743
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.42550167484454743
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.42550167484454743
269800 SENILE PLAQUE FORMATION	0.0172414	0.42550167484454743
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.42550167484454743
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.42550167484454743
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.42550167484454743
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.42550167484454743
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.42550167484454743
JUMPING FRENCHMAN OF MAINE	0.0172414	0.42550167484454743
SICKLE CELL ANEMIA	0.0172414	0.42550167484454743
MOTION SICKNESS	0.0172414	0.42550167484454743
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.42550167484454743
CARDIAC ARRHYTHMIA	0.0172414	0.42550167484454743
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.42550167484454743
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.42550167484454743
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.42550167484454743
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.42550167484454743
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.42550167484454743
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.42550167484454743
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.42550167484454743
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.017195212999999997	0.4243618227527193
DISTAL MONOSOMY 6P	0.017148944	0.42321994697735404
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.017117893	0.422453637251601
ACROCALLOSAL SYNDROME; ACLS	0.017051563000000002	0.42081667470259465
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.01704995	0.4207768673666751
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.017047559	0.42071785971622017
RETT SYNDROME; RTT	0.016994909000000002	0.4194185068109708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.016968833	0.4187749754461601
BRUNNER SYNDROME; BRNRS	0.016962374000000002	0.4186155733490091
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.016956699000000002	0.41847551964079843
MICROTIA	0.0169492	0.4182904513134202
MICROTIA-ANOTIA	0.0169492	0.4182904513134202
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.0169492	0.4182904513134202
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.0169492	0.4182904513134202
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.0169492	0.4182904513134202
184705 STEINFELD SYNDROME	0.0169492	0.4182904513134202
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.0169492	0.4182904513134202
BOHRING-OPITZ SYNDROME	0.016922793000000002	0.41763875117725846
COFFIN-SIRIS SYNDROME 5	0.016888587	0.4167945789934605
COCKAYNE SYNDROME	0.016866373	0.41624635818743566
PLAGUE	0.016832220000000002	0.4154034939942168
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.016814244	0.41495986307636745
SARCOIDOSIS	0.01679167	0.4144027578060333
MACROPHAGIC MYOFASCIITIS	0.01671834	0.41259304178434414
EISENMENGER SYNDROME	0.01664845	0.4108682217549448
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.016607393	0.4098549732795256
PRADER-WILLI SYNDROME; PWS	0.016597103000000002	0.40960102567468204
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.016590908000000005	0.40944813885135795
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.016540437	0.4082025616342479
FRONTONASAL DYSPLASIA 2; FND2	0.016511504000000003	0.4074885221735152
KLEEFSTRA SYNDROME 2; KLEFS2	0.016452837	0.4060406753189613
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.016448143000000002	0.4059248317759938
PYRUVATE DEHYDROGENASE DEFICIENCY	0.016410493	0.40499566488363603
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.016341439	0.4032914765546885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.016284758000000003	0.4018926423282415
CRANIOSYNOSTOSIS 6; CRS6	0.016198874	0.3997731052928296
FAMILIAL MULTIPLE LIPOMATOSIS	0.016108248999999998	0.39753656479827654
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.016099677	0.39732501583144275
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.016065974000000004	0.3964932572186107
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.01604762	0.39604029761323645
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.016043263	0.39593277091602525
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.015980019	0.3943719679694045
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.015941089999999998	0.39341123654968074
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.01588863	0.3921165726672614
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.01588863	0.3921165726672614
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.01586644	0.39156894415885724
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.01586644	0.39156894415885724
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.015840557	0.39093017585407913
PEDIATRIC-ONSET GRAVES DISEASE	0.015840314	0.39092417884067027
HENNEKAM-BEEMER SYNDROME	0.015765143	0.38906902865566556
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.015741484000000004	0.3884851465970656
INFANTILE SIALIC ACID STORAGE DISEASE	0.015717373	0.38789010959994363
CHROMOSOME 2Q37 DELETION SYNDROME	0.015696407	0.38737268827019133
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.015681597999999998	0.3870072159591973
BLAU SYNDROME	0.01568026	0.38697419536684746
OCULOCEREBROCUTANEOUS SYNDROME	0.015677463	0.3869051680149769
PHAKOMATOSIS PIGMENTOVASCULARIS	0.015585009	0.3846234895059186
FLYNN-AIRD SYNDROME	0.015585008999999999	0.38462348950591857
XERODERMA PIGMENTOSUM	0.015569448999999999	0.3842394832152124
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.015563470000000001	0.3840919270704739
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.015542002999999999	0.383562141527891
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.015528328000000001	0.3832246552794716
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.015496668	0.38244331600159515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.015475778	0.38192777028097485
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.015457077	0.3814662470391692
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.015452799	0.38136066998829254
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.01541327	0.3803851311280532
LIGNEOUS CONJUNCTIVITIS	0.015410983999999999	0.38032871477968855
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.015390363999999998	0.3798198324073003
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.015382349	0.3796220296810786
2Q23.1 MICRODELETION SYNDROME	0.015382349	0.3796220296810786
NEUROPATHY, PAINFUL	0.01535924	0.3790517211096179
LAURIN-SANDROW SYNDROME	0.015327954000000001	0.3782796118029963
JABERI-ELAHI SYNDROME; JABELS	0.015290077000000001	0.3773448427623101
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.015259544	0.3765913167935356
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.015238924	0.3760824344211473
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.015231893000000002	0.37590891589737135
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.015195779	0.3750176560527336
LYSINURIC PROTEIN INTOLERANCE	0.015179294	0.3746108216245658
GALACTOSEMIA	0.015169977000000001	0.37438088675242515
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.015154988	0.37401097220927637
MEND SYNDROME	0.015040826999999998	0.3711935851814289
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.015006888000000001	0.37035600230866056
WARBURG MICRO SYNDROME 1	0.014946383999999998	0.36886282000706117
SPINOCEREBELLAR ATAXIA TYPE 12	0.014939570000000001	0.36869465684093844
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.014934857	0.3685783443956878
INDOLENT SYSTEMIC MASTOCYTOSIS	0.0149069	0.36788839170486065
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.014848254	0.3664410631107248
HALL-RIGGS SYNDROME	0.014840229	0.36624301359382777
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.014769087999999998	0.3644873200509533
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.014743620000000002	0.36385879355919865
RAINE SYNDROME	0.014695104	0.36266146391910214
TRANSKETOLASE DEFICIENCY	0.014630054	0.3610560905765292
COFFIN-SIRIS SYNDROME 8; CSS8	0.014625919	0.36095404263230874
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.014609434	0.3605472082041409
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.014600473	0.3603260590800395
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.014600473	0.3603260590800395
CRANE-HEISE SYNDROME	0.014567090000000001	0.35950219776881565
FEMORAL-FACIAL SYNDROME	0.014567090000000001	0.35950219776881565
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.014538823000000001	0.3588045945670553
PETERS-PLUS SYNDROME; PTRPLS	0.014526343	0.3584965998043295
ANGELMAN SYNDROME	0.014475069000000002	0.35723120529599617
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.014455039	0.3567368835734483
DISTAL MONOSOMY 1Q	0.014416537000000002	0.35578669011555836
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.014405290000000001	0.35550912464309226
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.014391704	0.3551738348316826
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01436964	0.3546293158857866
RAYNAUD-CLAES SYNDROME; MRXSRC	0.014264193	0.3520269822523617
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.014244153999999998	0.3515324384182061
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.014244153999999998	0.3515324384182061
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.014240018999999998	0.3514303904739856
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.014218489	0.3508990501501487
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.014136404000000002	0.3488732688922686
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.014115784000000001	0.34836438651988033
ROTHMUND-THOMSON SYNDROME	0.014096858	0.3478973104878813
KERATODERMA HEREDITARIUM MUTILANS	0.0140845	0.3475923265713937
HARLEQUIN ICHTHYOSIS	0.0140845	0.3475923265713937
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.014059054	0.3469643430191245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.014059054	0.3469643430191245
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.014054918999999999	0.34686229507490407
TAY-SACHS DISEASE; TSD	0.014054918999999999	0.34686229507490407
INFANTILE LIVER FAILURE SYNDROME 1	0.014038503	0.3464571635023956
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.01398084	0.3450340944316379
GORLIN SYNDROME	0.013918054	0.343484594497944
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.013895087	0.34291779035407205
ZECHI-CEIDE SYNDROME	0.013890988000000002	0.34281663085628256
C SYNDROME	0.013870983000000002	0.34232292611042286
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	0.33806867441307065
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.33806867441307065
STROKE, ISCHEMIC	0.013698599999999998	0.33806867441307065
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.33806867441307065
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.013698599999999998	0.33806867441307065
PSEUDOXANTHOMA ELASTICUM; PXE	0.013698599999999998	0.33806867441307065
SICKLE CELL ANEMIA	0.013698599999999998	0.33806867441307065
ALAGILLE SYNDROME 1; ALGS1	0.013698599999999998	0.33806867441307065
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.33806867441307065
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	0.33806867441307065
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.33806867441307065
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	0.33806867441307065
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.33806867441307065
AORTA COARCTATION	0.013698599999999998	0.33806867441307065
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.33806867441307065
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.33806867441307065
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	0.33806867441307065
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013698599999999998	0.33806867441307065
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	0.33806867441307065
SECONDARY POLYCYTHEMIA	0.013698599999999998	0.33806867441307065
POLYCYTHEMIA VERA	0.013698599999999998	0.33806867441307065
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	0.33806867441307065
DONNAI-BARROW SYNDROME	0.013660107000000001	0.3371187030667884
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.013660107000000001	0.3371187030667884
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.013660107000000001	0.3371187030667884
MENTAL RETARDATION, X-LINKED 98; MRX98	0.013660107000000001	0.3371187030667884
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.013645639999999999	0.33676167099688825
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.013630298	0.3363830447429028
NEURONAL CEROID LIPOFUSCINOSIS	0.013626163	0.3362809967986824
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.013588939999999999	0.3353623678681582
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.013576930000000003	0.33506597226716983
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.013576930000000003	0.33506597226716983
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.013559462999999999	0.33463490299469134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.013552287	0.334457806006124
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.01353569	0.3340482075223933
INCLUSION BODY MYOSITIS	0.01353569	0.3340482075223933
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.01353569	0.3340482075223933
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.01353569	0.3340482075223933
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.01353569	0.3340482075223933
HYPOMAGNESEMIA 2, RENAL	0.013528419	0.333868766022411
TEMPLE SYNDROME	0.01351112	0.33344184283327694
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.013497084000000001	0.3330954474414806
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.013497084000000001	0.3330954474414806
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.013492949	0.33299339949726015
2P15P16.1 MICRODELETION SYNDROME	0.013480974	0.33269786766363507
KOOLEN-DE VRIES SYNDROME; KDVS	0.013431836999999999	0.3314852123226049
JOUBERT SYNDROME 35; JBTS35	0.013366054000000002	0.3298617492235354
IMMUNOGLOBULIN A VASCULITIS	0.013357579	0.3296525941262516
PORPHYRIA	0.013357579	0.3296525941262516
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.013347194	0.32939630200999304
LEBER CONGENITAL AMAUROSIS, TYPE II	0.013345434000000002	0.3293528668511471
ZECHI-CEIDE SYNDROME	0.013345434000000002	0.3293528668511471
SPINOCEREBELLAR ATAXIA TYPE 20	0.01333372	0.32906377625414635
LOWRY-WOOD SYNDROME	0.013329564000000002	0.3289612100495079
CLASSIC GALACTOSEMIA	0.013326574	0.3288874196376048
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.013289269999999999	0.32796679170261106
MENTAL RETARDATION, X-LINKED 9	0.013282073	0.3277891764536257
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.013261453	0.3272802940812375
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.013261453	0.3272802940812375
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.013261453	0.3272802940812375
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.013240974	0.32677489145737043
PHACE ASSOCIATION	0.013197582999999999	0.32570404203834524
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.013181613	0.3253099173299534
HUNTINGTON DISEASE	0.01317722	0.3252015021863113
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.013135173000000002	0.32416382143404127
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.013135173000000002	0.32416382143404127
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.013135173000000002	0.32416382143404127
TEMTAMY SYNDROME	0.013118688000000002	0.3237569870058734
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.013118688000000002	0.3237569870058734
MENTAL RETARDATION, X-LINKED 1	0.013114553000000001	0.323654939061653
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.013114553000000001	0.323654939061653
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.013114553000000001	0.323654939061653
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.013110548999999999	0.32355612407527845
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.013064444000000001	0.32241829566698754
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.013062917999999998	0.3223806354099426
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.01306033	0.3223167659831851
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.01306033	0.3223167659831851
MENTAL RETARDATION, X-LINKED 103	0.013059367	0.3222930000411575
TRISOMY 1Q	0.01305687	0.3222313764095448
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.013018073	0.3212739026267346
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.01299124	0.32061168920780664
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.012987	0.320507049961496
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.012987	0.320507049961496
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.012987	0.320507049961496
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.012987	0.320507049961496
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.012987	0.320507049961496
MULTIPLE MYELOMA	0.012987	0.320507049961496
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.012987	0.320507049961496
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.012955194	0.31972210753976077
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.01294985	0.31959022260290126
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.01294985	0.31959022260290126
BETHLEM MYOPATHY 2; BTHLM2	0.01294985	0.31959022260290126
SMITH-FINEMAN-MYERS SYNDROME	0.012879052999999998	0.31784301865925574
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.01286576	0.31751495981463135
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.012827544	0.3165718245700538
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.012820500000000002	0.31639798521839996
JUVENILE DERMATOMYOSITIS	0.01281616	0.3162908780653366
LYME DISEASE	0.01281616	0.3162908780653366
METACHROMATIC LEUKODYSTROPHY	0.012788133	0.3155991978397825
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.012740654	0.3144274603927107
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.012740654	0.3144274603927107
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.012740654	0.3144274603927107
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.012736519	0.31432541244849027
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.012736519	0.31432541244849027
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.012694252999999999	0.31328232698043196
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.012694252999999999	0.31328232698043196
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.012683867000000001	0.31302601018510595
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.012656164	0.3123423259774302
MEND SYNDROME; MEND	0.012631186999999999	0.31172591690783075
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.012593754000000002	0.31080210537312625
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012593754000000002	0.31080210537312625
9Q21.13 MICRODELETION SYNDROME	0.012589619000000002	0.31070005742890583
PALLISTER-KILLIAN SYNDROME	0.012589619000000002	0.31070005742890583
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.012573134000000001	0.31029322300073797
8Q21.11 MICRODELETION SYNDROME	0.012573134000000001	0.31029322300073797
CRANIOFACIAL DYSSYNOSTOSIS	0.012571869999999999	0.3102620286593849
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.01256913	0.31019440801436343
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.01250327	0.30856904462709434
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.012465218	0.3076299567495911
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.01238433	0.3056337163355397
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.012368337	0.3052390240085947
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.012368337	0.3052390240085947
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.012368337	0.3052390240085947
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.01235294	0.3048590404058953
PELGER-HUET ANOMALY; PHA	0.012306487999999999	0.3037126483611728
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.012294637	0.30342017673192095
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.012294637	0.30342017673192095
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.012282263	0.30311479795035295
HELSMOORTEL-VAN DER AA SYNDROME	0.012250206999999999	0.3023236857617362
GRISCELLI SYNDROME TYPE 1	0.012250206999999999	0.3023236857617362
ADULT POLYGLUCOSAN BODY DISEASE	0.012246714	0.30223748177886756
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.012229306999999998	0.3018078932504406
GAUCHER DISEASE, PERINATAL LETHAL	0.012220099000000002	0.3015806483966603
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0121951	0.30096369638757525
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.0121951	0.30096369638757525
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.0121951	0.30096369638757525
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0121951	0.30096369638757525
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.0121951	0.30096369638757525
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0121951	0.30096369638757525
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.012169319	0.3003274453476848
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.012169319	0.3003274453476848
SPASTIC PARAPLEGIA 16, X-LINKED	0.012152834	0.299920610919517
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0121347	0.29947308070899864
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.012096347	0.29852656443217007
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.012051684	0.2974243232392517
PAI SYNDROME	0.012048200000000002	0.2973383413679908
DISTAL TRISOMY 14Q	0.012048200000000002	0.2973383413679908
HOLZGREVE SYNDROME	0.012048200000000002	0.2973383413679908
EMANUEL SYNDROME	0.012038077	0.297088515167424
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.012033833	0.29698377720484326
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.012027102999999999	0.2968176870803925
SPINOCEREBELLAR ATAXIA TYPE 7	0.012015984	0.2965432805285698
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.011966603	0.29532460349506334
AGEL AMYLOIDOSIS	0.01194892	0.2948882035439993
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.011940284	0.2946750751168439
AICARDI-GOUTIERES SYNDROME 6	0.011940284	0.2946750751168439
SYMMETRICAL THALAMIC CALCIFICATIONS	0.011936149	0.2945730271726234
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.011936149	0.2945730271726234
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.011935953	0.29456819007538826
HENNEKAM SYNDROME	0.011935953	0.29456819007538826
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.011919664	0.29416619274445566
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.011898764000000001	0.2936504002331601
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.011826918	0.2918773079476797
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.011826918	0.2918773079476797
PYRIDOXINE-DEPENDENT EPILEPSY	0.011782548	0.2907822977215465
KID SYNDROME	0.011778493999999999	0.2906822487817957
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.011764700000000001	0.2903418257243407
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.011764700000000001	0.2903418257243407
INFANT BOTULISM	0.011764700000000001	0.2903418257243407
AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	0.011764700000000001	0.2903418257243407
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.011764700000000001	0.2903418257243407
NEONATAL ADRENOLEUKODYSTROPHY	0.011736709	0.28965103394521746
OCCIPITAL HORN SYNDROME	0.011708788	0.28896196970082116
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.011708788	0.28896196970082116
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.011708788	0.28896196970082116
XP21 MICRODELETION SYNDROME	0.011683887	0.28834743624035375
AMYOTROPHIC LATERAL SCLEROSIS 3	0.0116279	0.2869657292867698
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.0116279	0.2869657292867698
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.0116279	0.2869657292867698
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0116279	0.2869657292867698
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0116279	0.2869657292867698
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.0116279	0.2869657292867698
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.0116279	0.2869657292867698
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0116279	0.2869657292867698
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.0116279	0.2869657292867698
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0116279	0.2869657292867698
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0116279	0.2869657292867698
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.0116279	0.2869657292867698
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.0116279	0.2869657292867698
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0116279	0.2869657292867698
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0116279	0.2869657292867698
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.0116279	0.2869657292867698
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.0116279	0.2869657292867698
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.0116279	0.2869657292867698
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.0116279	0.2869657292867698
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.0116279	0.2869657292867698
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.0116279	0.2869657292867698
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0116279	0.2869657292867698
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.0116279	0.2869657292867698
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 42	0.0116279	0.2869657292867698
SCHAAF-YANG SYNDROME; SHFYNG	0.011611907000000001	0.2865710369598249
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.011611907	0.28657103695982483
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.011611907	0.28657103695982483
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.011584953	0.28590583737372627
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.011571413	0.2855716827994228
JOUBERT SYNDROME 14	0.011564834	0.28540931921416857
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.011553707	0.2851347152298056
DIENCEPHALIC SYNDROME	0.01152675	0.28446944160650456
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.011467350000000001	0.283003504995454
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.011455153999999999	0.2827025190879056
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.011450593	0.2825899578609191
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.01144746	0.2825126383423598
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.011415154	0.28171535638686157
PACHYGYRIA, FRONTOTEMPORAL	0.011411019	0.2816133084426411
DYSOSTOSIS, STANESCU TYPE	0.01139473	0.28121131111170844
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01139473	0.28121131111170844
ACROOTOOCULAR SYNDROME	0.01139473	0.28121131111170844
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.01139473	0.28121131111170844
GOLDENHAR SYNDROME	0.011386124	0.28099892305657875
TYSHCHENKO SYNDROME	0.011358554	0.28031852116488415
CLASSICAL EHLERS-DANLOS SYNDROME	0.01135321	0.28018663622802464
ANIRIDIA	0.01133821	0.2798164502151331
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.011301984000000001	0.2789224263149325
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.011301984000000001	0.2789224263149325
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.011281234	0.2784103356637659
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.011281234	0.2784103356637659
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.011238669	0.2773598711545173
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.011236	0.2772940027232901
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.011236	0.2772940027232901
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.011236	0.2772940027232901
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.011236	0.2772940027232901
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.011236	0.2772940027232901
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.011236	0.2772940027232901
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.011225862999999999	0.277043831015778
INFANTILE LIVER FAILURE SYNDROME 2	0.011224149000000001	0.2770015310940383
BOWEN-CONRADI SYNDROME	0.011224149000000001	0.2770015310940383
HYPOADRENOCORTICISM, FAMILIAL	0.011224149000000001	0.2770015310940383
DYSKERATOSIS CONGENITA	0.011183854	0.276007088068074
SILVER-RUSSELL SYNDROME; SRS	0.011183854	0.276007088068074
ALSTROM SYNDROME; ALMS	0.011183854	0.276007088068074
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.011183854	0.276007088068074
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.011179719	0.27590504012385353
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.011179719	0.27590504012385353
KEUTEL SYNDROME; KTLS	0.011179719	0.27590504012385353
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.011179719	0.27590504012385353
LIPOID PROTEINOSIS	0.011179719	0.27590504012385353
DYSSPONDYLOENCHONDROMATOSIS	0.011163234	0.2754982056956857
DYSOSTEOSCLEROSIS	0.011163234	0.2754982056956857
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.01115818	0.2753734776884088
CYCLIC VOMITING SYNDROME	0.011141633	0.2749651131580544
MYHRE SYNDROME	0.011140267	0.2749314015518138
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.011140267	0.2749314015518138
WIEACKER-WOLFF SYNDROME	0.011129572999999999	0.2746674836036896
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.011100763	0.27395647966826253
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.011086973	0.2736161553270776
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.011086973	0.2736161553270776
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.011070488	0.2732093208989098
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.011070488	0.2732093208989098
COFFIN-SIRIS SYNDROME 7; CSS7	0.011070488	0.2732093208989098
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.011070488	0.2732093208989098
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.01103426	0.2723152476405742
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.01103426	0.2723152476405742
B4GALT1-CDG	0.01101928	0.27194555520903313
HYPOPLASMINOGENEMIA	0.01101928	0.27194555520903313
AASE-SMITH SYNDROME I	0.01101928	0.27194555520903313
CRANIOSYNOSTOSIS, SAGITTAL, WITH DANDY-WALKER MALFORMATION AND HYDROCEPHALUS	0.01101928	0.27194555520903313
POLYMYOSITIS	0.01097772	0.2709198931626483
KABUKI SYNDROME	0.010976849	0.2708983976948331
NEPHROGENIC DIABETES INSIPIDUS	0.010953283000000001	0.270316810789513
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.010945616999999998	0.2701276210578578
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.010941464	0.27002512889042196
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.010939429	0.26997490698800636
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.010897169	0.2689319695943532
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01087963	0.2684991234290129
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.010863013000000001	0.2680890313639317
EPENDYMOMA	0.010846789	0.2676886381723882
SUBEPENDYMOMA	0.010846789	0.2676886381723882
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.010814982999999999	0.2669036957506529
SHASHI-PENA SYNDROME; SHAPNS	0.010797467000000002	0.26647141720386575
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.010771697	0.26583543763371803
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.010756713	0.2654656464859069
EPISODIC ATAXIA, TYPE 6	0.010756569	0.26546209270018317
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.010748303	0.26525809552801244
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.010716708	0.2644783603895252
CYSTINOSIS	0.01069725	0.2639981550936023
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.010682730000000001	0.2636398150331233
SHORT STATURE DUE TO GHSR DEFICIENCY	0.010682730000000001	0.2636398150331233
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.010682730000000001	0.2636398150331233
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.010682730000000001	0.2636398150331233
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0106383	0.2625433240629385
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0106383	0.2625433240629385
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0106383	0.2625433240629385
WOODHOUSE-SAKATI SYNDROME	0.0106383	0.2625433240629385
TERATOMA, PINEAL	0.0106383	0.2625433240629385
241519 HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS	0.0106383	0.2625433240629385
PAPILLON-LEFÈVRE SYNDROME	0.0106383	0.2625433240629385
BOOMERANG DYSPLASIA	0.0106383	0.2625433240629385
MARSHALL SYNDROME	0.0106383	0.2625433240629385
DIASTROPHIC DWARFISM	0.0106383	0.2625433240629385
FETAL ALCOHOL SYNDROME	0.010598848000000001	0.26156968549089876
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.010597322999999999	0.2615320499129214
5Q35 MICRODUPLICATION SYNDROME	0.010594713	0.2614676375466783
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.010545554	0.26025443926616265
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.010545554	0.26025443926616265
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.010545554	0.26025443926616265
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.010545554	0.26025443926616265
DK1-CDG	0.01054026	0.2601237882826794
ACRODERMATITIS ENTEROPATHICA	0.01054026	0.2601237882826794
1Q44 MICRODELETION SYNDROME	0.010512704000000001	0.25944373189793013
MASA SYNDROME	0.010492084	0.2589348495255419
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.010420682999999998	0.2571727394251106
WOLMAN DISEASE	0.010411864	0.25695509472859795
CENTRAL DIABETES INSIPIDUS	0.010407729000000001	0.25685304678437754
RABIES	0.010407729000000001	0.25685304678437754
LUJO HEMORRHAGIC FEVER	0.010407729000000001	0.25685304678437754
GRISCELLI SYNDROME TYPE 2	0.010407729000000001	0.25685304678437754
NIPAH VIRUS DISEASE	0.010407729000000001	0.25685304678437754
LASSA FEVER	0.010407729	0.2568530467843775
SCRUB TYPHUS	0.010407729	0.2568530467843775
RIFT VALLEY FEVER	0.010407729	0.2568530467843775
RECURRENT ACUTE PANCREATITIS	0.010407729	0.2568530467843775
VIRAL HEMORRHAGIC FEVER	0.010407729	0.2568530467843775
FAMILIAL MEDITERRANEAN FEVER	0.010407729	0.2568530467843775
HEPATOCELLULAR CARCINOMA	0.010398010000000001	0.25661319092709134
ZTTK SYNDROME; ZTTKS	0.010386587	0.2563312819387406
MENTAL RETARDATION, X-LINKED 90	0.010383837	0.25626341450304385
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.010383837	0.25626341450304385
LANDAU-KLEFFNER SYNDROME	0.010383837	0.25626341450304385
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.010383837	0.25626341450304385
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.01035575	0.2555702535334382
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.010230278	0.25247372157280307
ROBERTS SYNDROME	0.010230278	0.25247372157280307
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.010230278	0.25247372157280307
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.010223532999999998	0.2523072612623395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.010204463	0.2518366314446167
MYOPATHY, DISTAL, 4; MPD4	0.01019623	0.25163344868167437
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.01019623	0.25163344868167437
ALPORT SYNDROME	0.01015103	0.25051795482949446
MOSAIC TRISOMY 9	0.010091378	0.24904579909342742
ISOLATED CEREBELLAR AGENESIS	0.010069779000000001	0.24851275591393113
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.010053294	0.24810592148576333
CUTIS LAXA	0.010038103999999999	0.24773104645004176
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.010015543	0.24717426200758538
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01	0.24679067526102716
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.01	0.24679067526102716
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.01	0.24679067526102716
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.009999058	0.24676742757941758
WHIPPLE DISEASE	0.009977429	0.24623364402789552
REFSUM DISEASE	0.00992285	0.24488668520138834
DERMATITIS, ATOPIC	0.00992285	0.24488668520138834
257960 OCULOTRICHODYSPLASIA; OTD	0.00992285	0.24488668520138834
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.009879263999999999	0.24381102336419558
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.009875128999999998	0.24370897541997516
HUGHES-STOVIN SYNDROME	0.00986631	0.2434913307234625
KAWASAKI DISEASE	0.00986631	0.2434913307234625
RHABDOID TUMOR	0.00986631	0.2434913307234625
OMENN SYNDROME	0.00986631	0.2434913307234625
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00986631	0.2434913307234625
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00986631	0.2434913307234625
MICROSCOPIC POLYANGIITIS	0.00986631	0.2434913307234625
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00986631	0.2434913307234625
STEVENS-JOHNSON SYNDROME	0.00986631	0.2434913307234625
FAMILIAL COLD URTICARIA	0.00986631	0.2434913307234625
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00986631	0.2434913307234625
PAROXYSMAL COLD HEMOGLOBINURIA	0.00986631	0.2434913307234625
MARBURG HEMORRHAGIC FEVER	0.00986631	0.2434913307234625
MALT LYMPHOMA	0.00986631	0.2434913307234625
BABESIOSIS	0.00986631	0.2434913307234625
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00986631	0.2434913307234625
YELLOW FEVER	0.00986631	0.2434913307234625
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.009863347	0.24341820664638267
ARGININEMIA	0.009858903	0.24330853287029666
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.009858643999999998	0.24330214099180736
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.009838283	0.24279965049790841
2Q33.1 DELETION SYNDROME	0.009838283	0.24279965049790841
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00977604	0.24126355129788118
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.009735654	0.24026686247677204
GAPO SYNDROME; GAPOS	0.009726063	0.24003016554012918
ROIFMAN SYNDROME; RFMN	0.009705344000000001	0.2395188399400559
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.009698598999999999	0.23935237962959227
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.009685000000000001	0.23901676899030483
GMS SYNDROME	0.009684724	0.23900995756766763
DIAMOND-BLACKFAN ANEMIA 1	0.009684724	0.23900995756766763
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.009658909	0.2383728674394813
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.009628437	0.23762084689382587
PORPHYRIA VARIEGATA	0.009626239	0.23756660230340348
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.009605943	0.23706571594889372
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00960183	0.23696421094415884
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00959932	0.23690226648466836
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00959932	0.23690226648466836
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.009545824	0.23558203508829192
JUBERG-HAYWARD SYNDROME	0.009545824	0.23558203508829192
MELKERSSON-ROSENTHAL SYNDROME	0.00954529	0.235568856466233
LARON SYNDROME	0.009544544	0.23555044588185856
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.009528446999999999	0.23515318693189086
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.009508323	0.23465654537699557
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.234212568952201
KAGAMI-OGATA SYNDROME	0.009490333	0.234212568952201
DIAPHANOSPONDYLODYSOSTOSIS	0.009474124	0.23381254594667036
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.009467103	0.2336392742135696
XFE PROGEROID SYNDROME; XFEPS	0.00941029	0.23223718235020913
EPISODIC ATAXIA TYPE 6	0.009371809	0.2312875071527372
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.009355324	0.23088067272456939
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.009334948	0.2303778120446575
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.2299468168093817
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.009313349	0.22984476886516123
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.009313349	0.22984476886516123
FAMILIAL DYSAUTONOMIA	0.009313349	0.22984476886516123
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.22984476886516123
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.009313349	0.22984476886516123
NEUROFERRITINOPATHY	0.009296864	0.2294379344369934
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.009296864	0.2294379344369934
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.009296864	0.2294379344369934
HSD10 DISEASE, ATYPICAL TYPE	0.009296864	0.2294379344369934
MENTAL RETARDATION, X-LINKED 105; MRX105	0.009296864	0.2294379344369934
HISTIDINEMIA	0.009296864	0.2294379344369934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.009296864	0.2294379344369934
NANCE-HORAN SYNDROME	0.009296864	0.2294379344369934
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.009296864	0.2294379344369934
2Q31.1 MICRODELETION SYNDROME	0.009292517	0.22933065453045748
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00924434	0.22814169109425242
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.009159790000000001	0.2260550759349204
DISTAL MONOSOMY 17Q	0.009159790000000001	0.2260550759349204
RENAL TUBULAR DYSGENESIS	0.009159790000000001	0.2260550759349204
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.009110189	0.22483096950655818
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.009103044000000001	0.22465463756908421
PEROXISOME BIOGENESIS DISORDER 14B	0.00908482	0.2242048862424885
INHALATIONAL BOTULISM	0.00908482	0.2242048862424885
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00908482	0.2242048862424885
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00908482	0.2242048862424885
NON-HISTAMINIC ANGIOEDEMA	0.00908482	0.2242048862424885
PRIMARY PARATHYROID HYPERPLASIA	0.00908482	0.2242048862424885
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00908482	0.2242048862424885
PARATHYROID CARCINOMA	0.00908482	0.2242048862424885
COLD AGGLUTININ DISEASE	0.00908482	0.2242048862424885
ASPARTYLGLUCOSAMINURIA; AGU	0.009082883	0.22415708288869043
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.009064524000000001	0.2237039998879787
1Q21.1 MICRODELETION SYNDROME	0.009060167000000001	0.2235964731907675
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.009035007000000001	0.22297554785181076
GLYCOGEN STORAGE DISEASE IXA	0.00901961	0.22259556424911137
GAUCHER DISEASE	0.00900505	0.22223623702593132
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00898473	0.22173475837380086
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.22085085289128598
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.22074880494706556
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.008944113	0.22073236868809318
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00892857	0.22034878194153495
CODAS SYNDROME	0.008893377	0.2194802515180888
PAPILLARY TUMOR OF THE PINEAL REGION	0.00888979	0.21939172770287269
PINEOCYTOMA	0.00888979	0.21939172770287269
GABA-TRANSAMINASE DEFICIENCY	0.008870133	0.2189066112725121
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.008810014	0.2174229304119103
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.008805878999999999	0.21732088246768985
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.008789393999999999	0.21691404803952205
ELLIS-VAN CREVELD SYNDROME	0.008789393999999999	0.21691404803952205
CORTICOBASAL SYNDROME	0.00877193	0.2164830528042462
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.2164830528042462
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.2164830528042462
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.2164830528042462
BREATH-HOLDING SPELLS	0.00877193	0.2164830528042462
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.2164830528042462
LESCH-NYHAN SYNDROME	0.00877193	0.2164830528042462
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.2164830528042462
LOCKED-IN SYNDROME	0.00877193	0.2164830528042462
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.2164830528042462
KEIPERT SYNDROME	0.00877193	0.2164830528042462
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.008707079	0.21488259059611092
TEMPLE-BARAITSER SYNDROME	0.008705259	0.2148376746932134
KEPPEN-LUBINSKY SYNDROME	0.008705259	0.2148376746932134
SECKEL SYNDROME 7; SCKL7	0.008705259	0.2148376746932134
DPM1-CDG	0.008705259	0.2148376746932134
MEHMO SYNDROME	0.008705259	0.2148376746932134
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.008690594	0.2144757561679431
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.008688774	0.2144308402650456
DISTAL MONOSOMY 10P	0.008688774	0.2144308402650456
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00864225	0.2132826713274612
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00864225	0.2132826713274612
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00864225	0.2132826713274612
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00864225	0.2132826713274612
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00864225	0.2132826713274612
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.008618783	0.21270352764982617
STEINERT MYOTONIC DYSTROPHY	0.00856877	0.21146925344564318
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00856877	0.21146925344564318
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.008535977	0.21065995278425972
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.008510073	0.2100206662190635
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.008510073	0.2100206662190635
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.008473762999999999	0.2091245692771907
2Q24 MICRODELETION SYNDROME	0.008473762999999999	0.2091245692771907
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.008473762999999999	0.2091245692771907
FATCO SYNDROME	0.00840336	0.20738708888615054
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.20738708888615054
RETINOPATHY OF PREMATURITY	0.00840336	0.20738708888615054
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.20738708888615054
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.20738708888615054
OMPHALOCELE	0.00840336	0.20738708888615054
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.20738708888615054
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.20738708888615054
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.20738708888615054
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.20738708888615054
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.20738708888615054
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.20738708888615054
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.20738708888615054
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.20738708888615054
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.20738708888615054
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.20738708888615054
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.20738708888615054
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.20738708888615054
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.20738708888615054
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.20738708888615054
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.20738708888615054
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.20738708888615054
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.20738708888615054
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.20738708888615054
PEMPHIGOID GESTATIONIS	0.00840336	0.20738708888615054
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.20738708888615054
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.20738708888615054
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.20738708888615054
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	0.20738708888615054
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.20738708888615054
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.008359446999999999	0.20630335699387678
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.008333353	0.20565938140585066
6Q25 MICRODELETION SYNDROME	0.008299303000000001	0.20481905915658688
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.008288819	0.20456032381264316
MICROSPORIDIOSIS	0.008288819	0.20456032381264316
TIMOTHY SYNDROME; TS	0.008278577	0.20430756080304086
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.00826446	0.20395916640677486
AASE-SMITH SYNDROME	0.00826446	0.20395916640677486
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00826446	0.20395916640677486
DANDY-WALKER MALFORMATION-POSTAXIAL POLYDACTYLY SYNDROME	0.00826446	0.20395916640677486
CERVICAL HYPERTRICHOSIS-PERIPHERAL NEUROPATHY SYNDROME	0.00826446	0.20395916640677486
DANDY-WALKER MALFORMATION WITH OCCIPITAL CEPHALOCELE, AUTOSOMAL DOMINANT	0.00826446	0.20395916640677486
OROFACIODIGITAL SYNDROME TYPE 3	0.00826446	0.20395916640677486
FETAL AKINESIA DEFORMATION SEQUENCE	0.00826446	0.20395916640677486
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.008250196999999999	0.20360716886665006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.008250196999999999	0.20360716886665006
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.008226463	0.20302143587798555
MOEBIUS SYNDROME	0.00816689	0.201551229788253
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00816384	0.20147595863229842
MONOSOMY 5P	0.00816384	0.20147595863229842
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00816384	0.20147595863229842
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.008153477	0.2012202094555254
HADZISELIMOVIC SYNDROME	0.008082708	0.19947369652577063
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.008070443	0.19917100776256302
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.008070443	0.19917100776256302
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.0080379	0.19836787686806104
NIEMANN-PICK DISEASE, TYPE A	0.008036398	0.1983308089086368
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.008011042999999999	0.19770507115151248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.008011042999999999	0.19770507115151248
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.007993814	0.19727987549710527
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.007990422999999998	0.1971961887791242
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.007982933999999999	0.19701136724242124
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.007961888	0.19649197158726692
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.007957753	0.1963899236430465
SJÖGREN-LARSSON SYNDROME	0.007957753	0.1963899236430465
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.19627173558866398
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.1961696876444435
ADRENOMYODYSTROPHY	0.007948829	0.1961696876444435
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.007948829	0.1961696876444435
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.1961696876444435
INTELLECTUAL DISABILITY, WOLFF TYPE	0.007948829	0.1961696876444435
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.007948829	0.1961696876444435
QAZI-MARKOUIZOS SYNDROME	0.007948829	0.1961696876444435
GROWTH HORMONE INSENSITIVITY SYNDROME	0.007948034	0.19615006778576027
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.007901217	0.19499466788139075
XQ25 DUPLICATION SYNDROME	0.007867697	0.19416742553791577
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.007822889	0.19306160588020616
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.007787799	0.1921956174007152
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.007779547	0.19199196573548982
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.007779547	0.19199196573548982
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.007753643	0.19135267917029367
2P21 MICRODELETION SYNDROME	0.007753643	0.19135267917029367
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.007753643	0.19135267917029367
RELAPSING FEVER	0.0077474	0.1911986077517282
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.0077474	0.1911986077517282
INHALATIONAL ANTHRAX	0.0077474	0.1911986077517282
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0077474	0.1911986077517282
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.0077474	0.1911986077517282
RAT-BITE FEVER	0.0077474	0.1911986077517282
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.007746877	0.19118570059941203
NETHERTON SYNDROME	0.007746877	0.19118570059941203
PROPIONIC ACIDEMIA	0.007737158000000001	0.19094584474212586
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.007737158000000001	0.19094584474212586
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.007733023000000001	0.19084379679790545
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.007725263	0.19065228723390285
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.007725262999999999	0.19065228723390282
OTOPALATODIGITAL SYNDROME TYPE 2	0.007671458	0.1893244300056609
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.007667024000000001	0.18921500302025018
XYLOSIDASE DEFICIENCY	0.007604619	0.18767490581128374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00757136	0.18685410470443306
TEMTAMY SYNDROME; TEMTYS	0.007542873	0.18615107210781698
CHÉDIAK-HIGASHI SYNDROME	0.007513733	0.18543192408010634
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.007493766999999999	0.18493918181788016
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.007436954	0.1835370899545197
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.007436954	0.1835370899545197
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.007432819	0.18343504201029928
LEPRECHAUNISM	0.0074231	0.18319518615301308
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.007417138000000001	0.1830480495524225
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.007416334	0.18302820758213145
19Q13.11 MICRODELETION SYNDROME	0.007416334	0.18302820758213145
ERYTHROKERATODERMIA VARIABILIS	0.007416334	0.18302820758213145
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.007416334	0.18302820758213145
HALLERMANN-STREIFF SYNDROME; HSS	0.007416334	0.18302820758213145
TRISOMY XQ28	0.00740741	0.18280797158352852
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.18280797158352852
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.18280797158352852
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.18280797158352852
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.007355663000000001	0.1815309038762553
XQ25 MICRODUPLICATION SYNDROME	0.007342763	0.18121254390516858
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.007293094	0.17998675930021457
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.0072601	0.17917249814625835
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.007254613	0.17903708410274263
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.007254613	0.17903708410274263
DYSTONIA-APHONIA SYNDROME	0.007254613	0.17903708410274263
SPINAL MUSCULAR ATROPHY, TYPE IV	0.00724638	0.17883390133980023
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.00724638	0.17883390133980023
SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	0.00724638	0.17883390133980023
CARDIOMYOPATHY, DILATED, 1X	0.00724638	0.17883390133980023
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.00724638	0.17883390133980023
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00724638	0.17883390133980023
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00724638	0.17883390133980023
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.00724638	0.17883390133980023
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00724638	0.17883390133980023
PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	0.00724638	0.17883390133980023
MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA	0.00724638	0.17883390133980023
OPTIC ATROPHY 1; OPA1	0.00724638	0.17883390133980023
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5	0.00724638	0.17883390133980023
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.00724638	0.17883390133980023
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.00724638	0.17883390133980023
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00724638	0.17883390133980023
AXIAL OSTEOMALACIA	0.00724638	0.17883390133980023
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.00724638	0.17883390133980023
MYOSITIS	0.00724638	0.17883390133980023
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.00724638	0.17883390133980023
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 41	0.00724638	0.17883390133980023
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.007238128000000001	0.17863024967457483
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.007237384	0.1786118884483354
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007233249000000001	0.17850984050411497
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007233249000000001	0.17850984050411497
MULTIPLE CARBOXYLASE DEFICIENCY	0.007221943	0.17823081896666482
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.007212224000000001	0.17799096310937867
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.007212224000000001	0.17799096310937867
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.007212224000000001	0.17799096310937867
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.007208089000000001	0.17788891516515826
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.007208089000000001	0.17788891516515826
FRUCTOSE AND GALACTOSE INTOLERANCE	0.007208089000000001	0.17788891516515826
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.007208089000000001	0.17788891516515826
GALACTOSE EPIMERASE DEFICIENCY	0.0072054580000000005	0.17782398453849704
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.0072054580000000005	0.17782398453849704
HYDROXYKYNURENINURIA	0.0072054580000000005	0.17782398453849704
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.0072054580000000005	0.17782398453849704
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.007201323	0.1777219365942766
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.007191604000000001	0.17748208073699043
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.007179708999999999	0.1771885232287674
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0071255730000000005	0.17585249722917431
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00712147	0.17575123901511472
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00710071	0.17523890157327282
DYSTONIA 23; DYT23	0.00710071	0.17523890157327282
SPINOCEREBELLAR ATAXIA 12	0.00710071	0.17523890157327282
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.00710071	0.17523890157327282
FANCONI ANEMIA	0.0071006279999999995	0.1752368778897357
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.007095314	0.17510573332490198
JOHNSON NEUROECTODERMAL SYNDROME	0.007095314	0.17510573332490198
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.007078083000000001	0.17468048831235972
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.007057713	0.174177775706853
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.007041228000000001	0.1737709412786852
LYMPHANGIOLEIOMYOMATOSIS	0.007027579	0.17343409668602142
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0069834699999999994	0.17234552769651254
MASA SYNDROME	0.006980834000000001	0.17228047367451377
CURRY-JONES SYNDROME	0.006980834000000001	0.17228047367451377
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.006968832999999999	0.17198430018513297
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.006968832999999999	0.17198430018513297
EPISODIC ATAXIA, TYPE 3	0.0069659100000000005	0.17191216327075418
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0069659100000000005	0.17191216327075418
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.0069659100000000005	0.17191216327075418
VALINEMIA	0.0069659100000000005	0.17191216327075418
2Q23.1 MICRODUPLICATION SYNDROME	0.006914554	0.17064474507888364
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.006900923	0.17030834470943532
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.006895648	0.17017816262823515
CRANIOFRONTONASAL SYNDROME; CFNS	0.006892204000000001	0.17009316791967527
IMMUNODEFICIENCY 55; IMD55	0.0068914	0.17007332594938426
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0068914	0.17007332594938426
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0068914	0.17007332594938426
MARSHALL-SMITH SYNDROME	0.006889974000000001	0.1700381335990921
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.0068844380000000005	0.16990151028126757
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0068142440000000006	0.1681691878153403
MEVALONIC ACIDURIA	0.006773627	0.16716679812963256
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.006771933	0.16712499178924337
MENTAL RETARDATION, X-LINKED 102	0.006751313	0.16661610941685512
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00673773	0.16628089364264806
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00673773	0.16628089364264806
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00673773	0.16628089364264806
GILLESPIE SYNDROME; GLSP	0.006724024	0.1659426423431353
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0067131940000000005	0.16567536804182761
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.006711480000000001	0.16563306812008788
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.006709059	0.16557332009760717
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.006709059	0.16557332009760717
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.006692574000000001	0.16516648566943937
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00669183	0.16514812444319996
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00669183	0.16514812444319996
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00669183	0.16514812444319996
FOCAL MYOSITIS	0.00668119	0.1648855391647222
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00668119	0.1648855391647222
ACUTE PROMYELOCYTIC LEUKEMIA	0.00668119	0.1648855391647222
BETA-THALASSEMIA MAJOR	0.00668119	0.1648855391647222
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00668119	0.1648855391647222
ANTISYNTHETASE SYNDROME	0.00668119	0.1648855391647222
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00668119	0.1648855391647222
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00668119	0.1648855391647222
HEREDITARY SPHEROCYTOSIS	0.00668119	0.1648855391647222
CRYOGLOBULINEMIC VASCULITIS	0.00668119	0.1648855391647222
POSTORGASMIC ILLNESS SYNDROME	0.00668119	0.1648855391647222
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.00668119	0.1648855391647222
ABLEPHARON MACROSTOMIA SYNDROME	0.006680524	0.16486910290574983
SYNDROMIC DIARRHEA	0.006680524	0.16486910290574983
DISTAL TRISOMY 6P	0.006680524	0.16486910290574983
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.006680524	0.16486910290574983
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.006676389	0.16476705496152938
SYSTEMIC SCLEROSIS	0.006676389	0.16476705496152938
ADIPOSIS DOLOROSA	0.006676389	0.16476705496152938
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.006676389	0.16476705496152938
EBOLA HEMORRHAGIC FEVER	0.006676389	0.16476705496152938
BENIGN FAMILIAL INFANTILE EPILEPSY	0.006676389	0.16476705496152938
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.006676389	0.16476705496152938
ECTODERMAL DYSPLASIA SYNDROME	0.006676389	0.16476705496152938
GLYCOGEN STORAGE DISEASE IB	0.00666667	0.1645271991042432
GLYCOGEN STORAGE DISEASE IA	0.00666667	0.1645271991042432
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00666667	0.1645271991042432
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.00666667	0.1645271991042432
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	0.1645271991042432
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.00666667	0.1645271991042432
TYROSINEMIA, TYPE I; TYRSN1	0.00666667	0.1645271991042432
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00666667	0.1645271991042432
GLYCOGEN STORAGE DISEASE VI	0.00666667	0.1645271991042432
HEMOCHROMATOSIS, NEONATAL	0.00666667	0.1645271991042432
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	0.1645271991042432
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	0.1645271991042432
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	0.1645271991042432
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00666667	0.1645271991042432
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.1645271991042432
RIBOFLAVIN DEFICIENCY	0.00666667	0.1645271991042432
MPI-CDG	0.00666667	0.1645271991042432
NEONATAL HEMOCHROMATOSIS	0.00666667	0.1645271991042432
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.00666667	0.1645271991042432
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00666667	0.1645271991042432
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	0.1645271991042432
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	0.1645271991042432
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00666667	0.1645271991042432
HIRSCHSPRUNG DISEASE	0.006659904	0.1643602205333616
PROLIDASE DEFICIENCY	0.006659904	0.1643602205333616
BARBER-SAY SYNDROME; BBRSAY	0.006659904	0.1643602205333616
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.006659904	0.1643602205333616
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.006659904	0.1643602205333616
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00663243	0.16368218783214944
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.006600969999999999	0.16290578436777822
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006589498	0.1626226661051188
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.006585363	0.16252061816089838
TRISOMY 18P	0.00657038	0.16215085169215476
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00657038	0.16215085169215476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00654157	0.16143984775672776
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00654157	0.16143984775672776
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0064559000000000005	0.15932559204176655
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.006429978	0.1586858612533549
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00642207	0.15849069918735847
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0064067939999999995	0.1581137017518297
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.006389763	0.15769339255279266
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.006359504	0.15694662864852035
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.006338884	0.1564377462761321
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006305347000000001	0.1556100843885092
MONOSOMY 9P	0.006305347	0.1556100843885092
GENITOPATELLAR SYNDROME	0.006305347	0.1556100843885092
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.006305347	0.1556100843885092
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00628931	0.15521430618259308
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	0.00628931	0.15521430618259308
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00628931	0.15521430618259308
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB	0.00628931	0.15521430618259308
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00628931	0.15521430618259308
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.00628931	0.15521430618259308
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.00628931	0.15521430618259308
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	0.00628931	0.15521430618259308
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00628931	0.15521430618259308
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00628931	0.15521430618259308
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00628931	0.15521430618259308
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.00628931	0.15521430618259308
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00628931	0.15521430618259308
WELANDER DISTAL MYOPATHY; WDM	0.00628931	0.15521430618259308
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.00628931	0.15521430618259308
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.00628931	0.15521430618259308
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.00628931	0.15521430618259308
AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES	0.00628931	0.15521430618259308
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	0.00628931	0.15521430618259308
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.00628931	0.15521430618259308
CONGENITAL VARICELLA SYNDROME	0.006232208	0.15380508206871757
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0062305139999999995	0.15376327572832832
HARROD SYNDROME	0.006228073	0.15370303412449712
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.006228073	0.15370303412449712
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.006226379	0.1536612277841079
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.006214487	0.1533677443130875
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.006190824	0.15278376353821732
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.006186689	0.1526817155939969
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.006175548	0.15240676610268858
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00616764	0.15221160403669215
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00616764	0.15221160403669215
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00616764	0.15221160403669215
CHROMOSOME 10Q26 DELETION SYNDROME	0.006156217000000001	0.1519296950483415
EHLERS-DANLOS SYNDROME, TYPE VI	0.00614082	0.15154971144564208
SPINOCEREBELLAR ATAXIA TYPE 13	0.006135333	0.15141429740212636
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.00613497	0.1514053389006144
RECESSIVE X-LINKED ICHTHYOSIS	0.00613497	0.1514053389006144
CRANIOECTODERMAL DYSPLASIA 3	0.00613497	0.1514053389006144
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00613497	0.1514053389006144
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00613497	0.1514053389006144
LIPOSARCOMA	0.00613497	0.1514053389006144
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.00613497	0.1514053389006144
CHOLESTERYL ESTER STORAGE DISEASE	0.00613497	0.1514053389006144
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3	0.00613497	0.1514053389006144
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00613497	0.1514053389006144
TRICHODYSPLASIA-XERODERMA SYNDROME	0.00613497	0.1514053389006144
FAMILIAL PANCREATIC CARCINOMA	0.00613497	0.1514053389006144
LIMB-MAMMARY SYNDROME	0.00613497	0.1514053389006144
HYDATIDIFORM MOLE	0.00613497	0.1514053389006144
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.00613497	0.1514053389006144
DERMOODONTODYSPLASIA	0.00613497	0.1514053389006144
GASTROINTESTINAL STROMAL TUMOR	0.00613497	0.1514053389006144
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00613497	0.1514053389006144
KERATOSIS PILARIS ATROPHICANS	0.00613497	0.1514053389006144
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00613497	0.1514053389006144
SYSTEMIC MASTOCYTOSIS	0.00613497	0.1514053389006144
TOXIC EPIDERMAL NECROLYSIS	0.00613497	0.1514053389006144
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00613497	0.1514053389006144
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00613497	0.1514053389006144
CARCINOID SYNDROME	0.00613497	0.1514053389006144
NEUROENDOCRINE TUMOR OF STOMACH	0.00613497	0.1514053389006144
CREST SYNDROME	0.00613497	0.1514053389006144
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.00613497	0.1514053389006144
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00613497	0.1514053389006144
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00613497	0.1514053389006144
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00613497	0.1514053389006144
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00613497	0.1514053389006144
AMELO-ONYCHO-HYPOHIDROTIC SYNDROME	0.00613497	0.1514053389006144
ACQUIRED ICHTHYOSIS	0.00613497	0.1514053389006144
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.00613497	0.1514053389006144
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00613497	0.1514053389006144
COMPLEX REGIONAL PAIN SYNDROME	0.00613497	0.1514053389006144
PSEUDOMYXOMA PERITONEI	0.00613497	0.1514053389006144
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00613497	0.1514053389006144
ANONYCHIA WITH FLEXURAL PIGMENTATION	0.00613497	0.1514053389006144
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.00613497	0.1514053389006144
PEELING SKIN SYNDROME	0.00613497	0.1514053389006144
CONGENITAL LETHAL ERYTHRODERMA	0.00613497	0.1514053389006144
HELIX SYNDROME; HELIX	0.00613497	0.1514053389006144
LAMELLAR ICHTHYOSIS	0.00613497	0.1514053389006144
PRIMARY PERITONEAL CARCINOMA	0.00613497	0.1514053389006144
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.00613497	0.1514053389006144
CLASSIC MYCOSIS FUNGOIDES	0.00613497	0.1514053389006144
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00613497	0.1514053389006144
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00613497	0.1514053389006144
BURKITT LYMPHOMA	0.00613497	0.1514053389006144
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	0.00613497	0.1514053389006144
ATOPIC KERATOCONJUNCTIVITIS	0.00613497	0.1514053389006144
HURIEZ SYNDROME	0.00613497	0.1514053389006144
ABLEPHARON-MACROSTOMIA SYNDROME	0.00613497	0.1514053389006144
ADENOCARCINOMA OF THE ESOPHAGUS	0.00613497	0.1514053389006144
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00613497	0.1514053389006144
SÉZARY SYNDROME	0.00613497	0.1514053389006144
FAMILIAL MELANOMA	0.00613497	0.1514053389006144
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00613497	0.1514053389006144
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.00613497	0.1514053389006144
ORAL EROSIVE LICHEN	0.00613497	0.1514053389006144
TOOTH AGENESIS, SELECTIVE, 4	0.00613497	0.1514053389006144
CASTLEMAN DISEASE	0.00613497	0.1514053389006144
ADULT SYNDROME	0.00613497	0.1514053389006144
TRANSGREDIENS ET PROGREDIENS PALMOPLANTAR KERATODERMA	0.00613497	0.1514053389006144
PAROXYSMAL HEMICRANIA	0.00613497	0.1514053389006144
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.00613497	0.1514053389006144
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.00613497	0.1514053389006144
XERODERMA PIGMENTOSUM VARIANT	0.00613497	0.1514053389006144
CHAND SYNDROME	0.00613497	0.1514053389006144
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00613497	0.1514053389006144
DERMOODONTODYSPLASIA	0.00613497	0.1514053389006144
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00613497	0.1514053389006144
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00613497	0.1514053389006144
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00613497	0.1514053389006144
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00613497	0.1514053389006144
MASTOCYTOSIS	0.00613497	0.1514053389006144
CARNEY TRIAD	0.00613497	0.1514053389006144
CUTANEOUS MASTOCYTOSIS	0.00613497	0.1514053389006144
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00613497	0.1514053389006144
190360 TRICHODYSPLASIA-XERODERMA	0.00613497	0.1514053389006144
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00608428	0.15015435696771623
OKAMOTO SYNDROME	0.006064564	0.14966778447237158
PITT-HOPKINS SYNDROME	0.006060429	0.14956573652815117
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.006060429	0.14956573652815117
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.006017197000000001	0.1484988110808627
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.006015503	0.1484570047404735
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.005942318000000001	0.14665086718357567
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.005942318000000001	0.14665086718357567
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.0058594630000000005	0.14460608304370043
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0058594630000000005	0.14460608304370043
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.005848344	0.14433167649187767
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.005840557	0.1441395005930519
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.005840557	0.1441395005930519
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.005827724	0.14382279411948945
THANATOPHORIC DYSPLASIA	0.0058151290000000005	0.14351196126399818
THANATOPHORIC DYSPLASIA TYPE 1	0.0058151290000000005	0.14351196126399818
DUANE-RADIAL RAY SYNDROME; DRRS	0.00581395	0.1434828646433849
CRANIAL NERVES, RECURRENT PARESIS OF	0.00581395	0.1434828646433849
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00581395	0.1434828646433849
SCLEROSTEOSIS	0.00581395	0.1434828646433849
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00581395	0.1434828646433849
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00581395	0.1434828646433849
NEUROFIBROMATOSIS TYPE 2	0.00581395	0.1434828646433849
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00581395	0.1434828646433849
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00581395	0.1434828646433849
BRANCHIOOTIC SYNDROME	0.00581395	0.1434828646433849
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00581395	0.1434828646433849
MELKERSSON-ROSENTHAL SYNDROME	0.00581395	0.1434828646433849
AMYLOIDOSIS	0.00581395	0.1434828646433849
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00581395	0.1434828646433849
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00581395	0.1434828646433849
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00581395	0.1434828646433849
BROOKE-SPIEGLER SYNDROME	0.00581395	0.1434828646433849
WILDERVANCK SYNDROME	0.00581395	0.1434828646433849
MYOPATHY, DISTAL, 5; MPD5	0.00581395	0.1434828646433849
DELTA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R6	0.00581395	0.1434828646433849
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00581395	0.1434828646433849
SCLEROSTEOSIS 1; SOST1	0.00581395	0.1434828646433849
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00581395	0.1434828646433849
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	0.00581395	0.1434828646433849
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00581395	0.1434828646433849
BOR SYNDROME	0.00581395	0.1434828646433849
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00581395	0.1434828646433849
CRANIOMETAPHYSEAL DYSPLASIA	0.00581395	0.1434828646433849
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00581395	0.1434828646433849
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00581395	0.1434828646433849
APLASIA CUTIS CONGENITA	0.00581395	0.1434828646433849
CAMURATI-ENGELMANN DISEASE	0.00581395	0.1434828646433849
FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL	0.00581395	0.1434828646433849
SCLEROSTEOSIS 2; SOST2	0.00581395	0.1434828646433849
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00581395	0.1434828646433849
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00581395	0.1434828646433849
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.00581395	0.1434828646433849
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.005780413	0.142655202755762
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.005707274	0.14085020043597035
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.005707274	0.14085020043597035
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.005707274	0.14085020043597035
ARACHNOIDITIS	0.00570467	0.1407859361441324
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.005686654	0.14034131806358213
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.005673068000000001	0.1400060282521725
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.005650614	0.1394518844699414
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00564527	0.13931999953308188
SPINOCEREBELLAR ATAXIA TYPE 18	0.00564527	0.13931999953308188
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00564527	0.13931999953308188
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00564527	0.13931999953308188
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00564527	0.13931999953308188
EDINBURGH MALFORMATION SYNDROME	0.005632694	0.1390096355798736
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.005629994	0.13894300209755314
RAPID-ONSET DYSTONIA-PARKINSONISM	0.005589779	0.1379505333969909
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.005573294	0.13754369896882312
BEHR SYNDROME	0.005573294	0.13754369896882312
SPINOCEREBELLAR ATAXIA 13	0.005573294	0.13754369896882312
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.005548917000000001	0.13694209733973933
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.0055190099999999995	0.13620402046723615
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.005492263000000001	0.13554392944811552
17P13.3 MICRODUPLICATION SYNDROME	0.005474084000000001	0.13509528867955847
CHIME SYNDROME	0.005471643000000001	0.13503504707572728
ACROCARDIOFACIAL SYNDROME	0.005471643000000001	0.13503504707572728
WOLFRAM SYNDROME	0.005471643000000001	0.13503504707572728
STURGE-WEBER SYNDROME	0.005471643000000001	0.13503504707572728
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.0053997870000000005	0.13326170799957163
SALLA DISEASE	0.0053997870000000005	0.13326170799957163
SOTOS SYNDROME 2	0.005396764000000001	0.13318710317844024
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00535949	0.13226721561547225
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.005315623	0.13118461896030473
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.005315622999999999	0.1311846189603047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.005315622999999999	0.1311846189603047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.005315622999999999	0.1311846189603047
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.005313909	0.13114231903856496
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.005303999	0.1308977494793813
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00530279	0.13086791248674223
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00530279	0.13086791248674223
NATIVE AMERICAN MYOPATHY	0.00530279	0.13086791248674223
SENGERS SYNDROME	0.00530279	0.13086791248674223
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00530279	0.13086791248674223
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00530279	0.13086791248674223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.005299138	0.1307777845321369
LEUKOCYTE ADHESION DEFICIENCY	0.005295003	0.13067573658791648
RENPENNING SYNDROME 1; RENS1	0.005295003	0.13067573658791648
PRIMARY CILIARY DYSKINESIA	0.00527371	0.13015024520308316
ACHONDROPLASIA	0.00527371	0.13015024520308316
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00527371	0.13015024520308316
MONOSOMY 13Q34	0.005238994	0.129293486694847
14Q12 MICRODELETION SYNDROME	0.005234859	0.12919143875062655
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.0052183740000000004	0.12878460432245875
OROFACIODIGITAL SYNDROME TYPE 5	0.0052183740000000004	0.12878460432245875
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0052183740000000004	0.12878460432245875
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.005148134	0.1270511466194253
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.005148134	0.1270511466194253
%300712 CRANIOFACIOSKELETAL SYNDROME	0.005148134	0.1270511466194253
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0051481339999999995	0.12705114661942526
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0051481339999999995	0.12705114661942526
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0051481339999999995	0.12705114661942526
HALLERMANN-STREIFF SYNDROME	0.0051275140000000006	0.12654226424703707
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0051275140000000006	0.12654226424703707
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.005123157	0.12643473754982582
MULTIPLE SULFATASE DEFICIENCY	0.005123157	0.12643473754982582
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.005107759999999999	0.1260547539471264
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00510506	0.12598812046480592
METHYLMALONIC ACIDURIA, CBLA TYPE	0.005103033	0.12593809599493053
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.005103033	0.12593809599493053
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.005086548000000001	0.12553126156676273
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005084127	0.12547151354428204
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.005084127	0.12547151354428204
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0050692440000000005	0.12510421498229105
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.005063757	0.12496880093877533
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.005063757	0.12496880093877533
STT3B-CDG	0.005063757	0.12496880093877533
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.005063757	0.12496880093877533
STT3A-CDG	0.005063757	0.12496880093877533
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00504836	0.12458881733607592
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00504836	0.12458881733607592
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00504836	0.12458881733607592
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00504836	0.12458881733607592
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00504836	0.12458881733607592
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00504836	0.12458881733607592
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00504836	0.12458881733607592
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00504836	0.12458881733607592
EPISODIC ATAXIA TYPE 1	0.00504836	0.12458881733607592
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00504836	0.12458881733607592
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.005023983000000001	0.12398721570699213
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.005023983000000001	0.12398721570699213
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.005007498000000001	0.12358038127882433
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.005007498000000001	0.12358038127882433
GLYCINE ENCEPHALOPATHY; GCE	0.005003363000000001	0.12347833333460391
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.0049467090000000005	0.12208016544298006
MAN1B1-CDG	0.004933123	0.12174487563157042
COSTELLO SYNDROME	0.004930224	0.12167333101481224
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.004916638	0.12133804120340261
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.004916638	0.12133804120340261
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004887227000000001	0.12061220514839244
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.004887227	0.12061220514839241
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.004887227	0.12061220514839241
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004858368	0.11989999193865661
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004858368	0.11989999193865661
EPILEPSY-TELANGIECTASIA	0.004854233	0.11979794399443618
HYPERLEUCINE-ISOLEUCINEMIA	0.004854233	0.11979794399443618
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004854233	0.11979794399443618
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.004818313	0.11891147188889857
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.0047976930000000004	0.11840258951651032
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.004793253000000001	0.11829301445669446
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.004793253	0.11829301445669443
MATERNAL PHENYLKETONURIA	0.004777977	0.11791601702116569
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.004777977	0.11791601702116569
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.004777977	0.11791601702116569
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.004774204	0.1178229028993897
OGDEN SYNDROME; OGDNS	0.004774204	0.1178229028993897
SUPRABULBAR PARESIS, CONGENITAL	0.004772633	0.1177841320843062
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.004770068999999999	0.11772085495516925
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00476258	0.11753603341846626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.004721277	0.11651671389243567
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.004721277	0.11651671389243567
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00460258	0.11358738261428986
TRISOMY 17P	0.004581738	0.11307302148891082
METHYLMALONIC ACIDURIA, CBLB TYPE	0.004561614	0.11257637993401554
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.004559193	0.11251663191153483
GAUCHER DISEASE, TYPE II	0.004559193	0.11251663191153483
HYPEREKPLEXIA 4; HKPX4	0.004559193	0.11251663191153483
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.004557479	0.11247433198979509
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004557479	0.11247433198979509
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.004557479	0.11247433198979509
ACQUIRED METHEMOGLOBINEMIA	0.004557479	0.11247433198979509
CITRULLINEMIA TYPE I	0.004557479	0.11247433198979509
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.004557479	0.11247433198979509
CARDIAC LIPIDOSIS, FAMILIAL	0.00454431	0.11214933334954384
CHYLOMICRON RETENTION DISEASE	0.0045409940000000005	0.1120674975616273
ALPHA-METHYLACETOACETIC ACIDURIA	0.0045409940000000005	0.1120674975616273
GALACTOSEMIA	0.0045409940000000005	0.1120674975616273
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.0045409940000000005	0.1120674975616273
HYPERCALCEMIA, INFANTILE, 1	0.0045409940000000005	0.1120674975616273
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004538823	0.11201391930602811
ZUNICH NEUROECTODERMAL SYNDROME	0.004538573	0.11200774953914658
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.004538573	0.11200774953914658
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.004522338	0.1116070848778603
FILIPPI SYNDROME; FLPIS	0.004518203000000001	0.11150503693363989
SEVERE COMBINED IMMUNODEFICIENCY	0.00448777	0.110753978871618
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0044825640000000005	0.11062549964607712
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.004461944000000001	0.11011661727368888
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.004461944000000001	0.11011661727368888
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.004461944000000001	0.11011661727368888
OROFACIODIGITAL SYNDROME V; OFD5	0.004461944000000001	0.11011661727368888
ALZHEIMER DISEASE 10	0.00440529	0.10871844938206503
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00440529	0.10871844938206503
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.00440529	0.10871844938206503
PENOSCROTAL TRANSPOSITION	0.00440529	0.10871844938206503
PROGRESSIVE SUPRANUCLEAR PALSY	0.00440529	0.10871844938206503
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00440529	0.10871844938206503
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00440529	0.10871844938206503
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.00440529	0.10871844938206503
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.00440529	0.10871844938206503
CEREBROCORTICAL DEGENERATION OF INFANCY	0.00440529	0.10871844938206503
SWEENEY-COX SYNDROME; SWCOS	0.004391704	0.10838315957065542
CEREBELLAR ATAXIA, CAYMAN TYPE	0.004391704	0.10838315957065542
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.004387569	0.10828111162643496
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.004387569	0.10828111162643496
MUENKE SYNDROME	0.004366727	0.10776675050105594
1Q21.1 MICRODUPLICATION SYNDROME	0.004366727	0.10776675050105594
MACDERMOT-WINTER SYNDROME	0.004362293000000001	0.10765732351564522
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.004362293	0.10765732351564519
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.004345808	0.10725048908747739
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.004341673000000001	0.10714844114325699
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004341673000000001	0.10714844114325699
SANJAD-SAKATI SYNDROME	0.004341673	0.10714844114325696
COFFIN-LOWRY SYNDROME; CLS	0.004341673	0.10714844114325696
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.004341673	0.10714844114325696
LARSEN-LIKE SYNDROME	0.004333434	0.10694511030590939
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.004329299	0.10684306236168897
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.10684306236168897
CONE-ROD DYSTROPHY 1; CORD1	0.004312814	0.10643622793352116
PSEUDOURIDINURIA AND MENTAL DEFECT	0.004312814	0.10643622793352116
OCULORENOCEREBELLAR SYNDROME	0.004312814	0.10643622793352116
FETAL IODINE DEFICIENCY DISORDER	0.004312814	0.10643622793352116
X-LINKED ADRENOLEUKODYSTROPHY	0.004312814	0.10643622793352116
DERMATOLEUKODYSTROPHY	0.004312814	0.10643622793352116
T-SUBSTANCE ANOMALY	0.004312814	0.10643622793352116
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.004312814	0.10643622793352116
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.004312814	0.10643622793352116
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.004312814	0.10643622793352116
HOOFT DISEASE	0.004312814	0.10643622793352116
PENDRED SYNDROME	0.004312814	0.10643622793352116
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.004312814	0.10643622793352116
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.004312814	0.10643622793352116
GLUTATHIONURIA	0.004312814	0.10643622793352116
CEPHALIN LIPIDOSIS	0.004312814	0.10643622793352116
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.004312814	0.10643622793352116
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.004307327	0.10630081389000542
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.004307327	0.10630081389000542
KRABBE DISEASE	0.004276894	0.10554975582798354
MIXED CONNECTIVE TISSUE DISEASE	0.004272759	0.10544770788376312
ROSAÏ-DORFMAN DISEASE	0.004272759	0.10544770788376312
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.004272759	0.10544770788376312
OSTEOPETROSIS AND RELATED DISORDERS	0.004256274	0.10504087345559532
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.004253043	0.10496113538841848
POTOCKI-LUPSKI SYNDROME	0.004253043	0.10496113538841848
XQ28 (MECP2) DUPLICATION	0.004253043	0.10496113538841848
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.004253043	0.10496113538841848
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004253043	0.10496113538841848
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.004236558	0.10455430096025066
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.004236558	0.10455430096025066
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.004236558	0.10455430096025066
SCHWARTZ-JAMPEL SYNDROME	0.004231214	0.10442241602339117
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00422865	0.10435913889425424
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00422865	0.10435913889425424
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00422865	0.10435913889425424
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.004196343	0.10356183225968846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.004179858	0.10315499783152066
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.004175723	0.10305294988730022
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.004175723	0.10305294988730022
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.004175723	0.10305294988730022
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.004130797	0.10194421809962254
48,XXYY SYNDROME	0.004130797	0.10194421809962254
BRESEK SYNDROME	0.004056804	0.10011813985616361
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.004052669	0.10001609191194318
SIALIDOSIS TYPE 2	0.004036823	0.09962502740792456
ROBERTS SYNDROME; RBS	0.004036184	0.09960925748377536
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.004036184	0.09960925748377536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.004021547	0.09924802997239582
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0040215469999999994	0.09924802997239579
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.004020338	0.09921819297975674
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.004017774	0.09915491585061982
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.004017774	0.09915491585061982
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.004017774	0.09915491585061982
SIALIDOSIS TYPE 1	0.004016203	0.09911614503553631
NEURAMINIDASE DEFICIENCY	0.004016203	0.09911614503553631
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00401606	0.09911261592888009
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00401606	0.09911261592888009
COLCHICINE POISONING	0.00401606	0.09911261592888009
PEUTZ-JEGHERS SYNDROME	0.00401606	0.09911261592888009
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.00401606	0.09911261592888009
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00401606	0.09911261592888009
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00401606	0.09911261592888009
MYXOPAPILLARY EPENDYMOMA	0.00401606	0.09911261592888009
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00401606	0.09911261592888009
ACID PHOSPHATASE DEFICIENCY	0.00401606	0.09911261592888009
VISCERAL MYOPATHY; VSCM	0.00401606	0.09911261592888009
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00401606	0.09911261592888009
BENIGN OCCIPITAL EPILEPSY	0.00401606	0.09911261592888009
MÉNÉTRIER DISEASE	0.00401606	0.09911261592888009
CONGENITAL PANCREATIC CYST	0.00401606	0.09911261592888009
PORPHYRIA VARIEGATA	0.00401606	0.09911261592888009
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00401606	0.09911261592888009
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00401606	0.09911261592888009
CONGENITAL SHORT BOWEL SYNDROME	0.00401606	0.09911261592888009
ESOPHAGEAL ATRESIA	0.00401606	0.09911261592888009
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.09911261592888009
ATRESIA OF SMALL INTESTINE	0.00401606	0.09911261592888009
GRAFT VERSUS HOST DISEASE	0.00401606	0.09911261592888009
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00401606	0.09911261592888009
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00401606	0.09911261592888009
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00401606	0.09911261592888009
AA AMYLOIDOSIS	0.00401606	0.09911261592888009
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00401606	0.09911261592888009
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00401606	0.09911261592888009
EOSINOPHILIC GASTROENTERITIS	0.00401606	0.09911261592888009
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00401606	0.09911261592888009
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00401606	0.09911261592888009
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00401606	0.09911261592888009
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00401606	0.09911261592888009
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00401606	0.09911261592888009
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.09911261592888009
HYPERLIPOPROTEINEMIA, TYPE I	0.00401606	0.09911261592888009
LARYNGOTRACHEAL ANGIOMA	0.00401606	0.09911261592888009
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00401606	0.09911261592888009
CHYLOMICRON RETENTION DISEASE	0.00401606	0.09911261592888009
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.09911261592888009
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00401606	0.09911261592888009
SECONDARY SHORT BOWEL SYNDROME	0.00401606	0.09911261592888009
LIVER FAILURE, INFANTILE, TRANSIENT	0.00401606	0.09911261592888009
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00401606	0.09911261592888009
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00401606	0.09911261592888009
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00401606	0.09911261592888009
HEREDITARY ANGIOEDEMA TYPE 1	0.00401606	0.09911261592888009
PANCREATOBLASTOMA	0.00401606	0.09911261592888009
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00401606	0.09911261592888009
ANGIOEDEMA, HEREDITARY, TYPE III	0.00401606	0.09911261592888009
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.09911261592888009
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00401606	0.09911261592888009
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00401606	0.09911261592888009
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00401606	0.09911261592888009
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00401606	0.09911261592888009
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00401606	0.09911261592888009
HYPER-IGD SYNDROME	0.00401606	0.09911261592888009
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.00401606	0.09911261592888009
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00401606	0.09911261592888009
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.004013638999999999	0.09905286790639937
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.004013638999999999	0.09905286790639937
FADD-RELATED IMMUNODEFICIENCY	0.004013638999999999	0.09905286790639937
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.004013638999999999	0.09905286790639937
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.004013638999999999	0.09905286790639937
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.004013638999999999	0.09905286790639937
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.003997404	0.0986522032451131
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.0039974039999999995	0.0986522032451131
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.003997154	0.09864603347823157
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.003997154	0.09864603347823157
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.003976784000000001	0.09814332087272488
KETOADIPICACIDURIA	0.0039648470000000005	0.0978487268436658
MOSAIC TRISOMY 8	0.00393701	0.09716173564094166
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00393701	0.09716173564094166
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00393701	0.09716173564094166
3Q13 MICRODELETION SYNDROME	0.00393701	0.09716173564094166
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.00393701	0.09716173564094166
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00393701	0.09716173564094166
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00393701	0.09716173564094166
MIRROR MOVEMENTS 1; MRMV1	0.00393701	0.09716173564094166
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.00384615	0.09491939556551997
CEREBELLAR HYPOPLASIA	0.00384615	0.09491939556551997
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00384615	0.09491939556551997
GRACILE BONE DYSPLASIA; GCLEB	0.0038417929999999996	0.09481186886830872
HURLER SYNDROME	0.003825308	0.09440503444014092
HURLER SYNDROME	0.003825308	0.09440503444014092
EDINBURGH MALFORMATION SYNDROME	0.0038211729999999998	0.09430298649592049
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.0038211729999999998	0.09430298649592049
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.0038211729999999998	0.09430298649592049
DISTAL MONOSOMY 3P	0.003816739	0.09419355951050976
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0038002540000000003	0.09378672508234197
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.003800254	0.09378672508234195
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.003800254	0.09378672508234195
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.003800254	0.09378672508234195
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.09348134630077397
BARTTER SYNDROME	0.00378788	0.09348134630077397
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.09348134630077397
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.09348134630077397
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.09348134630077397
LARON SYNDROME	0.00378788	0.09348134630077397
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.09348134630077397
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.09348134630077397
ALAND ISLAND EYE DISEASE	0.00378788	0.09348134630077397
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.09348134630077397
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.09348134630077397
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.09348134630077397
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.09348134630077397
XANTHINURIA, TYPE I	0.00378788	0.09348134630077397
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.09348134630077397
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.09348134630077397
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.09348134630077397
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.09348134630077397
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.09348134630077397
PERRY SYNDROME	0.00378788	0.09348134630077397
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.09348134630077397
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.09348134630077397
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.09348134630077397
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.09348134630077397
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.09348134630077397
PYGMY	0.00378788	0.09348134630077397
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.09348134630077397
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.09348134630077397
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.09348134630077397
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.09348134630077397
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.09348134630077397
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.09348134630077397
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.09348134630077397
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.09348134630077397
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.09348134630077397
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.09348134630077397
PROGESTERONE RESISTANCE	0.00378788	0.09348134630077397
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.09348134630077397
PARAOXONASE 1	0.00378788	0.09348134630077397
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.09348134630077397
OSTEOMESOPYKNOSIS	0.00378788	0.09348134630077397
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.09348134630077397
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.09348134630077397
HYPERPROGLUCAGONEMIA	0.00378788	0.09348134630077397
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.09348134630077397
HEINZ BODY ANEMIAS	0.00378788	0.09348134630077397
GLUTATHIONE REDUCTASE	0.00378788	0.09348134630077397
GLOMUVENOUS MALFORMATIONS	0.00378788	0.09348134630077397
FLOOD FACTOR DEFICIENCY	0.00378788	0.09348134630077397
MACULAR CORNEAL DYSTROPHY	0.00378788	0.09348134630077397
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.09348134630077397
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.09348134630077397
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.09348134630077397
COUMARIN RESISTANCE	0.00378788	0.09348134630077397
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.09348134630077397
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.09348134630077397
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.09348134630077397
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.09348134630077397
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.09348134630077397
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.09348134630077397
CARBOXYLESTERASE 1	0.00378788	0.09348134630077397
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.09348134630077397
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.09348134630077397
BEETURIA	0.00378788	0.09348134630077397
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.09348134630077397
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.09348134630077397
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.09348134630077397
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.09348134630077397
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.09348134630077397
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.09348134630077397
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.09348134630077397
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.09348134630077397
CALVARIAL HYPEROSTOSIS	0.00378788	0.09348134630077397
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.09348134630077397
PACMAN DYSPLASIA	0.00378788	0.09348134630077397
OVARIAN CANCER	0.00378788	0.09348134630077397
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.09348134630077397
FINGERPRINT BODY MYOPATHY	0.00378788	0.09348134630077397
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.09348134630077397
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.09348134630077397
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.09348134630077397
ICHTHYOSIS, X-LINKED	0.00378788	0.09348134630077397
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.09348134630077397
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.09348134630077397
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.09348134630077397
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.09348134630077397
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.09348134630077397
XM SYSTEM	0.00378788	0.09348134630077397
DELETED IN AZOOSPERMIA	0.00378788	0.09348134630077397
GONADOBLASTOMA	0.00378788	0.09348134630077397
ONCOCYTOMA	0.00378788	0.09348134630077397
MACROCYTOSIS, FAMILIAL	0.00378788	0.09348134630077397
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.09348134630077397
APOLIPOPROTEIN(A)	0.00378788	0.09348134630077397
SCHIZOPHRENIA 4	0.00378788	0.09348134630077397
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.09348134630077397
TRISOMY 18-LIKE SYNDROME	0.00378788	0.09348134630077397
ZINC, ELEVATED PLASMA	0.00378788	0.09348134630077397
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.09348134630077397
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.09348134630077397
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.09348134630077397
CITRULLINE TRANSPORT DEFECT	0.00378788	0.09348134630077397
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.09348134630077397
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.09348134630077397
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.09348134630077397
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.09348134630077397
AREDYLD	0.00378788	0.09348134630077397
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.09348134630077397
HYPOASCORBEMIA	0.00378788	0.09348134630077397
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.09348134630077397
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.09348134630077397
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.09348134630077397
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.09348134630077397
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.09348134630077397
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.09348134630077397
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.09348134630077397
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.09348134630077397
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.09348134630077397
LYMPHOKINE DEFICIENCY	0.00378788	0.09348134630077397
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.09348134630077397
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.09348134630077397
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.09348134630077397
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.09348134630077397
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	0.09348134630077397
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.09348134630077397
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.09348134630077397
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.09348134630077397
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.09348134630077397
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.09348134630077397
LIPASE DEFICIENCY, COMBINED	0.00378788	0.09348134630077397
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.09348134630077397
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.09348134630077397
ACETYLATION, SLOW	0.00378788	0.09348134630077397
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.09348134630077397
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.09348134630077397
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.09348134630077397
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.09348134630077397
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.09348134630077397
ALKAPTONURIA	0.00378788	0.09348134630077397
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.09348134630077397
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.09348134630077397
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.09348134630077397
OSTEOGENIC SARCOMA	0.00378788	0.09348134630077397
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.09348134630077397
ETHANOLAMINOSIS	0.00378788	0.09348134630077397
SHUKLA-VERNON SYNDROME; SHUVER	0.003782393	0.09334593225725825
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.003782393	0.09334593225725825
HAREL-YOON SYNDROME; HAYOS	0.003765908	0.09293909782909043
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.0037659079999999997	0.09293909782909042
MAJEED SYNDROME	0.00373134	0.09208599182284812
IDIOPATHIC BRONCHIECTASIS	0.00373134	0.09208599182284812
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.00373134	0.09208599182284812
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00373134	0.09208599182284812
REYNOLDS SYNDROME	0.00373134	0.09208599182284812
KERION CELSI	0.00373134	0.09208599182284812
REACTIVE ARTHRITIS	0.00373134	0.09208599182284812
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.00373134	0.09208599182284812
JUVENILE IDIOPATHIC ARTHRITIS	0.00373134	0.09208599182284812
CONGENITAL PRIMARY MEGAURETER	0.00373134	0.09208599182284812
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00373134	0.09208599182284812
HEREDITARY ELLIPTOCYTOSIS	0.00373134	0.09208599182284812
PSORIASIS 14, PUSTULAR	0.00373134	0.09208599182284812
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.09208599182284812
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.00373134	0.09208599182284812
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.00373134	0.09208599182284812
NEPHROBLASTOMA	0.00373134	0.09208599182284812
PYODERMA GANGRENOSUM	0.00373134	0.09208599182284812
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00373134	0.09208599182284812
BACTERIAL SUSCEPTIBILITY DUE TO TLR SIGNALING PATHWAY DEFICIENCY	0.00373134	0.09208599182284812
CYCLIC NEUTROPENIA	0.00373134	0.09208599182284812
POLYEMBRYOMA	0.00373134	0.09208599182284812
TETANUS	0.00373134	0.09208599182284812
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00373134	0.09208599182284812
PANCREATITIS, HEREDITARY	0.00373134	0.09208599182284812
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00373134	0.09208599182284812
PULMONARY BLASTOMA	0.00373134	0.09208599182284812
PYOMYOSITIS	0.00373134	0.09208599182284812
MALAKOPLAKIA	0.00373134	0.09208599182284812
SCHNITZLER SYNDROME	0.00373134	0.09208599182284812
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.00373134	0.09208599182284812
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.00373134	0.09208599182284812
MUCKLE-WELLS SYNDROME	0.00373134	0.09208599182284812
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00373134	0.09208599182284812
DUBIN-JOHNSON SYNDROME	0.00373134	0.09208599182284812
CLASSIC HODGKIN LYMPHOMA	0.00373134	0.09208599182284812
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00373134	0.09208599182284812
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.00373134	0.09208599182284812
CAFFEY DISEASE	0.00373134	0.09208599182284812
AMERICAN TRYPANOSOMIASIS	0.00373134	0.09208599182284812
FOLLICULAR LYMPHOMA	0.00373134	0.09208599182284812
FEVER, FAMILIAL LIFELONG PERSISTENT	0.00373134	0.09208599182284812
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.00373134	0.09208599182284812
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.00373134	0.09208599182284812
CHRONIC GRANULOMATOUS DISEASE	0.00373134	0.09208599182284812
CHOLANGIOCARCINOMA	0.00373134	0.09208599182284812
IMMUNODEFICIENCY 32B; IMD32B	0.00373134	0.09208599182284812
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00373134	0.09208599182284812
TUBERCULOSIS	0.00373134	0.09208599182284812
CIRRHOSIS, FAMILIAL	0.00373134	0.09208599182284812
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.00373134	0.09208599182284812
KAPOSI SARCOMA	0.00373134	0.09208599182284812
OSTEOSARCOMA	0.00373134	0.09208599182284812
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00373134	0.09208599182284812
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00373134	0.09208599182284812
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00373134	0.09208599182284812
DYSTONIA 12; DYT12	0.00373134	0.09208599182284812
CONGENITAL FIBRINOGEN DEFICIENCY	0.00373134	0.09208599182284812
ACUTE MONOBLASTIC LEUKEMIA	0.00373134	0.09208599182284812
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00373134	0.09208599182284812
HALOTHANE HEPATITIS	0.00373134	0.09208599182284812
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00373134	0.09208599182284812
CHRONIC MYELOID LEUKEMIA	0.00373134	0.09208599182284812
PONTIAC FEVER	0.00373134	0.09208599182284812
CINCA SYNDROME; CINCA	0.00373134	0.09208599182284812
TYPHOID	0.00373134	0.09208599182284812
ROTOR SYNDROME	0.00373134	0.09208599182284812
MANTLE CELL LYMPHOMA	0.00373134	0.09208599182284812
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00373134	0.09208599182284812
KLATSKIN TUMOR	0.00373134	0.09208599182284812
CUTANEOUS SMALL VESSEL VASCULITIS	0.00373134	0.09208599182284812
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.09208599182284812
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00373134	0.09208599182284812
MU-HEAVY CHAIN DISEASE	0.00373134	0.09208599182284812
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00373134	0.09208599182284812
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.00373134	0.09208599182284812
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00373134	0.09208599182284812
BUDD-CHIARI SYNDROME	0.00373134	0.09208599182284812
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00373134	0.09208599182284812
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.00373134	0.09208599182284812
HODGKIN LYMPHOMA	0.00373134	0.09208599182284812
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00373134	0.09208599182284812
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00373134	0.09208599182284812
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00373134	0.09208599182284812
PRIMARY SCLEROSING CHOLANGITIS	0.00373134	0.09208599182284812
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.00373134	0.09208599182284812
ADULT IDIOPATHIC NEUTROPENIA	0.00373134	0.09208599182284812
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00373134	0.09208599182284812
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.00373134	0.09208599182284812
RAGWEED SENSITIVITY	0.00373134	0.09208599182284812
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.00373134	0.09208599182284812
STIFF-PERSON SYNDROME; SPS	0.00373134	0.09208599182284812
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.00373134	0.09208599182284812
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00373134	0.09208599182284812
GAMMA-HEAVY CHAIN DISEASE	0.00373134	0.09208599182284812
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00373134	0.09208599182284812
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.00373134	0.09208599182284812
ALPHA-HEAVY CHAIN DISEASE	0.00373134	0.09208599182284812
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00373134	0.09208599182284812
PSEUDODIASTROPHIC DYSPLASIA	0.00373134	0.09208599182284812
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.00373134	0.09208599182284812
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.003711624	0.09159941932750348
17P11.2 MICRODUPLICATION SYNDROME	0.003711624	0.09159941932750348
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003711624	0.09159941932750348
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.003711624	0.09159941932750348
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0037116239999999993	0.09159941932750346
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0037074889999999996	0.09149737138328304
NIJMEGEN BREAKAGE SYNDROME	0.00370628	0.09146753439064399
CRANIOFRONTONASAL DYSPLASIA	0.003691004	0.09109053695511524
DYSTONIA 28, CHILDHOOD-ONSET	0.0036549239999999995	0.09020011619877344
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.003634304	0.0896912338263852
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.003634304	0.0896912338263852
20P12.3 MICRODELETION SYNDROME	0.003605863	0.08898933646687532
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.003585243	0.0884804540944871
GENITOPALATOCARDIAC SYNDROME	0.0035112499999999996	0.08665437585102816
DESANTO-SHINAWI SYNDROME	0.003496613	0.0862931483396486
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.003496613	0.0862931483396486
ATHYREOSIS	0.0034954039999999997	0.08626331134700953
THYROID ECTOPIA	0.0034954039999999997	0.08626331134700953
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0034954039999999997	0.08626331134700953
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0034954039999999997	0.08626331134700953
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0034954039999999997	0.08626331134700953
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.003491269	0.08616126340278911
SANDHOFF DISEASE	0.003491269	0.08616126340278911
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.003491269	0.08616126340278911
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0034759929999999997	0.08578426596726035
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.003474784	0.08575442897462131
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.003474784	0.08575442897462131
COWCHOCK SYNDROME; COWCK	0.003474784	0.08575442897462131
SPASTIC PARAPLEGIA TYPE 2	0.003474784	0.08575442897462131
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.003474784	0.08575442897462131
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.003474784	0.08575442897462131
MYOTONIA PERMANENS	0.003474784	0.08575442897462131
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.003474784	0.08575442897462131
CHANARIN-DORFMAN SYNDROME	0.003474784	0.08575442897462131
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00347222	0.08569115184548437
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00347222	0.08569115184548437
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.003439913	0.08489384521091858
TRANSIENT NEONATAL DIABETES MELLITUS	0.003423428	0.08448701078275077
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.0034234279999999996	0.08448701078275077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.0034234279999999996	0.08448701078275077
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0034234279999999996	0.08448701078275077
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0034234279999999996	0.08448701078275077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.0034234279999999996	0.08448701078275077
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.003419293	0.08438496283853034
THANATOPHORIC DYSPLASIA, TYPE I	0.003300374	0.08145015280739372
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.003300374	0.08145015280739372
OXOGLUTARIC ACIDURIA	0.003300374	0.08145015280739372
DEXTROCARDIA	0.003300374	0.08145015280739372
CHROMOSOME 17P13.1 DELETION SYNDROME	0.003300374	0.08145015280739372
KNOBLOCH SYNDROME	0.003296239	0.08134810486317329
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.003296239	0.08134810486317329
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.003296239	0.08134810486317329
LARGE CONGENITAL MELANOCYTIC NEVUS	0.003296239	0.08134810486317329
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.003296239	0.08134810486317329
MUCOPOLYSACCHARIDOSIS, TYPE II	0.003296239	0.08134810486317329
NEUROFIBROMATOSIS TYPE 1	0.003296239	0.08134810486317329
GAUCHER DISEASE, TYPE IIIC	0.003296239	0.08134810486317329
ALEXANDER DISEASE	0.003296239	0.08134810486317329
MUCOPOLYSACCHARIDOSIS TYPE 1	0.0032797539999999997	0.08094127043500549
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.0032797539999999997	0.08094127043500549
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.0032797539999999997	0.08094127043500549
NEPHRONOPHTHISIS 18; NPHP18	0.0032797539999999997	0.08094127043500549
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.0032797539999999997	0.08094127043500549
FAMILIAL LAMBDOID SYNOSTOSIS	0.0032797539999999997	0.08094127043500549
BIEMOND SYNDROME II	0.0032797539999999997	0.08094127043500549
BIEMOND SYNDROME TYPE 2	0.0032797539999999997	0.08094127043500549
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0032409739999999998	0.07998421619634322
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0032409739999999998	0.07998421619634322
PEROXISOME BIOGENESIS DISORDER 5B	0.0032409739999999998	0.07998421619634322
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.0032409739999999998	0.07998421619634322
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0032409739999999998	0.07998421619634322
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.0032409739999999998	0.07998421619634322
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.0032409739999999998	0.07998421619634322
SPINOCEREBELLAR ATAXIA 5; SCA5	0.0032409739999999998	0.07998421619634322
HUNTINGTON DISEASE; HD	0.003236839	0.0798821682521228
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.003236839	0.0798821682521228
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00316607	0.07813565532236803
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00310937	0.07673635219363802
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00310937	0.07673635219363802
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00310937	0.07673635219363802
MEIER-GORLIN SYNDROME 3; MGORS3	0.00310937	0.07673635219363802
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00310937	0.07673635219363802
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00310937	0.07673635219363802
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00310937	0.07673635219363802
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00310937	0.07673635219363802
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00310937	0.07673635219363802
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0030644440000000004	0.07562762040596033
ROIFMAN-CHITAYAT SYNDROME	0.0030644440000000004	0.07562762040596033
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.0030644440000000004	0.07562762040596033
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.003060309	0.07552557246173988
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.003060309	0.07552557246173988
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.003043824	0.07511873803357208
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.0029551939999999995	0.07293143227873358
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.0029551939999999995	0.07293143227873358
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.0029551939999999995	0.07293143227873358
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.0029551939999999995	0.07293143227873358
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.0029551939999999995	0.07293143227873358
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002951059	0.07282938433451315
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.002951059	0.07282938433451315
CUSHING SYNDROME	0.00294985	0.0727995473418741
SANDHOFF DISEASE	0.00294985	0.0727995473418741
PERINEURAL CYST	0.00294985	0.0727995473418741
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00294985	0.0727995473418741
MYOTONIA FLUCTUANS	0.00294985	0.0727995473418741
SPONDYLOOCULAR SYNDROME; SOS	0.00294985	0.0727995473418741
ISAAC SYNDROME	0.00294985	0.0727995473418741
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00294985	0.0727995473418741
CAMURATI-ENGELMANN DISEASE	0.00294985	0.0727995473418741
ACTH-INDEPENDENT CUSHING SYNDROME	0.00294985	0.0727995473418741
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.00294985	0.0727995473418741
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00294985	0.0727995473418741
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00294985	0.0727995473418741
MUSCLE GLYCOGENOSIS, X-LINKED	0.00294985	0.0727995473418741
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00294985	0.0727995473418741
CHRONIC GRAFT VERSUS HOST DISEASE	0.00294985	0.0727995473418741
GLYCOGEN STORAGE DISEASE VII	0.00294985	0.0727995473418741
STIFF SKIN SYNDROME	0.00294985	0.0727995473418741
MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION	0.00294985	0.0727995473418741
GLYCOGEN STORAGE DISEASE IXB	0.00294985	0.0727995473418741
GLYCOGEN STORAGE DISEASE IV	0.00294985	0.0727995473418741
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00294985	0.0727995473418741
ATAXIA WITH VITAMIN E DEFICIENCY	0.00294985	0.0727995473418741
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00294985	0.0727995473418741
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00294985	0.0727995473418741
GLYCOGEN STORAGE DISEASE V; GSD5	0.00294985	0.0727995473418741
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00294985	0.0727995473418741
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.00294985	0.0727995473418741
SPINAL MUSCULAR ATROPHY, TYPE II	0.00294985	0.0727995473418741
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00294985	0.0727995473418741
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00294985	0.0727995473418741
EPISODIC ATAXIA, TYPE 8	0.00294985	0.0727995473418741
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00294985	0.0727995473418741
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00294985	0.0727995473418741
NOONAN SYNDROME	0.00294985	0.0727995473418741
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00294985	0.0727995473418741
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00294985	0.0727995473418741
EPISODIC ATAXIA TYPE 7	0.00294985	0.0727995473418741
HEMOCHROMATOSIS TYPE 2	0.00294985	0.0727995473418741
POSTPOLIOMYELITIS SYNDROME	0.00294985	0.0727995473418741
159100 MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE	0.00294985	0.0727995473418741
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES	0.00294985	0.0727995473418741
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00294985	0.0727995473418741
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00294985	0.0727995473418741
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00294985	0.0727995473418741
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.00294985	0.0727995473418741
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.00294985	0.0727995473418741
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00294985	0.0727995473418741
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00294985	0.0727995473418741
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00294985	0.0727995473418741
THORACIC OUTLET SYNDROME	0.00294985	0.0727995473418741
MULTIPLE OSTEOCHONDROMAS	0.00294985	0.0727995473418741
POTASSIUM-AGGRAVATED MYOTONIA	0.00294985	0.0727995473418741
BECKER MUSCULAR DYSTROPHY	0.00294985	0.0727995473418741
EVANS SYNDROME	0.00294985	0.0727995473418741
NEUROGENIC THORACIC OUTLET SYNDROME	0.00294985	0.0727995473418741
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00294985	0.0727995473418741
FRIEDREICH ATAXIA	0.00294985	0.0727995473418741
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00294985	0.0727995473418741
EPISODIC ATAXIA, TYPE 7; EA7	0.00294985	0.0727995473418741
JUVENILE PRIMARY LATERAL SCLEROSIS	0.00294985	0.0727995473418741
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.00294985	0.0727995473418741
NEURALGIC AMYOTROPHY	0.00294985	0.0727995473418741
PYLE DISEASE; PYL	0.00294985	0.0727995473418741
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00294985	0.0727995473418741
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00294985	0.0727995473418741
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00294985	0.0727995473418741
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00294985	0.0727995473418741
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00294985	0.0727995473418741
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00294985	0.0727995473418741
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00294985	0.0727995473418741
X-LINKED SIDEROBLASTIC ANEMIA	0.00294985	0.0727995473418741
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00294985	0.0727995473418741
AMYOTROPHIC LATERAL SCLEROSIS 1	0.00294985	0.0727995473418741
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00294985	0.0727995473418741
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00294985	0.0727995473418741
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.00294985	0.0727995473418741
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00294985	0.0727995473418741
%300211 EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX	0.00294985	0.0727995473418741
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00294985	0.0727995473418741
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00294985	0.0727995473418741
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.00294985	0.0727995473418741
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	0.00294985	0.0727995473418741
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00294985	0.0727995473418741
MONOMELIC AMYOTROPHY	0.00294985	0.0727995473418741
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY	0.00294985	0.0727995473418741
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00294985	0.0727995473418741
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.00294985	0.0727995473418741
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.0029345739999999997	0.07242254990634535
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0029345739999999997	0.07242254990634535
CHROMOSOME 13Q14 DELETION SYNDROME	0.0029345739999999997	0.07242254990634535
SAUL-WILSON SYNDROME; SWILS	0.0028984939999999997	0.07153212915000356
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.0028984939999999997	0.07153212915000356
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.0028984939999999997	0.07153212915000356
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.0028984939999999997	0.07153212915000356
NOONAN SYNDROME 6; NS6	0.0028984939999999997	0.07153212915000356
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0028984939999999997	0.07153212915000356
PERMANENT NEONATAL DIABETES MELLITUS	0.0028984939999999997	0.07153212915000356
7P22.1 MICRODUPLICATION SYNDROME	0.0028984939999999997	0.07153212915000356
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0028984939999999997	0.07153212915000356
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.002894359	0.07143008120578313
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.002894359	0.07143008120578313
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.002894359	0.07143008120578313
DYSTONIA 16	0.002877874	0.07102324677761533
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.002877874	0.07102324677761533
MENTAL RETARDATION, X-LINKED 97; MRX97	0.002877874	0.07102324677761533
MENTAL RETARDATION, X-LINKED 19	0.002877874	0.07102324677761533
CARDIAC-UROGENITAL SYNDROME; CUGS	0.002877874	0.07102324677761533
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.002877874	0.07102324677761533
DESBUQUOIS DYSPLASIA 1	0.002877874	0.07102324677761533
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00275482	0.06798638880225828
PYCNODYSOSTOSIS	0.00275482	0.06798638880225828
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00275482	0.06798638880225828
CZEIZEL-LOSONCI SYNDROME	0.00275482	0.06798638880225828
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00275482	0.06798638880225828
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00275482	0.06798638880225828
ABSENT RADIUS-ANOGENITAL ANOMALIES SYNDROME	0.00275482	0.06798638880225828
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00275482	0.06798638880225828
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00275482	0.06798638880225828
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00275482	0.06798638880225828
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00275482	0.06798638880225828
CRANIOFACIAL CONODYSPLASIA	0.00275482	0.06798638880225828
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00275482	0.06798638880225828
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00275482	0.06798638880225828
HB BART'S HYDROPS FETALIS	0.00275482	0.06798638880225828
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00275482	0.06798638880225828
LETHAL OMPHALOCELE-CLEFT PALATE SYNDROME	0.00275482	0.06798638880225828
RADIAL APLASIA, X-LINKED	0.00275482	0.06798638880225828
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00275482	0.06798638880225828
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00275482	0.06798638880225828
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00275482	0.06798638880225828
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00275482	0.06798638880225828
KLEEBLATTSCHAEDEL SYNDROME	0.00275482	0.06798638880225828
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00275482	0.06798638880225828
CAMPOMELIC DYSPLASIA	0.00275482	0.06798638880225828
METATROPIC DYSPLASIA	0.00275482	0.06798638880225828
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.00275482	0.06798638880225828
SPINOCEREBELLAR ATAXIA TYPE 32	0.00269542	0.0665204521912078
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00269542	0.0665204521912078
SCHOLTE SYNDROME; SHLTS	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00269542	0.0665204521912078
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00269542	0.0665204521912078
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.00269542	0.0665204521912078
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA TYPE 26	0.00269542	0.0665204521912078
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 31	0.00269542	0.0665204521912078
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 15	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 32; SCA32	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA TYPE 31	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00269542	0.0665204521912078
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.00269542	0.0665204521912078
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA TYPE 27	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 26	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA TYPE 5	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 14	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 41; SCA41	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 30; SCA30	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00269542	0.0665204521912078
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00269542	0.0665204521912078
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00269542	0.0665204521912078
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00269542	0.0665204521912078
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00269542	0.0665204521912078
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00269542	0.0665204521912078
SPINOCEREBELLAR ATAXIA TYPE 10	0.00269542	0.0665204521912078
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00251889	0.062163856400824884
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00251889	0.062163856400824884
CATEL-MANZKE SYNDROME	0.00251889	0.062163856400824884
COLOBOMA, OCULAR	0.00251889	0.062163856400824884
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	0.00251889	0.062163856400824884
OROFACIODIGITAL SYNDROME XVII	0.00251889	0.062163856400824884
NORMAL PRESSURE HYDROCEPHALUS	0.00251889	0.062163856400824884
MACROCEPHALY, BENIGN FAMILIAL	0.00251889	0.062163856400824884
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00251889	0.062163856400824884
CAMPOMELIC DYSPLASIA	0.00251889	0.062163856400824884
TRISOMY 5P	0.00251889	0.062163856400824884
FRONTOFACIONASAL DYSPLASIA	0.00240964	0.05946766827359815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00240964	0.05946766827359815
GLYCINE ENCEPHALOPATHY	0.00240964	0.05946766827359815
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00240964	0.05946766827359815
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.002368337	0.058448348747567526
3Q29 MICRODUPLICATION SYNDROME	0.002368337	0.058448348747567526
RUVALCABA SYNDROME	0.002368337	0.058448348747567526
CHROMOSOME 1P35 DELETION SYNDROME	0.002368337	0.058448348747567526
FILIPPI SYNDROME	0.002368337	0.058448348747567526
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.002368337	0.058448348747567526
8P11.2 DELETION SYNDROME	0.002368337	0.058448348747567526
22Q11.2 MICRODUPLICATION SYNDROME	0.002368337	0.058448348747567526
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.002368337	0.058448348747567526
COHEN SYNDROME	0.002368337	0.058448348747567526
15Q13.3 MICRODELETION SYNDROME	0.002368337	0.058448348747567526
KBG SYNDROME	0.002368337	0.058448348747567526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.002368337	0.058448348747567526
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.002368337	0.058448348747567526
DPAGT1-CDG	0.002368337	0.058448348747567526
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.002368337	0.058448348747567526
17Q11.2 MICRODUPLICATION SYNDROME	0.002368337	0.058448348747567526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.002368337	0.058448348747567526
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.002368337	0.058448348747567526
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002368337	0.058448348747567526
CHROMOSOME 16P13.3 DELETION SYNDROME	0.002368337	0.058448348747567526
15Q24 MICRODELETION SYNDROME	0.002368337	0.058448348747567526
KABUKI SYNDROME 1	0.002368337	0.058448348747567526
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002368337	0.058448348747567526
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002368337	0.058448348747567526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.002368337	0.058448348747567526
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.002368337	0.058448348747567526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.002368337	0.058448348747567526
RUBINSTEIN-TAYBI SYNDROME	0.002368337	0.058448348747567526
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002368337	0.058448348747567526
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.002368337	0.058448348747567526
15Q14 MICRODELETION SYNDROME	0.002368337	0.058448348747567526
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.002368337	0.058448348747567526
2Q37 MICRODELETION SYNDROME	0.002368337	0.058448348747567526
GLASS SYNDROME	0.002368337	0.058448348747567526
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.002368337	0.058448348747567526
PELIZAEUS-MERZBACHER DISEASE	0.002368337	0.058448348747567526
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002368337	0.058448348747567526
JUVENILE POLYPOSIS OF INFANCY	0.00235294	0.05806836514486813
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00235294	0.05806836514486813
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.00235294	0.05806836514486813
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00235294	0.05806836514486813
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00235294	0.05806836514486813
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00235294	0.05806836514486813
MELNICK-NEEDLES SYNDROME	0.00235294	0.05806836514486813
USHER SYNDROME, TYPE IF	0.00235294	0.05806836514486813
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00235294	0.05806836514486813
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00235294	0.05806836514486813
DYSTONIA 16; DYT16	0.00235294	0.05806836514486813
GLYCOGEN STORAGE DISEASE IXC	0.00235294	0.05806836514486813
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00235294	0.05806836514486813
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00235294	0.05806836514486813
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00235294	0.05806836514486813
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.00235294	0.05806836514486813
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00235294	0.05806836514486813
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00235294	0.05806836514486813
%614990 USHER SYNDROME, TYPE IK; USH1K	0.00235294	0.05806836514486813
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00235294	0.05806836514486813
NEONATAL MARFAN SYNDROME	0.00235294	0.05806836514486813
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00235294	0.05806836514486813
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00235294	0.05806836514486813
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00235294	0.05806836514486813
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00235294	0.05806836514486813
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00235294	0.05806836514486813
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00235294	0.05806836514486813
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00235294	0.05806836514486813
CHST3-RELATED SKELETAL DYSPLASIA	0.00235294	0.05806836514486813
BARTH SYNDROME; BTHS	0.00235294	0.05806836514486813
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00235294	0.05806836514486813
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.00235294	0.05806836514486813
260150 PALANT CLEFT PALATE SYNDROME	0.00235294	0.05806836514486813
OTOONYCHOPERONEAL SYNDROME	0.00235294	0.05806836514486813
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00235294	0.05806836514486813
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00235294	0.05806836514486813
ODONTOCHONDRODYSPLASIA; ODCD	0.00235294	0.05806836514486813
FRANK-TER HAAR SYNDROME; FTHS	0.00235294	0.05806836514486813
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00235294	0.05806836514486813
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00235294	0.05806836514486813
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001843403	0.04549346711482032
DISTAL MONOSOMY 15Q	0.001843403	0.04549346711482032
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001843403	0.04549346711482032
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001843403	0.04549346711482032
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001843403	0.04549346711482032
C SYNDROME	0.001843403	0.04549346711482032
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001843403	0.04549346711482032
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001843403	0.04549346711482032
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001843403	0.04549346711482032
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001843403	0.04549346711482032
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001843403	0.04549346711482032
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001843403	0.04549346711482032
20Q11.2 MICRODUPLICATION SYNDROME	0.001843403	0.04549346711482032
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001843403	0.04549346711482032
DUANE RETRACTION SYNDROME	0.001843403	0.04549346711482032
KBG SYNDROME	0.001843403	0.04549346711482032
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001843403	0.04549346711482032
8P23.1 MICRODELETION SYNDROME	0.001843403	0.04549346711482032
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001843403	0.04549346711482032
ALG3-CDG	0.001843403	0.04549346711482032
ALG1-CDG	0.001843403	0.04549346711482032
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001843403	0.04549346711482032
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001843403	0.04549346711482032
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001843403	0.04549346711482032
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.001826918	0.04508663268665252
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001826918	0.04508663268665252
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001826918	0.04508663268665252
TOWNES-BROCKS SYNDROME 1; TBS1	0.001826918	0.04508663268665252
LIG4 SYNDROME	0.001826918	0.04508663268665252
PENTASOMY X	0.001826918	0.04508663268665252
FETAL TRIMETHADIONE SYNDROME	0.001826918	0.04508663268665252
PHENOBARBITAL EMBRYOPATHY	0.001826918	0.04508663268665252
3Q29 MICRODELETION SYNDROME	0.001826918	0.04508663268665252
17Q21.31 MICRODUPLICATION SYNDROME	0.001826918	0.04508663268665252
HYPERTRICHOSIS CUBITI	0.001826918	0.04508663268665252
TRISOMY 9P	0.001826918	0.04508663268665252
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001826918	0.04508663268665252
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001826918	0.04508663268665252
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001826918	0.04508663268665252
MIETENS SYNDROME	0.001826918	0.04508663268665252
EAR-PATELLA-SHORT STATURE SYNDROME	0.001826918	0.04508663268665252
ALAZAMI-YUAN SYNDROME	0.001826918	0.04508663268665252
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.001826918	0.04508663268665252
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001826918	0.04508663268665252
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001826918	0.04508663268665252
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.001826918	0.04508663268665252
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.001826918	0.04508663268665252
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001826918	0.04508663268665252
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001826918	0.04508663268665252
WARSAW BREAKAGE SYNDROME; WABS	0.001826918	0.04508663268665252
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.001826918	0.04508663268665252
RING CHROMOSOME 14 SYNDROME	0.001826918	0.04508663268665252
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001826918	0.04508663268665252
SECKEL SYNDROME 8; SCKL8	0.0018269179999999999	0.04508663268665252
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.0018269179999999999	0.04508663268665252
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0018269179999999999	0.04508663268665252
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0018269179999999999	0.04508663268665252
LOWRY-MACLEAN SYNDROME	0.0018269179999999999	0.04508663268665252
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.0018269179999999999	0.04508663268665252
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0018269179999999999	0.04508663268665252
BETA-UREIDOPROPIONASE DEFICIENCY	0.0018269179999999999	0.04508663268665252
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.0018269179999999999	0.04508663268665252
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.0018269179999999999	0.04508663268665252
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0018269179999999999	0.04508663268665252
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0018269179999999999	0.04508663268665252
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.0018227830000000001	0.04498458474243209
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.0018227830000000001	0.04498458474243209
MOYNAHAN SYNDROME	0.0018227830000000001	0.04498458474243209
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.0018227830000000001	0.04498458474243209
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.0018227830000000001	0.04498458474243209
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0018227830000000001	0.04498458474243209
INCONTINENTIA PIGMENTI; IP	0.0018227830000000001	0.04498458474243209
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0018227830000000001	0.04498458474243209
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.0018227830000000001	0.04498458474243209
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0018227830000000001	0.04498458474243209
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0018227830000000001	0.04498458474243209
ANGELMAN SYNDROME (TYPE 1)	0.0018227830000000001	0.04498458474243209
DISTAL TRISOMY 15Q	0.0018227830000000001	0.04498458474243209
ANGELMAN SYNDROME (TYPE 2)	0.0018227830000000001	0.04498458474243209
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0018227830000000001	0.04498458474243209
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.0018227830000000001	0.04498458474243209
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.0018227830000000001	0.04498458474243209
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0018227830000000001	0.04498458474243209
CONGENITAL RUBELLA SYNDROME	0.0018227830000000001	0.04498458474243209
TYROSINEMIA TYPE 2	0.0018227830000000001	0.04498458474243209
RENPENNING SYNDROME	0.0018227830000000001	0.04498458474243209
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.0018227830000000001	0.04498458474243209
WOLF-HIRSCHHORN SYNDROME	0.0018227830000000001	0.04498458474243209
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001822783	0.04498458474243209
TETRASOMY 18P	0.001822783	0.04498458474243209
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001611907	0.03978036169879766
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001611907	0.03978036169879766
SEVERE CANAVAN DISEASE	0.001611907	0.03978036169879766
15Q11Q13 MICRODUPLICATION SYNDROME	0.001611907	0.03978036169879766
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001611907	0.03978036169879766
11P15.4 MICRODUPLICATION SYNDROME	0.001611907	0.03978036169879766
HYPERPROLINEMIA, TYPE I	0.001611907	0.03978036169879766
ELEJALDE DISEASE	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001611907	0.03978036169879766
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001611907	0.03978036169879766
MENTAL RETARDATION, X-LINKED 88	0.001611907	0.03978036169879766
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001611907	0.03978036169879766
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001611907	0.03978036169879766
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001611907	0.03978036169879766
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001611907	0.03978036169879766
GRISCELLI SYNDROME, TYPE 1	0.001611907	0.03978036169879766
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001611907	0.03978036169879766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001611907	0.03978036169879766
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001611907	0.03978036169879766
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001611907	0.03978036169879766
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001611907	0.03978036169879766
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001611907	0.03978036169879766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001611907	0.03978036169879766
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001611907	0.03978036169879766
MENTAL RETARDATION, X-LINKED 72	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001611907	0.03978036169879766
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001611907	0.03978036169879766
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001611907	0.03978036169879766
MAPLE SYRUP URINE DISEASE	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001611907	0.03978036169879766
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001611907	0.03978036169879766
HARTNUP DISEASE	0.0016119069999999999	0.03978036169879765
LEIGH SYNDROME; LS	0.0016119069999999999	0.03978036169879765
PRADER-WILLI-LIKE SYNDROME	0.0016119069999999999	0.03978036169879765
CHROMOSOME 5Q12 DELETION SYNDROME	0.0016119069999999999	0.03978036169879765
DISTAL 16P11.2 MICRODELETION SYNDROME	0.0016119069999999999	0.03978036169879765
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0016119069999999999	0.03978036169879765
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0016119069999999999	0.03978036169879765
DISTAL MONOSOMY 19P13.3	0.0016119069999999999	0.03978036169879765
WILSON-TURNER SYNDROME	0.0016119069999999999	0.03978036169879765
POTOCKI-SHAFFER SYNDROME	0.0016119069999999999	0.03978036169879765
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0016119069999999999	0.03978036169879765
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.0016119069999999999	0.03978036169879765
IMMUNODEFICIENCY 49; IMD49	0.0016119069999999999	0.03978036169879765
MOSAIC TRISOMY 14	0.0016119069999999999	0.03978036169879765
FREE SIALIC ACID STORAGE DISEASE	0.0016119069999999999	0.03978036169879765
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0016119069999999999	0.03978036169879765
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0016119069999999999	0.03978036169879765
RECOMBINANT 8 SYNDROME	0.0016119069999999999	0.03978036169879765
FETAL HYDANTOIN SYNDROME	0.001301984	0.03213175105390532
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.03213175105390532
BARATELA-SCOTT SYNDROME	0.001301984	0.03213175105390532
HOLMES-GANG SYNDROME	0.001301984	0.03213175105390532
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.001301984	0.03213175105390532
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.03213175105390532
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.03213175105390532
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.03213175105390532
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.03213175105390532
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.03213175105390532
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.001301984	0.03213175105390532
6Q16 MICRODELETION SYNDROME	0.001301984	0.03213175105390532
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.001301984	0.03213175105390532
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001301984	0.03213175105390532
TOLUENE EMBRYOPATHY	0.001301984	0.03213175105390532
RING CHROMOSOME 12 SYNDROME	0.001301984	0.03213175105390532
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.001301984	0.03213175105390532
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.03213175105390532
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.03213175105390532
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.03213175105390532
SAY-BARBER-MILLER SYNDROME	0.001301984	0.03213175105390532
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001301984	0.03213175105390532
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001301984	0.03213175105390532
LIG4 SYNDROME	0.001301984	0.03213175105390532
ALPERS-HUTTENLOCHER SYNDROME	0.001301984	0.03213175105390532
ALAZAMI SYNDROME; ALAZS	0.001301984	0.03213175105390532
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.001301984	0.03213175105390532
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.03213175105390532
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.03213175105390532
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001301984	0.03213175105390532
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.03213175105390532
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.03213175105390532
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.001301984	0.03213175105390532
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.001301984	0.03213175105390532
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.03213175105390532
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.001301984	0.03213175105390532
2Q32Q33 MICRODELETION SYNDROME	0.001301984	0.03213175105390532
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.001301984	0.03213175105390532
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001301984	0.03213175105390532
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.001301984	0.03213175105390532
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.03213175105390532
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.03213175105390532
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.03213175105390532
AL-RAQAD SYNDROME; ARS	0.001301984	0.03213175105390532
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.03213175105390532
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001301984	0.03213175105390532
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001301984	0.03213175105390532
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.03213175105390532
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.032029703109684886
RENIER-GABREELS-JASPER SYNDROME	0.001297849	0.032029703109684886
DUPLICATION/INVERSION 15Q11	0.001297849	0.032029703109684886
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.032029703109684886
WORSTER-DROUGHT SYNDROME	0.001297849	0.032029703109684886
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.001297849	0.032029703109684886
NEVUS COMEDONICUS SYNDROME	0.001297849	0.032029703109684886
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.032029703109684886
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.001297849	0.032029703109684886
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001297849	0.032029703109684886
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.032029703109684886
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.032029703109684886
PERRAULT SYNDROME 3	0.001297849	0.032029703109684886
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001297849	0.032029703109684886
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001297849	0.032029703109684886
KLEEFSTRA SYNDROME	0.001297849	0.032029703109684886
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001297849	0.032029703109684886
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.001297849	0.032029703109684886
BRANCHIOSKELETOGENITAL SYNDROME	0.001297849	0.032029703109684886
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.001297849	0.032029703109684886
BARTSOCAS-PAPAS SYNDROME	0.0012813640000000001	0.031622868681517084
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0012813640000000001	0.031622868681517084
MICROCEPHALY-CARDIOMYOPATHY	0.0012813640000000001	0.031622868681517084
WAGR SYNDROME	0.0012813640000000001	0.031622868681517084
FEINGOLD SYNDROME	0.0012813640000000001	0.031622868681517084
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0012813640000000001	0.031622868681517084
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.0012813640000000001	0.031622868681517084
WAARDENBURG SYNDROME TYPE 3	0.0012813640000000001	0.031622868681517084
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.0012813640000000001	0.031622868681517084
COFFIN-SIRIS SYNDROME 10; CSS10	0.0012813640000000001	0.031622868681517084
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.0012813640000000001	0.031622868681517084
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.0012813640000000001	0.031622868681517084
OCULOPALATOCEREBRAL SYNDROME	0.0012813640000000001	0.031622868681517084
NIJMEGEN BREAKAGE SYNDROME	0.0012813640000000001	0.031622868681517084
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0012813640000000001	0.031622868681517084
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0012813640000000001	0.031622868681517084
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0012813640000000001	0.031622868681517084
PSEUDOPROGERIA SYNDROME	0.0012813640000000001	0.031622868681517084
FACIOCARDIOMELIC SYNDROME	0.0012813640000000001	0.031622868681517084
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.0012813640000000001	0.031622868681517084
FEINGOLD SYNDROME 2; FGLDS2	0.0012813640000000001	0.031622868681517084
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.0012813640000000001	0.031622868681517084
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.0012813640000000001	0.031622868681517084
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.0012813640000000001	0.031622868681517084
MUCOLIPIDOSIS TYPE IV	0.0012813640000000001	0.031622868681517084
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0012813640000000001	0.031622868681517084
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.0012813640000000001	0.031622868681517084
MMEP SYNDROME	0.0012813640000000001	0.031622868681517084
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.0012813640000000001	0.031622868681517084
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.0012813640000000001	0.031622868681517084
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.0012813640000000001	0.031622868681517084
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0012813640000000001	0.031622868681517084
PIEBALDISM	0.0012813640000000001	0.031622868681517084
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.0012813640000000001	0.031622868681517084
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.0012813640000000001	0.031622868681517084
BARDET-BIEDL SYNDROME 20	0.0012813640000000001	0.031622868681517084
CHROMOSOME XP11.3 DELETION SYNDROME	0.0012813640000000001	0.031622868681517084
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0012813640000000001	0.031622868681517084
MENTAL RETARDATION, X-LINKED 63	0.0012813640000000001	0.031622868681517084
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.0012813640000000001	0.031622868681517084
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0012813640000000001	0.031622868681517084
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0012813640000000001	0.031622868681517084
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0012813640000000001	0.031622868681517084
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.0012813640000000001	0.031622868681517084
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0012813640000000001	0.031622868681517084
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0012813640000000001	0.031622868681517084
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0012813640000000001	0.031622868681517084
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.0012813640000000001	0.031622868681517084
GERODERMA OSTEODYSPLASTICUM; GO	0.0012813640000000001	0.031622868681517084
15Q24 RECURRENT MICRODELETION SYNDROME	0.0012813640000000001	0.031622868681517084
FANCONI ANEMIA	0.0012813640000000001	0.031622868681517084
2P15-16.1 MICRODELETION SYNDROME	0.0012813640000000001	0.031622868681517084
MEIER-GORLIN SYNDROME 1; MGORS1	0.0012813640000000001	0.031622868681517084
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.0012813640000000001	0.031622868681517084
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.0012813640000000001	0.031622868681517084
LARYNGEAL ABDUCTOR PARALYSIS	0.0012813640000000001	0.031622868681517084
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0012813640000000001	0.031622868681517084
MONOSOMY 22	0.0012813640000000001	0.031622868681517084
CRI DU CHAT SYNDROME (5P DELETION)	0.0012813640000000001	0.031622868681517084
FEINGOLD SYNDROME 1; FGLDS1	0.0012813640000000001	0.031622868681517084
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.0012813640000000001	0.031622868681517084
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0012813640000000001	0.031622868681517084
RUVALCABA SYNDROME	0.0012813640000000001	0.031622868681517084
FRYNS-SMEETS-THIRY SYNDROME	0.0012813640000000001	0.031622868681517084
FRASER SYNDROME	0.0012813640000000001	0.031622868681517084
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.0012813640000000001	0.031622868681517084
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0012813640000000001	0.031622868681517084
207790 ARACHNOID CYSTS, INTRACRANIAL	0.0012813640000000001	0.031622868681517084
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.0012813640000000001	0.031622868681517084
VELOCARDIOFACIAL SYNDROME	0.0012813640000000001	0.031622868681517084
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.0012813640000000001	0.031622868681517084
9Q SUBTELOMERIC DELETION SYNDROME	0.0012813640000000001	0.031622868681517084
ACHALASIA-MICROCEPHALY SYNDROME	0.0012813640000000001	0.031622868681517084
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.0012813640000000001	0.031622868681517084
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0012813640000000001	0.031622868681517084
JOHANSON-BLIZZARD SYNDROME	0.0012813640000000001	0.031622868681517084
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.0012813640000000001	0.031622868681517084
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.0012813640000000001	0.031622868681517084
ACHALASIA-MICROCEPHALY SYNDROME	0.0012813640000000001	0.031622868681517084
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.0012813640000000001	0.031622868681517084
JOHANSON-BLIZZARD SYNDROME; JBS	0.0012813640000000001	0.031622868681517084
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.02682548006605045
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.02682548006605045
TRISOMY X	0.001086973	0.02682548006605045
KEUTEL SYNDROME	0.001086973	0.02682548006605045
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.02682548006605045
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.02682548006605045
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.02682548006605045
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.02682548006605045
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.02682548006605045
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.02682548006605045
ISOVALERIC ACIDEMIA	0.001086973	0.02682548006605045
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.02682548006605045
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.02682548006605045
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.02682548006605045
TAY-SACHS DISEASE	0.001086973	0.02682548006605045
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.02682548006605045
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.02682548006605045
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.02682548006605045
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.02682548006605045
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.02682548006605045
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.02682548006605045
CANAVAN DISEASE	0.001086973	0.02682548006605045
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.02682548006605045
HARTNUP DISORDER	0.001086973	0.02682548006605045
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.02682548006605045
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.02682548006605045
SCHINDLER DISEASE, TYPE I	0.001086973	0.02682548006605045
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.02682548006605045
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.02682548006605045
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.02682548006605045
FUCOSIDOSIS	0.001086973	0.02682548006605045
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.02682548006605045
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.02682548006605045
DIGEORGE SYNDROME; DGS	0.001086973	0.02682548006605045
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.02682548006605045
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.02682548006605045
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.02682548006605045
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.02682548006605045
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.02682548006605045
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.02682548006605045
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.02682548006605045
SULFOCYSTEINURIA	0.001086973	0.02682548006605045
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.02682548006605045
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.02682548006605045
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.02682548006605045
AU-KLINE SYNDROME; AUKS	0.001070488	0.026418645637882647
BARDET-BIEDL SYNDROME 3; BBS3	0.001070488	0.026418645637882647
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001070488	0.026418645637882647
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001070488	0.026418645637882647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.001070488	0.026418645637882647
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.001070488	0.026418645637882647
GERMAN SYNDROME	0.001070488	0.026418645637882647
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.001070488	0.026418645637882647
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.001070488	0.026418645637882647
WEAVER SYNDROME	0.001070488	0.026418645637882647
FARBER DISEASE	0.001070488	0.026418645637882647
CHROMOSOME 15Q14 DELETION SYNDROME	0.001070488	0.026418645637882647
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.001070488	0.026418645637882647
RICHARDS-RUNDLE SYNDROME; RRNS	0.001070488	0.026418645637882647
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.001070488	0.026418645637882647
LAMB-SHAFFER SYNDROME	0.001070488	0.026418645637882647
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.001070488	0.026418645637882647
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001070488	0.026418645637882647
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.001070488	0.026418645637882647
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001070488	0.026418645637882647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.001070488	0.026418645637882647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.001070488	0.026418645637882647
PERIPHERAL HYPOTHYROIDISM	0.001070488	0.026418645637882647
ISOLATED PLAGIOCEPHALY	0.001070488	0.026418645637882647
IMMUNODEFICIENCY 23; IMD23	0.001070488	0.026418645637882647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.001070488	0.026418645637882647
CHROMOSOME 18P DELETION SYNDROME	0.001070488	0.026418645637882647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.001070488	0.026418645637882647
PRIMARY CONGENITAL HYPOTHYROIDISM	0.001070488	0.026418645637882647
PERMANENT CONGENITAL HYPOTHYROIDISM	0.001070488	0.026418645637882647
BARDET-BIEDL SYNDROME 2	0.001070488	0.026418645637882647
BARDET-BIEDL SYNDROME 8; BBS8	0.001070488	0.026418645637882647
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.001070488	0.026418645637882647
BARDET-BIEDL SYNDROME 13; BBS13	0.001070488	0.026418645637882647
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.001070488	0.026418645637882647
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.001070488	0.026418645637882647
MACROCEPHALY/AUTISM SYNDROME	0.001070488	0.026418645637882647
BARDET-BIEDL SYNDROME 14; BBS14	0.001070488	0.026418645637882647
BARDET-BIEDL SYNDROME 16; BBS16	0.001070488	0.026418645637882647
CREE MENTAL RETARDATION SYNDROME	0.001070488	0.026418645637882647
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.001070488	0.026418645637882647
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.001070488	0.026418645637882647
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.001070488	0.026418645637882647
NOONAN SYNDROME 5; NS5	0.001070488	0.026418645637882647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.001070488	0.026418645637882647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.001070488	0.026418645637882647
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.001070488	0.026418645637882647
CHROMOSOME 9P DELETION SYNDROME	0.001070488	0.026418645637882647
CHOPS SYNDROME; CHOPS	0.001070488	0.026418645637882647
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.001070488	0.026418645637882647
16P13.11 MICRODUPLICATION SYNDROME	0.001070488	0.026418645637882647
JOUBERT SYNDROME 28	0.001070488	0.026418645637882647
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.001070488	0.026418645637882647
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.001070488	0.026418645637882647
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001070488	0.026418645637882647
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.001070488	0.026418645637882647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.001070488	0.026418645637882647
OCULOFACIOCARDIODENTAL SYNDROME	0.001070488	0.026418645637882647
TRISOMY 12P	0.001070488	0.026418645637882647
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.001070488	0.026418645637882647
MCKUSICK-KAUFMAN SYNDROME	0.001070488	0.026418645637882647
OTOFACIOCERVICAL SYNDROME	0.001070488	0.026418645637882647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.001070488	0.026418645637882647
DISTAL MONOSOMY 9P	0.001070488	0.026418645637882647
FAMILIAL THYROID DYSHORMONOGENESIS	0.001070488	0.026418645637882647
ELSAHY-WATERS SYNDROME; ESWS	0.001070488	0.026418645637882647
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.001070488	0.026418645637882647
8P23.1 DUPLICATION SYNDROME	0.001070488	0.026418645637882647
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.001070488	0.026418645637882647
3MC SYNDROME 2	0.001070488	0.026418645637882647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001070488	0.026418645637882647
PEROXISOME BIOGENESIS DISORDER 3B	0.001070488	0.026418645637882647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001070488	0.026418645637882647
ALDH18A1-RELATED DE BARSY SYNDROME	0.001070488	0.026418645637882647
ARTERIAL TORTUOSITY SYNDROME	0.001070488	0.026418645637882647
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001070488	0.026418645637882647
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.001070488	0.026418645637882647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.001070488	0.026418645637882647
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001070488	0.026418645637882647
OPITZ G/BBB SYNDROME	0.001070488	0.026418645637882647
N SYNDROME	0.001070488	0.026418645637882647
MENTAL RETARDATION, X-LINKED 107; MRX107	0.001070488	0.026418645637882647
PERLMAN SYNDROME	0.001070488	0.026418645637882647
COHEN-GIBSON SYNDROME; COGIS	0.001070488	0.026418645637882647
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.001070488	0.026418645637882647
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.001070488	0.026418645637882647
RAHMAN SYNDROME	0.001070488	0.026418645637882647
MENTAL RETARDATION, X-LINKED 41	0.001070488	0.026418645637882647
ALPHA-MANNOSIDOSIS	0.001070488	0.026418645637882647
SHWACHMAN-DIAMOND SYNDROME	0.001070488	0.026418645637882647
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.001070488	0.026418645637882647
MENTAL RETARDATION, X-LINKED 99	0.001070488	0.026418645637882647
BARDET-BIEDL SYNDROME 1; BBS1	0.001070488	0.026418645637882647
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.001066353	0.026316597693662208
HYPERLYSINEMIA, TYPE I	0.001066353	0.026316597693662208
AUTISM, SUSCEPTIBILITY TO, 18	0.001066353	0.026316597693662208
OHDO SYNDROME	0.001066353	0.026316597693662208
HEREDITARY HYPEREKPLEXIA	0.001066353	0.026316597693662208
DERMOTRICHIC SYNDROME	0.001066353	0.026316597693662208
MOMO SYNDROME	0.001066353	0.026316597693662208
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.001066353	0.026316597693662208
GLUTATHIONE SYNTHETASE DEFICIENCY	0.001066353	0.026316597693662208
RAMON SYNDROME	0.001066353	0.026316597693662208
RAMON SYNDROME	0.001066353	0.026316597693662208
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.001066353	0.026316597693662208
MENTAL RETARDATION, FRA12A TYPE	0.001066353	0.026316597693662208
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.001066353	0.026316597693662208
NOONAN SYNDROME 7; NS7	0.001066353	0.026316597693662208
CROUZON SYNDROME	0.001066353	0.026316597693662208
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001066353	0.026316597693662208
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.001066353	0.026316597693662208
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.001066353	0.026316597693662208
BETA-MANNOSIDOSIS	0.001066353	0.026316597693662208
ASPARTYLGLUCOSAMINURIA	0.001066353	0.026316597693662208
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.001066353	0.026316597693662208
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.001066353	0.026316597693662208
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.001066353	0.026316597693662208
COWDEN SYNDROME 6; CWS6	0.001066353	0.026316597693662208
GALACTOSIALIDOSIS	0.001066353	0.026316597693662208
1P36 MICRODELETION SYNDROME	0.001066353	0.026316597693662208
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.001066353	0.026316597693662208
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.026316597693662208
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.001066353	0.026316597693662208
COWDEN SYNDROME 5; CWS5	0.001066353	0.026316597693662208
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.001066353	0.026316597693662208
HYPERPROLINEMIA, TYPE II	0.001066353	0.026316597693662208
PROTEUS SYNDROME	0.001066353	0.026316597693662208
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.001066353	0.026316597693662208
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.001066353	0.026316597693662208
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.001066353	0.026316597693662208
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.001066353	0.026316597693662208
RING CHROMOSOME 10 SYNDROME	0.001066353	0.026316597693662208
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.001066353	0.026316597693662208
DYSEQUILIBRIUM SYNDROME	0.001066353	0.026316597693662208
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.001066353	0.026316597693662208
CYSTATHIONINURIA	0.001066353	0.026316597693662208
MENTAL RETARDATION, X-LINKED 82	0.001066353	0.026316597693662208
311450 PALLISTER W SYNDROME;;W SYNDROME	0.001066353	0.026316597693662208
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.001066353	0.026316597693662208
FOUNTAIN SYNDROME	0.001066353	0.026316597693662208
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001066353	0.026316597693662208
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.001066353	0.026316597693662208
HADDAD SYNDROME	0.001066353	0.026316597693662208
CLARK-BARAITSER SYNDROME	0.001066353	0.026316597693662208
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.001066353	0.026316597693662208
MENTAL RETARDATION, X-LINKED 96; MRX96	0.001066353	0.026316597693662208
ZIMMERMANN-LABAND SYNDROME	0.001066353	0.026316597693662208
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.001066353	0.026316597693662208
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.001066353	0.026316597693662208
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.001066353	0.026316597693662208
MENTAL RETARDATION, X-LINKED 100	0.001066353	0.026316597693662208
IMMUNODEFICIENCY 47	0.001066353	0.026316597693662208
AUTISM	0.001066353	0.026316597693662208
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.001066353	0.026316597693662208
EPILEPSY-TELANGIECTASIA SYNDROME	0.001066353	0.026316597693662208
SJOGREN-LARSSON SYNDROME; SLS	0.001066353	0.026316597693662208
KIFAFA SEIZURE DISORDER	0.001066353	0.026316597693662208
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.001066353	0.026316597693662208
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.001066353	0.026316597693662208
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.001066353	0.026316597693662208
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.001066353	0.026316597693662208
FOUNTAIN SYNDROME	0.001066353	0.026316597693662208
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.001066353	0.026316597693662208
DYSOSTEOSCLEROSIS	0.001066353	0.026316597693662208
ZLOTOGORA-OGUR SYNDROME	0.001066353	0.026316597693662208
224250 DYSMYELINATION WITH JAUNDICE	0.001066353	0.026316597693662208
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.001066353	0.026316597693662208
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.001066353	0.026316597693662208
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.001066353	0.026316597693662208
POTOCKI-SHAFFER SYNDROME	0.001066353	0.026316597693662208
GURRIERI SYNDROME	0.001066353	0.026316597693662208
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.001066353	0.026316597693662208
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001066353	0.026316597693662208
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.001066353	0.026316597693662208
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.001066353	0.026316597693662208
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.001066353	0.026316597693662208
ACQUIRED PARTIAL LIPODYSTROPHY	0.001066353	0.026316597693662208
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.001066353	0.026316597693662208
ERMINE PHENOTYPE	0.00075643	0.018667987048769877
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.018667987048769877
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00075643	0.018667987048769877
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.018667987048769877
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.018667987048769877
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.018667987048769877
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.018667987048769877
RHIZOMELIC SYNDROME	0.00075643	0.018667987048769877
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00075643	0.018667987048769877
MARTSOLF SYNDROME	0.00075643	0.018667987048769877
DISTAL TRISOMY 5Q	0.00075643	0.018667987048769877
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.018667987048769877
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.018667987048769877
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.018667987048769877
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.018667987048769877
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.018667987048769877
TEEBI-SHALTOUT SYNDROME; TBSH	0.00075643	0.018667987048769877
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.018667987048769877
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.018667987048769877
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.018667987048769877
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.018667987048769877
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.018667987048769877
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00075643	0.018667987048769877
STIMMLER SYNDROME	0.00075643	0.018667987048769877
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.018667987048769877
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00075643	0.018667987048769877
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.018667987048769877
3MC SYNDROME 1	0.00075643	0.018667987048769877
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.018667987048769877
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.018667987048769877
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.018667987048769877
BOWEN-CONRADI SYNDROME	0.00075643	0.018667987048769877
BLOOM SYNDROME	0.00075643	0.018667987048769877
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00075643	0.018667987048769877
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.018667987048769877
PAGOD SYNDROME	0.00075643	0.018667987048769877
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.018667987048769877
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.018667987048769877
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.018667987048769877
HYPERREFLEXIA	0.00075643	0.018667987048769877
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00075643	0.018667987048769877
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.018667987048769877
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.018667987048769877
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.018667987048769877
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.018667987048769877
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.018667987048769877
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.018667987048769877
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00075643	0.018667987048769877
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.018667987048769877
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.018667987048769877
SAY SYNDROME	0.00075643	0.018667987048769877
SATOYOSHI SYNDROME	0.00075643	0.018667987048769877
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.018667987048769877
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.018667987048769877
ADDUCTED THUMBS SYNDROME	0.00075643	0.018667987048769877
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.018667987048769877
WEAVER-WILLIAMS SYNDROME	0.00075643	0.018667987048769877
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.018667987048769877
XK APROSENCEPHALY SYNDROME	0.00075643	0.018667987048769877
OLIVER SYNDROME	0.00075643	0.018667987048769877
POLAND SYNDROME	0.00075643	0.018667987048769877
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.018667987048769877
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.018667987048769877
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.018667987048769877
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.018667987048769877
FETAL METHYLMERCURY SYNDROME	0.00075643	0.018667987048769877
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.018667987048769877
BLOOM SYNDROME	0.00075643	0.018667987048769877
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.018667987048769877
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.018667987048769877
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.018667987048769877
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.018667987048769877
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.018667987048769877
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.018667987048769877
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.018667987048769877
TRISOMY 4P	0.00075643	0.018667987048769877
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.018667987048769877
NON-DISTAL TRISOMY 13Q	0.00075643	0.018667987048769877
NON-DISTAL TRISOMY 10Q	0.00075643	0.018667987048769877
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.018667987048769877
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.018667987048769877
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.018667987048769877
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00075643	0.018667987048769877
VERVERI-BRADY SYNDROME; VERBRAS	0.00075643	0.018667987048769877
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.018667987048769877
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.018667987048769877
RING CHROMOSOME 1 SYNDROME	0.00075643	0.018667987048769877
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.018667987048769877
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.018667987048769877
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.018667987048769877
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.018667987048769877
FAMILIAL VISCERAL MYOPATHY	0.00075643	0.018667987048769877
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.018667987048769877
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.018667987048769877
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.018667987048769877
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.018667987048769877
SECKEL SYNDROME 4	0.00075643	0.018667987048769877
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.018667987048769877
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00075643	0.018667987048769877
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.018667987048769877
MEIER-GORLIN SYNDROME 2; MGORS2	0.00075643	0.018667987048769877
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.018667987048769877
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.018667987048769877
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.018667987048769877
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.018667987048769877
RING CHROMOSOME 6 SYNDROME	0.00075643	0.018667987048769877
XYLT1-CDG	0.00075643	0.018667987048769877
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.018667987048769877
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.018667987048769877
PRIMARY PULMONARY HYPOPLASIA	0.00075643	0.018667987048769877
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.018667987048769877
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.018667987048769877
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00075643	0.018667987048769877
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.01346376400513544
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.01346376400513544
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.01346376400513544
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.01346376400513544
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.01346376400513544
WAARDENBURG-SHAH SYNDROME	0.000545554	0.01346376400513544
TREACHER-COLLINS SYNDROME	0.000545554	0.01346376400513544
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.01346376400513544
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.01346376400513544
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.01346376400513544
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.01346376400513544
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.01346376400513544
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.01346376400513544
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.01346376400513544
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.01346376400513544
CHAR SYNDROME	0.000545554	0.01346376400513544
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.01346376400513544
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.01346376400513544
NOONAN SYNDROME 9; NS9	0.000545554	0.01346376400513544
SENIOR-LOKEN SYNDROME 9	0.000545554	0.01346376400513544
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.01346376400513544
ALG6-CDG	0.000545554	0.01346376400513544
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.01346376400513544
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.01346376400513544
AARSKOG-SCOTT SYNDROME	0.000545554	0.01346376400513544
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.01346376400513544
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.01346376400513544
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.01346376400513544
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.01346376400513544
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.01346376400513544
SENIOR-LOKEN SYNDROME	0.000545554	0.01346376400513544
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.01346376400513544
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.01346376400513544
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.01346376400513544
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.01346376400513544
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.01346376400513544
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.01346376400513544
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.01346376400513544
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.01346376400513544
W SYNDROME	0.000545554	0.01346376400513544
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.01346376400513544
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.01346376400513544
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.01346376400513544
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01346376400513544
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.01346376400513544
16P11.2P12.2 MICRODELETION SYNDROME	0.000545554	0.01346376400513544
X SMALL RINGS	0.000545554	0.01346376400513544
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.01346376400513544
AUSTRALIA ANTIGEN	0.000545554	0.01346376400513544
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01346376400513544
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.01346376400513544
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.01346376400513544
GERODERMA OSTEODYSPLASTICA	0.000545554	0.01346376400513544
CURRARINO SYNDROME	0.000545554	0.01346376400513544
CHAR SYNDROME	0.000545554	0.01346376400513544
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.01346376400513544
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.01346376400513544
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.01346376400513544
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.01346376400513544
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.01346376400513544
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.01346376400513544
MICROVILLUS INCLUSION DISEASE	0.000545554	0.01346376400513544
48,XYYY SYNDROME	0.000545554	0.01346376400513544
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.01346376400513544
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.01346376400513544
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.01346376400513544
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.01346376400513544
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.01346376400513544
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.01346376400513544
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.01346376400513544
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.01346376400513544
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.01346376400513544
TRISOMY 8Q	0.000545554	0.01346376400513544
DISTAL TRISOMY 18Q	0.000545554	0.01346376400513544
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.01346376400513544
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.01346376400513544
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.01346376400513544
PELLAGRA-LIKE SYNDROME	0.000545554	0.01346376400513544
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.01346376400513544
TRANSALDOLASE DEFICIENCY	0.000545554	0.01346376400513544
OROTIC ACIDURIA	0.000545554	0.01346376400513544
TETRASOMY X	0.000545554	0.01346376400513544
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.01346376400513544
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.01346376400513544
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.01346376400513544
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.01346376400513544
CODAS SYNDROME	0.000545554	0.01346376400513544
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.01346376400513544
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.01346376400513544
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.01346376400513544
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.01346376400513544
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.01346376400513544
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.01346376400513544
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.01346376400513544
THYROID HEMIAGENESIS	0.000545554	0.01346376400513544
THYROID HYPOPLASIA	0.000545554	0.01346376400513544
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.01346376400513544
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.01346376400513544
NOONAN SYNDROME 11; NS11	0.000545554	0.01346376400513544
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.01346376400513544
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.01346376400513544
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.01346376400513544
ATELOSTEOGENESIS TYPE III	0.000545554	0.01346376400513544
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.01346376400513544
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.01346376400513544
STEEL SYNDROME; STLS	0.000545554	0.01346376400513544
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.01346376400513544
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.01346376400513544
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.01346376400513544
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.01346376400513544
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.01346376400513544
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.01346376400513544
FRONTOOCULAR SYNDROME	0.000545554	0.01346376400513544
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.01346376400513544
NOONAN SYNDROME 2; NS2	0.000545554	0.01346376400513544
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.01346376400513544
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.01346376400513544
CDAGS SYNDROME	0.000545554	0.01346376400513544
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.01346376400513544
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.01346376400513544
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.01346376400513544
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.01346376400513544
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.01346376400513544
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.01346376400513544
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.01346376400513544
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.01346376400513544
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.01346376400513544
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.01346376400513544
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.01346376400513544
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.01346376400513544
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.01346376400513544
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.01346376400513544
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.01346376400513544
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.01346376400513544
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.01346376400513544
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.01346376400513544
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.01346376400513544
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.01346376400513544
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.01346376400513544
HEREDITARY OROTIC ACIDURIA	0.000545554	0.01346376400513544
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.01346376400513544
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.01346376400513544
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.01346376400513544
NOONAN SYNDROME 3; NS3	0.000545554	0.01346376400513544
FRIAS SYNDROME	0.000545554	0.01346376400513544
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.01346376400513544
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.01346376400513544
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.01346376400513544
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.01346376400513544
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.01346376400513544
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.01346376400513544
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.013361716060915008
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.013361716060915008
THYROCEREBRORENAL SYNDROME	0.000541419	0.013361716060915008
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.013361716060915008
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.013361716060915008
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.013361716060915008
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.013361716060915008
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.013361716060915008
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.013361716060915008
HYPER-BETA-ALANINEMIA	0.000541419	0.013361716060915008
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.013361716060915008
ATAXIA-TELANGIECTASIA	0.000541419	0.013361716060915008
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.013361716060915008
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.013361716060915008
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.013361716060915008
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.013361716060915008
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.013361716060915008
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.013361716060915008
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.013361716060915008
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.013361716060915008
DARIER-WHITE DISEASE; DAR	0.000541419	0.013361716060915008
THREONINEMIA	0.000541419	0.013361716060915008
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.013361716060915008
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.013361716060915008
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.013361716060915008
EPILEPSY, READING	0.000541419	0.013361716060915008
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.013361716060915008
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.013361716060915008
CRANIOSYNOSTOSIS 2	0.000541419	0.013361716060915008
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.013361716060915008
FLYNN-AIRD SYNDROME	0.000541419	0.013361716060915008
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.013361716060915008
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.013361716060915008
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.013361716060915008
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.013361716060915008
ONDINE SYNDROME	0.000541419	0.013361716060915008
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.013361716060915008
HYPOPHOSPHATASIA	0.000541419	0.013361716060915008
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.013361716060915008
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.013361716060915008
CRIGLER-NAJJAR SYNDROME	0.000541419	0.013361716060915008
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.013361716060915008
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.013361716060915008
MPDU1-CDG	0.000541419	0.013361716060915008
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.013361716060915008
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000541419	0.013361716060915008
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.013361716060915008
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.013361716060915008
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.013361716060915008
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.013361716060915008
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.013361716060915008
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.013361716060915008
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.013361716060915008
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.013361716060915008
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000541419	0.013361716060915008
ALG2-CDG	0.000541419	0.013361716060915008
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.013361716060915008
KUFOR-RAKEB SYNDROME	0.000541419	0.013361716060915008
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.013361716060915008
ROMANO-WARD SYNDROME	0.000541419	0.013361716060915008
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.013361716060915008
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.013361716060915008
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.013361716060915008
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.013361716060915008
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000541419	0.013361716060915008
PARIETAL FORAMINA	0.000541419	0.013361716060915008
MOGS-CDG	0.000541419	0.013361716060915008
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.013361716060915008
ALG9-CDG	0.000541419	0.013361716060915008
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.013361716060915008
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.013361716060915008
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.013361716060915008
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.013361716060915008
THYROCEREBRORETINAL SYNDROME	0.000541419	0.013361716060915008
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.013361716060915008
AICA-RIBOSIDURIA	0.000541419	0.013361716060915008
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.013361716060915008
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.013361716060915008
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.013361716060915008
PARTINGTON SYNDROME	0.000541419	0.013361716060915008
CRONKHITE-CANADA SYNDROME	0.000541419	0.013361716060915008
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.013361716060915008
ATKIN-FLAITZ SYNDROME	0.000541419	0.013361716060915008
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.013361716060915008
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.013361716060915008
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.013361716060915008
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.013361716060915008
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.013361716060915008
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.013361716060915008
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.013361716060915008
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.013361716060915008
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.013361716060915008
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.013361716060915008
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.013361716060915008
DIAMINOPENTANURIA	0.000541419	0.013361716060915008
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.013361716060915008
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.013361716060915008
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.013361716060915008
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.013361716060915008
LEIGH SYNDROME	0.000541419	0.013361716060915008
EPISODIC ATAXIA TYPE 3	0.000541419	0.013361716060915008
HYPERPROLINEMIA TYPE 1	0.000541419	0.013361716060915008
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.013361716060915008
CRISPONI SYNDROME	0.000541419	0.013361716060915008
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.013361716060915008
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.013361716060915008
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.013361716060915008
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.013361716060915008
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.013361716060915008
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.013361716060915008
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.013361716060915008
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.013361716060915008
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.013361716060915008
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.013361716060915008
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.013361716060915008
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.013361716060915008
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.013361716060915008
GM1 GANGLIOSIDOSIS	0.000541419	0.013361716060915008
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.013361716060915008
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.013361716060915008
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.013361716060915008
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.013361716060915008
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.013361716060915008
BERNARD-SOULIER SYNDROME	0.000541419	0.013361716060915008
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.013361716060915008
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.013361716060915008
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000541419	0.013361716060915008
CHROMOSOME 17Q12 DELETION SYNDROME	0.000524934	0.012954881632747203
NEUROFACIODIGITORENAL SYNDROME	0.000524934	0.012954881632747203
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.000524934	0.012954881632747203
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.000524934	0.012954881632747203
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.000524934	0.012954881632747203
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.000524934	0.012954881632747203
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.000524934	0.012954881632747203
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000524934	0.012954881632747203
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.000524934	0.012954881632747203
MUCOPOLYSACCHARIDOSIS TYPE 7	0.000524934	0.012954881632747203
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.000524934	0.012954881632747203
CARNOSINEMIA	0.000524934	0.012954881632747203
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.000524934	0.012954881632747203
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.000524934	0.012954881632747203
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.000524934	0.012954881632747203
CUTIS VERTICIS GYRATA AND MENTAL DEFICIENCY	0.000524934	0.012954881632747203
CYSTEINE PEPTIDURIA	0.000524934	0.012954881632747203
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.000524934	0.012954881632747203
LEBER CONGENITAL AMAUROSIS, TYPE I	0.000524934	0.012954881632747203
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.000524934	0.012954881632747203
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.000524934	0.012954881632747203
CAHMR SYNDROME	0.000524934	0.012954881632747203
UNVERRICHT-LUNDBORG DISEASE	0.000524934	0.012954881632747203
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.000524934	0.012954881632747203
PENDRED SYNDROME	0.000524934	0.012954881632747203
MEDNIK SYNDROME	0.000524934	0.012954881632747203
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.000524934	0.012954881632747203
LARSEN SYNDROME	0.000524934	0.012954881632747203
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD	0.000524934	0.012954881632747203
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.000524934	0.012954881632747203
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.000524934	0.012954881632747203
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.000524934	0.012954881632747203
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.000524934	0.012954881632747203
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.000524934	0.012954881632747203
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.000524934	0.012954881632747203
FETAL IODINE SYNDROME	0.000524934	0.012954881632747203
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.000524934	0.012954881632747203
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.000524934	0.012954881632747203
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.000524934	0.012954881632747203
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.000524934	0.012954881632747203
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.000524934	0.012954881632747203
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.000524934	0.012954881632747203
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.000524934	0.012954881632747203
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.000524934	0.012954881632747203
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.000524934	0.012954881632747203
OSTEOGLOSPHONIC DYSPLASIA	0.000524934	0.012954881632747203
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.000524934	0.012954881632747203
3MC SYNDROME	0.000524934	0.012954881632747203
22Q11.2 DISTAL DELETION SYNDROME	0.000524934	0.012954881632747203
15Q26 OVERGROWTH SYNDROME	0.000524934	0.012954881632747203
MEGALENCEPHALY	0.000524934	0.012954881632747203
MCDONOUGH SYNDROME	0.000524934	0.012954881632747203
MATTHEW-WOOD SYNDROME	0.000524934	0.012954881632747203
LEBER OPTIC ATROPHY AND DYSTONIA	0.000524934	0.012954881632747203
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.000524934	0.012954881632747203
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.012954881632747203
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000524934	0.012954881632747203
LAURENCE-MOON SYNDROME	0.000524934	0.012954881632747203
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.000524934	0.012954881632747203
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.000524934	0.012954881632747203
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.000524934	0.012954881632747203
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.000524934	0.012954881632747203
SCARF SYNDROME	0.000524934	0.012954881632747203
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.000524934	0.012954881632747203
16P11.2-P12.2 MICRODELETION SYNDROME	0.000524934	0.012954881632747203
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.012954881632747203
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.000524934	0.012954881632747203
WAGR 11P13 DELETION SYNDROME	0.000524934	0.012954881632747203
NF1-MICRODELETION SYNDROME	0.000524934	0.012954881632747203
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.000524934	0.012954881632747203
ELLIS VAN CREVELD SYNDROME	0.000524934	0.012954881632747203
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.000524934	0.012954881632747203
WILLIAMS-BEUREN SYNDROME (WBS)	0.000524934	0.012954881632747203
22Q11 DUPLICATION SYNDROME	0.000524934	0.012954881632747203
CHILDHOOD ABSENCE EPILEPSY	0.000524934	0.012954881632747203
8P23.1 DELETION SYNDROME	0.000524934	0.012954881632747203
ATR-16 SYNDROME	0.000524934	0.012954881632747203
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.000524934	0.012954881632747203
CAT-EYE SYNDROME (TYPE I)	0.000524934	0.012954881632747203
7Q11.23 DUPLICATION SYNDROME	0.000524934	0.012954881632747203
2Q37 MONOSOMY	0.000524934	0.012954881632747203
PRADER-WILLI SYNDROME (TYPE 2)	0.000524934	0.012954881632747203
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.000524934	0.012954881632747203
ACROGERIA	0.000524934	0.012954881632747203
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.000524934	0.012954881632747203
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.000524934	0.012954881632747203
ARGININOSUCCINIC ACIDURIA	0.000524934	0.012954881632747203
GEMIGNANI SYNDROME	0.000524934	0.012954881632747203
N SYNDROME	0.000524934	0.012954881632747203
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.000524934	0.012954881632747203
%614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	0.000524934	0.012954881632747203
IRIDA SYNDROME	0.000524934	0.012954881632747203
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.000524934	0.012954881632747203
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	0.000524934	0.012954881632747203
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.000524934	0.012954881632747203
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.000524934	0.012954881632747203
DEAFNESS AND MYOPIA; DFNMYP	0.000524934	0.012954881632747203
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.000524934	0.012954881632747203
TELECANTHUS	0.000524934	0.012954881632747203
THUMB DEFORMITY AND ALOPECIA	0.000524934	0.012954881632747203
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.000524934	0.012954881632747203
FACIOCARDIORENAL SYNDROME	0.000524934	0.012954881632747203
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.000524934	0.012954881632747203
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.000524934	0.012954881632747203
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.000524934	0.012954881632747203
OPTIC ATROPHY 2	0.000524934	0.012954881632747203
OROFACIODIGITAL SYNDROME XI; OFD11	0.000524934	0.012954881632747203
CARPENTER SYNDROME	0.000524934	0.012954881632747203
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.000524934	0.012954881632747203
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.000524934	0.012954881632747203
POLYVALVULAR HEART DISEASE SYNDROME	0.000524934	0.012954881632747203
MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	0.000524934	0.012954881632747203
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.000524934	0.012954881632747203
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.000524934	0.012954881632747203
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.000524934	0.012954881632747203
HYPOCHONDROPLASIA	0.000524934	0.012954881632747203
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.000524934	0.012954881632747203
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.000524934	0.012954881632747203
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.000524934	0.012954881632747203
HYPOTRICHOSIS-INTELLECTUAL DISABILITY, LOPES TYPE	0.000524934	0.012954881632747203
MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	0.000524934	0.012954881632747203
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.000524934	0.012954881632747203
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.000524934	0.012954881632747203
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.000524934	0.012954881632747203
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.000524934	0.012954881632747203
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.000524934	0.012954881632747203
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.000524934	0.012954881632747203
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.000524934	0.012954881632747203
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.000524934	0.012954881632747203
X-LINKED INTELLECTUAL DISABILITY-RETINITIS PIGMENTOSA SYNDROME	0.000524934	0.012954881632747203
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.000524934	0.012954881632747203
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.000524934	0.012954881632747203
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.000524934	0.012954881632747203
ISOLATED BRACHYCEPHALY	0.000524934	0.012954881632747203
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.000524934	0.012954881632747203
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.000524934	0.012954881632747203
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.000524934	0.012954881632747203
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.000524934	0.012954881632747203
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.000524934	0.012954881632747203
TRYPTOPHANURIA WITH DWARFISM	0.000524934	0.012954881632747203
TYROSINE TRANSAMINASE DEFICIENCY	0.000524934	0.012954881632747203
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.000524934	0.012954881632747203
BARDET-BIEDL SYNDROME 4; BBS4	0.000524934	0.012954881632747203
BARDET-BIEDL SYNDROME 7; BBS7	0.000524934	0.012954881632747203
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000524934	0.012954881632747203
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.000524934	0.012954881632747203
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	0.000524934	0.012954881632747203
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.000524934	0.012954881632747203
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.000524934	0.012954881632747203
DOWN SYNDROME	0.000524934	0.012954881632747203
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.000524934	0.012954881632747203
PFEIFFER-PALM-TELLER SYNDROME	0.000524934	0.012954881632747203
NOONAN SYNDROME 8; NS8	0.000524934	0.012954881632747203
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.000524934	0.012954881632747203
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.000524934	0.012954881632747203
FRAXE INTELLECTUAL DISABILITY	0.000524934	0.012954881632747203
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.000524934	0.012954881632747203
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.000524934	0.012954881632747203
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.000524934	0.012954881632747203
SPASTIC DIPLEGIA, INFANTILE TYPE	0.000524934	0.012954881632747203
MICROPHTHALMIA, SYNDROMIC 12	0.000524934	0.012954881632747203
RODRIGUES BLINDNESS	0.000524934	0.012954881632747203
SACCHAROPINURIA	0.000524934	0.012954881632747203
COENZYME Q10 DEFICIENCY	0.000524934	0.012954881632747203
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.000524934	0.012954881632747203
BARDET-BIEDL SYNDROME 6; BBS6	0.000524934	0.012954881632747203
SONODA SYNDROME	0.000524934	0.012954881632747203
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.000524934	0.012954881632747203
GRANGE SYNDROME; GRNG	0.000524934	0.012954881632747203
BARDET-BIEDL SYNDROME 9; BBS9	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 23	0.000524934	0.012954881632747203
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 84	0.000524934	0.012954881632747203
SPASTIC PARAPLEGIA-GLAUCOMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.012954881632747203
SOTOS SYNDROME 3	0.000524934	0.012954881632747203
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.000524934	0.012954881632747203
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.000524934	0.012954881632747203
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 95	0.000524934	0.012954881632747203
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.000524934	0.012954881632747203
601095 HARROD SYNDROME	0.000524934	0.012954881632747203
SPONDYLO-OCULAR SYNDROME	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 92	0.000524934	0.012954881632747203
PRADER-WILLI SYNDROME (TYPE 1)	0.000524934	0.012954881632747203
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.000524934	0.012954881632747203
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.000524934	0.012954881632747203
ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	0.000524934	0.012954881632747203
VAN DEN BOSCH SYNDROME	0.000524934	0.012954881632747203
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.000524934	0.012954881632747203
KENNERKNECHT SYNDROME	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 45	0.000524934	0.012954881632747203
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	0.000524934	0.012954881632747203
KEIPERT SYNDROME; KPTS	0.000524934	0.012954881632747203
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 20	0.000524934	0.012954881632747203
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000524934	0.012954881632747203
ALPORT SYNDROME - INTELLECTUAL DISABILITY - MIDFACE HYPOPLASIA - ELLIPTOCYTOSIS	0.000524934	0.012954881632747203
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.000524934	0.012954881632747203
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.000524934	0.012954881632747203
BARDET-BIEDL SYNDROME 19; BBS19	0.000524934	0.012954881632747203
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.000524934	0.012954881632747203
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.012954881632747203
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 53	0.000524934	0.012954881632747203
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 2	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 81	0.000524934	0.012954881632747203
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 46	0.000524934	0.012954881632747203
MENTAL RETARDATION, X-LINKED 77	0.000524934	0.012954881632747203
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.000524934	0.012954881632747203
OSTEOPENIA AND SPARSE HAIR	0.000524934	0.012954881632747203
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.000524934	0.012954881632747203
FRONTOMETAPHYSEAL DYSPLASIA	0.000524934	0.012954881632747203
HYDROXYPROLINEMIA	0.000524934	0.012954881632747203
MONILETHRIX	0.000524934	0.012954881632747203
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.000524934	0.012954881632747203
DESBUQUOIS SYNDROME	0.000524934	0.012954881632747203
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.000524934	0.012954881632747203
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.000524934	0.012954881632747203
FIBULAR HEMIMELIA	0.000524934	0.012954881632747203
HOMOCARNOSINOSIS	0.000524934	0.012954881632747203
HYDROXYLYSINURIA	0.000524934	0.012954881632747203
HYPOCHONDROPLASIA	0.000524934	0.012954881632747203
CARNOSINASE DEFICIENCY	0.000524934	0.012954881632747203
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	0.000524934	0.012954881632747203
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.000524934	0.012954881632747203
LELIS SYNDROME	0.000524934	0.012954881632747203
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.012954881632747203
PERIORAL MYOCLONIA WITH ABSENCES	0.000524934	0.012954881632747203
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.000524934	0.012954881632747203
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.000524934	0.012954881632747203
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.012954881632747203
WEISMANN-NETTER SYNDROME	0.000524934	0.012954881632747203
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.000524934	0.012954881632747203
RING CHROMOSOME 8 SYNDROME	0.000524934	0.012954881632747203
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.000524934	0.012954881632747203
DIBASIC AMINO ACIDURIA I	0.000524934	0.012954881632747203
DICARBOXYLICAMINO ACIDURIA	0.000524934	0.012954881632747203
DYSAUTONOMIA-LIKE DISORDER	0.000524934	0.012954881632747203
ACRODYSOSTOSIS	0.000524934	0.012954881632747203
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.012954881632747203
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.000524934	0.012954881632747203
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.000524934	0.012954881632747203
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.012954881632747203
CRANIODIAPHYSEAL DYSPLASIA	0.000524934	0.012954881632747203
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.000524934	0.012954881632747203
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.000524934	0.012954881632747203
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.000524934	0.012954881632747203
FORMIMINOTRANSFERASE DEFICIENCY	0.000524934	0.012954881632747203
COOPER-JABS SYNDROME	0.000524934	0.012954881632747203
MYOCLONIC-ATONIC EPILEPSY	0.000524934	0.012954881632747203
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.000524934	0.012954881632747203
URBAN-ROGERS-MEYER SYNDROME	0.000524934	0.012954881632747203
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.000524934	0.012954881632747203
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.000524934	0.012954881632747203
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.000524934	0.012954881632747203
BAMFORTH-LAZARUS SYNDROME	0.000524934	0.012954881632747203
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.012954881632747203
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.000524934	0.012954881632747203
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.000524934	0.012954881632747203
METAPHYSEAL ACROSCYPHODYSPLASIA	0.000524934	0.012954881632747203
SUMMITT SYNDROME	0.000524934	0.012954881632747203
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.000524934	0.012954881632747203
METAPHYSEAL ACROSCYPHODYSPLASIA	0.000524934	0.012954881632747203
BJÖRNSTAD SYNDROME	0.000524934	0.012954881632747203
ATKIN-FLAITZ SYNDROME	0.000524934	0.012954881632747203
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.000524934	0.012954881632747203
MORQUIO SYNDROME C	0.000524934	0.012954881632747203
MUCOLIPIDOSIS III ALPHA/BETA	0.000524934	0.012954881632747203
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.000524934	0.012954881632747203
BARDET-BIEDL SYNDROME	0.000524934	0.012954881632747203
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.012954881632747203
OLIVER SYNDROME	0.000524934	0.012954881632747203
OROFACIODIGITAL SYNDROME III	0.000524934	0.012954881632747203
MICROCEPHALY - INTELLECTUAL DISABILITY - PHALANGEAL AND NEUROLOGICAL ANOMALIES	0.000524934	0.012954881632747203
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.000524934	0.012954881632747203
STICKLER SYNDROME TYPE 1	0.000524934	0.012954881632747203
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.000524934	0.012954881632747203
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.000524934	0.012954881632747203
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.000524934	0.012954881632747203
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.000524934	0.012954881632747203
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.000524934	0.012954881632747203
IMINOGLYCINURIA	0.000524934	0.012954881632747203
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.000524934	0.012954881632747203
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.000524934	0.012954881632747203
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.000524934	0.012954881632747203
HEART-HAND SYNDROME TYPE 2	0.000524934	0.012954881632747203
LAMBERT SYNDROME	0.000524934	0.012954881632747203
245800 LAURENCE-MOON SYNDROME	0.000524934	0.012954881632747203
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.000524934	0.012954881632747203
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.000524934	0.012954881632747203
LYSINE MALABSORPTION SYNDROME	0.000524934	0.012954881632747203
3MC SYNDROME 3	0.000524934	0.012954881632747203
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.000524934	0.012954881632747203
RETINITIS PIGMENTOSA	0.000524934	0.012954881632747203
MCDONOUGH SYNDROME	0.000524934	0.012954881632747203
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.000524934	0.012954881632747203
